Nanopremix Revolution: How Nanotechnology Could Transform Livestock Feed Additives and Boost Nutrient Efficiency

Application of Nanotechnology in the Development of Livestock Premix Feed Additives: Fabrication Principles, Characterization, Controlled-Release Mechanisms, and Prospects for Improving Nutrient Efficiency

 

ABSTRACT

 

Improving nutrient utilization efficiency is one of the major challenges facing the modern livestock industry amid the growing demand for sustainable, efficient, and environmentally friendly animal production. Premix feed additives serve as sources of micronutrients, vitamins, minerals, amino acids, enzymes, probiotics, phytobiotics, and other bioactive compounds that are incorporated into animal diets in small quantities to optimize growth performance, health, reproductive capacity, and feed conversion efficiency. However, conventional premixes still face several limitations, including low bioavailability, degradation of active compounds caused by heat, oxidation, moisture, and acidic conditions in the gastrointestinal tract, as well as substantial nutrient losses during feed storage, mixing, and distribution. These limitations may result in a considerable proportion of nutrients being inadequately utilized by animals, thereby reducing their overall biological efficiency (McClements, 2020; Duncan, 2011).

Nanotechnology offers an innovative approach through the engineering of materials at the nanoscale (1–100 nm), which can modify the physicochemical properties of materials without necessarily altering their chemical composition. Particle-size reduction increases specific surface area, accelerates dissolution rates, improves solubility, enhances stability, and may facilitate the interaction of particles with and their transport across the gastrointestinal mucosa. Furthermore, nanoparticles enable the development of nutrient delivery systems with controlled-release properties, protection against gastrointestinal degradation, and enhanced absorption through both transcellular and paracellular pathways. Various carrier matrices, including chitosan, alginate, lipids, silica, zeolites, proteins, and polysaccharides, have been investigated as delivery systems for micronutrients in animal nutrition (Khan et al., 2018; Rai et al., 2021).

This article presents a narrative review that comprehensively examines the development and application of nanotechnology in the production of livestock premix feed additives. The review covers the fundamental principles of nanopremix fabrication using top-down and bottom-up approaches; physicochemical characterization of nanoparticles; laboratory-scale procedures for producing mineral- and vitamin-based nanopremixes; mechanisms governing the release of active compounds; interactions between nanoparticles and the gastrointestinal system; and their potential effects on nutrient bioavailability, feed-use efficiency, gastrointestinal health, immune responses, production performance, and the sustainability of livestock production.

Various studies have indicated that nanopremixes can enhance the absorption efficiency of essential minerals, including zinc (Zn), copper (Cu), iron (Fe), and selenium (Se), while improving the stability of lipophilic vitamins and phytogenic compounds compared with conventional premixes. The use of nanoparticles has also been reported to increase average daily gain (ADG), improve feed conversion ratio (FCR), enhance antioxidant enzyme activity, strengthen intestinal mucosal integrity, and reduce mineral excretion into the environment, thereby supporting the principles of sustainable livestock production (Swain et al., 2015; El Sabry et al., 2022; Yausheva et al., 2018).

Nevertheless, the implementation of nanopremixes at an industrial scale continues to face several challenges, including standardization of manufacturing processes, control of particle-size uniformity, storage stability, safety assessment and nanotoxicological evaluation, regulatory frameworks governing the use of nanomaterials in animal feed, production-cost considerations, and public acceptance of nanotechnology in the livestock sector. Therefore, multidisciplinary research integrating animal nutrition, feed technology, materials science, nanotechnology, toxicology, and process engineering remains essential to develop nanotechnology-based premix systems that are safe, effective, economically viable, and sustainable. This review is expected to provide a scientific reference for researchers, academics, feed manufacturers, and policymakers in the development of next-generation premix feed additives capable of improving livestock production efficiency while simultaneously reducing environmental impacts.

Keywords: nanotechnology; nanopremix; feed additives; bioavailability; controlled release; nanominerals; nanovitamins; animal nutrition; feed efficiency; sustainable livestock production.

 

CHAPTER 1. INTRODUCTION

1.1 Background

1.1.1 The Urgency of Feed Efficiency and the Role of Premix Feed Additives

The global livestock industry is currently facing major challenges in meeting the continuously increasing demand for animal-derived protein, driven by human population growth, urbanization, rising incomes, and changing dietary patterns. The Food and Agriculture Organization of the United Nations (FAO) projects that demand for meat, milk, and other livestock products will continue to increase toward 2050, requiring livestock production systems to produce greater quantities of animal products while using resources more efficiently and sustainably (FAO, 2023). In this context, feed efficiency has become one of the key determinants of livestock production profitability because feed costs may account for approximately 60–80% of total production costs in various poultry, ruminant, and monogastric production systems (Makkar & Beever, 2013).

Feed efficiency describes the ability of animals to convert consumed nutrients into economically valuable biological outputs, such as body weight gain, milk production, egg production, and reproductive performance. Feed efficiency is commonly evaluated using parameters such as the Feed Conversion Ratio (FCR), Feed Efficiency Ratio (FER), and Average Daily Gain (ADG). A lower FCR and a higher ADG generally indicate greater efficiency of the production system (NRC, 2012). Consequently, various nutritional strategies have been continuously developed to improve nutrient utilization and minimize nutrient losses during digestion and metabolism.

One widely adopted approach is the use of feed additives. Feed additives are substances incorporated into animal diets at relatively low concentrations to improve nutritional quality, gastrointestinal health, production performance, metabolic efficiency, feed stability, and the quality of animal-derived products (EFSA, 2021). Unlike major feed ingredients, which primarily serve as sources of energy and protein, feed additives function as bioactive or functional components that optimize nutrient utilization by the animal.

In modern feed manufacturing, feed additives encompass a broad range of active substances, including vitamins, minerals, synthetic amino acids, enzymes, probiotics, prebiotics, synbiotics, phytobiotics, antioxidants, mycotoxin binders, organic acids, and immunomodulators (Windisch et al., 2008). Numerous studies have demonstrated that the appropriate use of feed additives can promote growth, improve intestinal health, reduce oxidative stress, enhance immune responses, and decrease livestock mortality (Gadde et al., 2017).

Most feed additives are marketed in the form of a premix, defined as a homogeneous mixture containing one or more active ingredients combined with a carrier to facilitate uniform distribution throughout the complete feed. Premixes serve as delivery vehicles for essential micronutrients required by animals in relatively small quantities but with critical physiological functions. Without an appropriately formulated premix, the distribution of vitamins and minerals within a diet may become uneven, potentially resulting in nutrient imbalances and impaired production performance (Leeson & Summers, 2008).

Premixes generally contain fat-soluble vitamins (A, D, E, and K), water-soluble vitamins (B-complex vitamins and vitamin C), macro- and trace minerals, essential amino acids, antioxidants, and various other bioactive compounds. These micronutrients function as enzyme cofactors, metabolic regulators, components of the immune system, and modulators of physiological processes that ultimately influence livestock productivity (Underwood & Suttle, 1999).

Trace minerals such as zinc (Zn), copper (Cu), iron (Fe), manganese (Mn), and selenium (Se) are among the most important components of livestock premixes. Zinc is involved in more than 300 enzymatic systems and plays important roles in growth, epithelial integrity, reproduction, and immune function. Selenium is an essential component of glutathione peroxidase and contributes to cellular protection against oxidative damage caused by reactive oxygen species. Copper is involved in energy metabolism, hemoglobin synthesis, and the activity of various oxidative enzymes (Suttle, 2010). Deficiencies of these minerals can lead to impaired growth, reduced fertility, decreased milk or egg production, and increased susceptibility to disease.

In addition to minerals, vitamins play equally important physiological roles. Vitamin A is involved in epithelial cell differentiation and visual function; vitamin D regulates calcium and phosphorus metabolism; vitamin E serves as a major biological antioxidant; and vitamin K is essential for blood coagulation. Vitamin deficiencies can cause a range of metabolic disturbances that directly affect livestock production performance (McDowell, 2000).

Although micronutrient requirements are relatively small compared with those for energy and protein, micronutrient deficiencies can have substantial economic consequences. Therefore, premix formulation represents a critical component of modern feed manufacturing. Nevertheless, conventional premixes continue to face several challenges associated with the stability and bioavailability of their active components.

Many premix components are sensitive to environmental factors such as heat, moisture, light, oxygen, and pH changes. Vitamins A and E, for example, are susceptible to oxidation during feed processing and storage. Similarly, certain minerals can interact with other dietary components, thereby reducing their biological availability upon reaching the gastrointestinal tract (Coelho, 2002). Consequently, a proportion of active ingredients may undergo degradation before they can be effectively utilized by the animal.

In addition to stability-related limitations, the efficiency of micronutrient absorption is frequently a major constraint. Many inorganic minerals exhibit relatively low solubility and tend to form complexes that are poorly absorbed in the gastrointestinal tract. Consequently, a substantial proportion of dietary mineral supplementation may be excreted in feces without being efficiently utilized by the animal (Swain et al., 2015). This phenomenon not only increases feed-related costs but may also contribute to environmental pollution through the accumulation of minerals in soil and water systems.

The limited bioavailability of nutrients has stimulated researchers to develop more effective nutrient-delivery systems. One approach that has developed rapidly over the past two decades is the application of nanotechnology to improve the efficiency of feed additives. This technology enables particle-size engineering at the nanoscale, resulting in a substantial increase in specific surface area and potentially enhancing interactions with biological systems (Khan et al., 2018).

In animal nutrition, nanotechnology has increasingly been investigated to improve mineral solubility, protect vitamins against degradation, control the release of active compounds, and enhance nutrient absorption through the gastrointestinal tract. Several studies have reported that minerals formulated at the nanoscale may exhibit greater absorption efficiency than their conventional counterparts, potentially allowing lower supplementation levels without compromising animal performance (Rajendran, 2013; Swain et al., 2015).

These developments have led to the emergence of the concept of nanopremix, defined as a premix containing nutrients or bioactive ingredients in nanoparticulate form or incorporated into nanoscale delivery systems. Nanopremixes are increasingly regarded as a potential next-generation approach to feed additive technology, with the capacity to improve nutrient efficiency, animal health, and the sustainability of livestock production through the application of advanced materials technology (El Sabry et al., 2022).

With increasing demands for greater production efficiency, reduced reliance on antibiotic growth promoters (AGPs), and the development of more environmentally sustainable livestock production systems, nanopremix technology represents a promising avenue for innovation. Therefore, a comprehensive understanding of the underlying concepts, fabrication methods, physicochemical characteristics, and biological mechanisms of nanopremixes is essential to support their future implementation at an industrial scale in livestock production.

1.1.2 Limitations of Conventional Premixes and Factors Affecting Nutrient Bioavailability

Although premixes have become an integral component of modern animal feed formulations, their biological effectiveness is not always optimal. Numerous studies have demonstrated that not all active ingredients contained in premixes can be efficiently utilized by animals. A proportion of nutrients may undergo degradation during feed manufacturing, storage, transportation, and passage through the gastrointestinal tract, resulting in the amount of nutrients ultimately absorbed by the intestine being substantially lower than the administered dose (McDowell, 2000; Coelho, 2002). This limitation may reduce the efficiency of conventional premix utilization and encourage the use of higher supplementation levels as a safety margin, which ultimately increases feed production costs and may increase nutrient excretion into the environment (Suttle, 2010).

The concept of nutrient bioavailability is an important parameter for evaluating the effectiveness of a premix. Bioavailability can be defined as the proportion of a nutrient that becomes available for absorption, transport, metabolism, and utilization by body tissues following ingestion. Thus, a high nutrient content in a premix does not necessarily translate into optimal physiological benefits when its bioavailability is low (Hurrell & Egli, 2010). In animal nutrition, improving nutrient bioavailability can directly influence growth efficiency, productivity, health status, reproductive performance, and resilience to physiological stress and disease (NRC, 2012).

1.1.3 Nutrient Degradation During Premix Manufacturing and Storage

One of the major limitations of conventional premixes is the relatively low chemical stability of various active ingredients. Vitamins are among the nutrient groups most susceptible to degradation as a result of exposure to elevated temperatures, oxygen, light, trace metals, and moisture during mixing, pelleting, extrusion, and storage (McDowell, 2000). For example, vitamin A is highly susceptible to oxidation, resulting in substantial reductions in biological activity when stored under inadequately protected conditions. Similarly, vitamin E may undergo lipid peroxidation, thereby reducing its antioxidant capacity, whereas vitamin C is highly sensitive to heat and oxygen and may experience substantial losses during feed manufacturing, with losses exceeding 50% under certain processing conditions (Coelho, 2002).

Minerals also present specific formulation challenges. Inorganic mineral sources such as zinc sulfate (ZnSO₄), copper sulfate (CuSO₄), and ferrous sulfate (FeSO₄) exhibit relatively high reactivity toward other components of the premix. Metal ions may catalyze oxidative reactions involving vitamins, accelerate antioxidant degradation, and form complexes with other compounds, thereby compromising the stability and biological effectiveness of the formulation (Leeson & Summers, 2008). Consequently, premix formulation must carefully consider ingredient compatibility to minimize nutrient losses and maintain product stability.

In addition to chemical factors, physical conditions during storage can substantially affect premix quality. Fluctuations in temperature and humidity may promote caking, particle segregation, and loss of blend homogeneity. Particles with different sizes and densities are susceptible to separation during transportation and handling, resulting in non-uniform nutrient distribution in the final feed. This phenomenon, known as particle segregation, may cause some animals to receive excessive amounts of specific micronutrients while others receive insufficient quantities (Fahrenholz, 2012).

1.1.4 Low Nutrient Solubility and Dissolution

Successful nutrient absorption in the gastrointestinal tract is strongly influenced by the ability of an active ingredient to dissolve and disperse within gastrointestinal fluids. Many trace minerals exhibit limited solubility, meaning that only a fraction may be present in an ionic or otherwise absorbable form at the intestinal epithelium. Zinc oxide (ZnO), for example, has substantially lower solubility than zinc sulfate and may consequently exhibit lower bioavailability, despite having a relatively high elemental zinc content (Swain et al., 2015).

The principles of dissolution kinetics described by the Noyes–Whitney equation indicate that the dissolution rate of a particle is influenced by its surface area, diffusion coefficient, diffusion-layer thickness, and the concentration gradient between the particle surface and the surrounding medium. Larger particles have a lower specific surface area and therefore generally dissolve more slowly than smaller or nanoscale particles (Noyes & Whitney, 1897; McClements, 2020). Consequently, a proportion of nutrients may remain insufficiently dissolved before reaching or passing through the intestinal segments that represent major sites of nutrient absorption.

From a formulation perspective, this limitation is particularly important because solubility and dissolution are prerequisites for many subsequent steps in nutrient bioavailability, including release from the feed matrix, maintenance in an absorbable chemical form, transport across the intestinal barrier, and subsequent systemic utilization. Therefore, strategies that increase effective surface area and improve dissolution behavior may provide an important basis for enhancing micronutrient delivery. Nanotechnology is of particular interest in this context because nanoscale engineering can substantially increase specific surface area and modify interfacial and dissolution characteristics, although improved dissolution does not automatically guarantee greater biological absorption or safety.

1.2 Nutrient–Nutrient Interactions and Complex Formation

The bioavailability of a nutrient is also influenced by its interactions with other nutrients within the gastrointestinal tract. Essential minerals may compete for the same transporters expressed on the surface of enterocytes. For example, zinc, iron, and copper may compete for pathways involving the divalent metal transporter 1 (DMT1), such that excessive supplementation of one mineral may interfere with the absorption of another (Underwood & Suttle, 1999).

In addition to transporter competition, the formation of poorly soluble complexes is another important factor contributing to reduced mineral absorption. Phytic acid, which is abundant in plant-based feed ingredients such as maize, soybean, rice bran, and wheat, can bind Zn²⁺, Fe²⁺, Ca²⁺, and Mg²⁺ ions to form mineral–phytate complexes that are relatively resistant to digestion and poorly available for absorption, particularly in monogastric animals (Selle & Ravindran, 2007). This phenomenon helps explain why a substantial proportion of supplemented minerals may ultimately be excreted in feces rather than being effectively utilized by the animal.

Negative interactions may also occur between vitamins and minerals. Copper and iron ions can promote oxidative reactions involving vitamin A, vitamin E, and certain B-complex vitamins through redox-mediated mechanisms. Consequently, the feed industry commonly employs coated vitamins or encapsulation technologies to improve vitamin stability during feed processing and storage (Coelho, 2002).

1.2.1 Physiological Barriers in the Gastrointestinal Tract

The gastrointestinal tract is a highly specialized biological system designed to selectively regulate nutrient absorption while simultaneously protecting the body from potentially harmful foreign substances. As a result, many premix components encounter multiple physiological barriers before reaching the systemic circulation. The stomach provides a strongly acidic environment, with gastric pH commonly ranging from approximately 2 to 4 in poultry and other monogastric animals, which can promote protein denaturation, degradation or transformation of acid-sensitive compounds, and structural changes in certain bioactive substances (Allen & Flemström, 2005).

Upon entering the small intestine, nutrients and particulate materials must interact with the mucus layer, which serves as an important physical and biochemical barrier between the intestinal lumen and the epithelial surface. The mucus layer is primarily composed of mucin glycoproteins that form a hydrated three-dimensional network capable of interacting with and retaining particulate materials, thereby influencing their diffusion and access to the enterocyte surface (Ensign et al., 2012). Consequently, particle size and surface characteristics can be important determinants of interactions with and transport through the intestinal mucus layer.

Nutrients and particulate delivery systems must subsequently cross or interact with the intestinal epithelial barrier through mechanisms that may include passive diffusion, carrier-mediated transport, active transport, endocytosis, and paracellular transport, depending on the physicochemical characteristics of the substance. The efficiency of these processes is influenced by particle size, surface charge, hydrophilic–hydrophobic characteristics, solubility, and interactions with membrane proteins (Florence, 2005). Conventional premixes, which generally contain particles in the micrometer range, may exhibit different dissolution, dispersion, and mucosal-interaction characteristics compared with nanoscale delivery systems.

1.2.2 Nutrient Excretion and Environmental Impacts

The limited bioavailability of nutrients supplied through conventional premixes affects not only animal performance but also has important environmental consequences. Unabsorbed minerals are excreted primarily through feces and urine and may subsequently accumulate in agricultural soils and aquatic environments. Excessive accumulation of zinc, copper, phosphorus, and other nutrients in livestock manure can contribute to soil and water pollution, eutrophication, alterations in soil microbial communities, and, in some circumstances, the selection or co-selection of antimicrobial-resistant microorganisms through interactions between metal exposure and antimicrobial resistance determinants (Nicholson et al., 2003).

Within the framework of sustainable livestock production, improving nutrient-use efficiency is therefore an important strategy for reducing the environmental footprint of animal agriculture. Increasing nutrient bioavailability may allow supplementation levels to be more precisely aligned with physiological requirements without compromising animal productivity, thereby reducing unnecessary mineral excretion and minimizing nutrient losses to the environment (Mottet et al., 2017).

1.2.3 The Urgency of Developing Nanotechnology-Based Nutrient Delivery Systems

The various limitations associated with conventional premixes have stimulated the development of advanced nutrient delivery systems capable of protecting active ingredients during storage and feed processing, improving their stability within the gastrointestinal tract, and optimizing their availability for intestinal absorption. One promising approach is the application of nanotechnology, which enables the engineering of materials at the nanoscale, commonly within the range of approximately 1–100 nm, together with surface modification to alter properties such as solubility, colloidal stability, mucosal interactions, cellular uptake, and controlled release (Khan et al., 2018; McClements, 2020).

Nanoparticles and nanoscale delivery systems can also function as carrier systems for protecting vitamins, minerals, amino acids, enzymes, phytobiotics, and other bioactive compounds against degradation caused by oxidation, heat, light, moisture, and unfavorable gastrointestinal conditions. Appropriate encapsulation or nanostructuring may increase the fraction of an active compound that remains available at the intended site of release and absorption compared with conventional delivery systems (Rai et al., 2021). However, the extent of these benefits depends strongly on particle composition, size distribution, surface properties, matrix structure, gastrointestinal conditions, and the biological characteristics of the target nutrient.

 

CHAPTER 2. NANOTECHNOLOGY AS A SOLUTION FOR THE DEVELOPMENT OF PREMIX FEED ADDITIVES

 

2.1 Fundamental Principles of Nanotechnology in Animal Nutrition: Nanoparticle Size, Surface Area, Quantum Effects, and Mechanisms of Enhanced Bioavailability

Advances in materials science over the past three decades have generated numerous innovations capable of transforming conventional approaches to feed formulation and nutrient delivery systems. One of the most promising innovations is the application of nanotechnology, which involves the engineering of materials at dimensions of approximately 1–100 nm and can result in physical, chemical, mechanical, optical, and biological characteristics that differ from those of materials at the micrometer or macroscopic scale (ISO/TS 80004-1:2015; Khan et al., 2018). In animal nutrition, nanotechnology should not be viewed merely as a technology for particle miniaturization, but rather as a multidisciplinary approach integrating nutritional science, materials chemistry, biotechnology, pharmaceutical sciences, and process engineering to improve nutrient-use efficiency.

The fundamental concept of nanotechnology is based on the observation that reducing particle dimensions to the nanoscale can substantially alter the physicochemical properties of a material. At the nanoscale, the surface-area-to-volume ratio increases markedly, resulting in a larger proportion of atoms or molecules being located at or near the particle surface and therefore being more available for interactions with the surrounding biological environment (Nel et al., 2006). This phenomenon can contribute to changes in reactivity, dissolution behavior, adsorption capacity, and mass-transfer characteristics compared with conventional particles.

In animal nutrition, an increase in specific surface area may have important implications for the dissolution rate of nutrients. According to the Noyes–Whitney relationship, the dissolution rate of a solid is influenced by the surface area available for contact with the dissolution medium (Noyes & Whitney, 1897). Consequently, reducing the particle size of mineral compounds from the micrometer to the nanoscale can potentially accelerate dissolution in gastrointestinal fluids, increase the availability of soluble or ionic species, and improve the fraction of nutrients available for subsequent absorption (McClements, 2020).

As an illustrative example, reducing the characteristic particle diameter of a zinc-containing material from 10 µm to 100 nm can substantially increase its surface-area-to-volume ratio. For geometrically similar particles, this corresponds to an approximately 100-fold increase in specific surface area per unit mass, assuming comparable particle shape and density. The resulting increase in interfacial contact with gastrointestinal fluids may enhance wetting and dissolution kinetics. However, increased dissolution does not necessarily translate directly into increased intestinal absorption because bioavailability is also governed by chemical speciation, intestinal transport mechanisms, interactions with dietary components, and physiological barriers (Swain et al., 2015).

Another important characteristic of nanoparticles is their relatively high surface free energy. Atoms and molecules located at the particle surface have different coordination environments from those in the bulk material and may therefore exhibit greater surface reactivity. High surface energy can enhance interactions between nanoparticles and proteins, lipids, polysaccharides, and biological membranes, potentially influencing their adhesion to the intestinal mucus layer and cellular uptake through mechanisms such as endocytosis (Nel et al., 2006; Fadeel et al., 2018).

These characteristics are particularly relevant to nutrient delivery systems, because successful nutrient absorption is not determined solely by the amount of nutrient present. It also depends on the ability of the delivery system to navigate or interact appropriately with several physiological barriers within the gastrointestinal tract, including the mucus layer, epithelial barrier, and cellular membrane. Nanoparticles with appropriately engineered physicochemical properties, including particle size and surface chemistry, may modify their residence time, mucus interactions, cellular uptake, and release behavior at the intestinal interface (Ensign et al., 2012). Nevertheless, these effects are highly dependent on nanoparticle composition, morphology, surface charge, surface functionalization, aggregation state, and gastrointestinal conditions.

2.2 Increased Specific Surface Area and Its Implications for Nutrient Bioavailability

Specific surface area is one of the most important parameters in nanoscale material engineering. As particle size decreases toward the nanoscale, the surface-area-to-volume ratio increases substantially. Consequently, a greater proportion of the material is present at the interface between the particle and its surrounding biological environment.

In premix-based delivery systems, an increased specific surface area may provide several potential physicochemical and physiological advantages, including:

1. faster particle wetting and hydration after entering the gastrointestinal tract;

2. enhanced dissolution kinetics of appropriately formulated vitamins and minerals;

3. increased opportunities for interactions with digestive enzymes and gastrointestinal components;

4. improved mass transfer and diffusion toward the intestinal epithelial surface; and

5. more rapid establishment of concentration gradients that may facilitate subsequent absorption processes.

From a theoretical perspective, increased surface area may also facilitate the release of active compounds from a carrier matrix, thereby increasing the rate at which nutrients become available when the delivery system reaches intestinal regions that contribute substantially to nutrient absorption (McClements, 2020). However, the actual release profile depends on the physicochemical properties of the active ingredient, carrier material, particle structure, gastrointestinal pH, ionic strength, digestive enzymes, and residence time.

In polymer-based nanoparticles composed of materials such as chitosan, alginate, or proteins, surface properties can facilitate hydrogen bonding, electrostatic interactions, and other non-covalent interactions with components of the intestinal mucus layer. These interactions may contribute to mucoadhesion, defined as the ability of a material to adhere to mucosal surfaces and potentially prolong its residence time at the absorption interface (Sogias et al., 2008). Prolonged residence may increase the opportunity for nutrient release and interaction with the intestinal epithelium; however, mucoadhesion does not necessarily imply enhanced systemic absorption, as excessive adhesion may also limit mucus penetration.

Thus, optimization of nanoparticle surface properties requires a balance between mucosal retention and mucus penetration. An effective nutrient-delivery system should provide sufficient residence time for controlled release while maintaining appropriate mobility through the mucus layer and accessibility to the epithelial surface.

2.3 Quantum Effects in Nanomaterials

In addition to changes in surface area and interfacial properties, certain nanomaterials may exhibit altered physicochemical behavior as a result of the quantum size effect, also referred to in specific contexts as quantum confinement. This phenomenon becomes relevant when the dimensions of a material approach characteristic electronic length scales, causing electronic states to become spatially confined and resulting in properties that differ from those of the corresponding bulk material (Kelsall et al., 2005).

Quantum effects are particularly relevant to certain metal nanoparticles, semiconductor nanomaterials, and metal oxides, depending on their composition and particle dimensions. Examples include ZnO, CuO, Fe₂O₃, and selenium-based nanomaterials. Changes in electronic structure may influence optical properties, electrical behavior, catalytic activity, redox processes, and interactions with reactive oxygen species (ROS).

In animal nutrition, however, quantum effects are generally not the primary objective of nanoparticle formulation. Rather, they may contribute indirectly to changes in the biological and physicochemical behavior of specific nanomaterials. For example, selenium nanoparticles (SeNPs) have attracted considerable research interest as potential selenium sources because their biological activity, absorption characteristics, and toxicity profile may differ from those of conventional inorganic selenium sources (Zhang et al., 2008; Surai & Fisinin, 2014). Such differences may be related to particle size, surface chemistry, dissolution behavior, redox properties, and biological transformation, rather than being attributable solely to quantum effects.

Nevertheless, nanoscale-induced changes in physicochemical properties also warrant careful consideration because they may alter the toxicokinetic and toxicological profiles of nanomaterials. Therefore, comprehensive characterization of particle size and size distribution, morphology, surface charge, surface chemistry, aggregation or agglomeration behavior, dissolution, colloidal stability, and biological safety is essential before nanomaterials are considered for application in animal-feed systems (EFSA Scientific Committee, 2021).

2.3.1 Mechanisms by Which Nanoparticles Enhance Nutrient Bioavailability

A major potential advantage of nanopremixes over conventional premixes lies in their ability to enhance nutrient bioavailability through several complementary mechanisms that may operate simultaneously.

The first mechanism involves enhanced solubility and dissolution kinetics. Reducing particle size can increase the specific surface area available for interaction with gastrointestinal fluids, thereby potentially accelerating nutrient dissolution and increasing the concentration of soluble or otherwise bioavailable species available for subsequent absorption.

The second mechanism is protection against gastrointestinal degradation. Nutrients encapsulated within or associated with nanoparticulate matrices may be protected from acidic gastric conditions, oxidation, hydrolysis, and enzymatic degradation. This protective function is particularly relevant for labile compounds such as vitamins A and E, carotenoids, omega-3 fatty acids, phytobiotics, probiotics, and certain feed enzymes, depending on the composition and architecture of the delivery system (Acosta, 2009).

The third mechanism involves enhanced mucoadhesion and modulation of mucosal interactions. Nanoparticles based on chitosan, alginate, or other polysaccharides can interact with mucin through electrostatic, hydrogen-bonding, and other non-covalent interactions. In particular, positively charged chitosan-based systems may exhibit strong interactions with negatively charged mucin, potentially increasing residence time at the intestinal mucosal surface. Prolonged residence may increase the opportunity for nutrient release and interaction with the absorptive epithelium before the delivery system is removed through gastrointestinal transit (Sogias et al., 2008).

The fourth mechanism involves interactions with transcellular and paracellular transport pathways. Depending on their size, composition, surface chemistry, and biological environment, nanoparticles may interact with enterocytes through endocytic mechanisms, including clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis. Some nanoscale delivery systems may also transiently influence epithelial tight-junction permeability, thereby modifying paracellular transport. However, such effects are highly system-dependent and must be carefully controlled because excessive disruption of epithelial barrier function may compromise intestinal integrity (Florence, 2005; des Rieux et al., 2006).

The fifth mechanism is controlled release. Nanoparticulate delivery systems can be engineered to release active compounds in response to changes in pH, enzymatic activity, ionic strength, or gastrointestinal residence time. Such systems may facilitate more site-specific release in the small intestine, where substantial nutrient absorption occurs, thereby potentially increasing the fraction of the active ingredient available for absorption while reducing premature degradation in the stomach (McClements, 2020).

Nanotechnology may also enable the co-encapsulation of multiple nutrients or bioactive compounds within a single delivery system. For example, vitamin E may be co-delivered with selenium or zinc to support complementary antioxidant and immune-related functions. Such approaches provide opportunities for developing multifunctional nanopremixes that combine essential nutrients with bioactive compounds in an integrated delivery platform. However, potential synergistic interactions should be demonstrated experimentally rather than assumed solely on the basis of co-encapsulation.

Overall, these principles provide a mechanistic basis for the potential advantages of nanoparticulate nutrient-delivery systems over conventional premixes. Through controlled manipulation of particle size, surface characteristics, solubility, stability, and release behavior, nanopremixes may improve nutrient utilization, reduce unnecessary supplementation, support animal production performance, and decrease nutrient losses to the environment. These developments may ultimately contribute to the transition toward more efficient and sustainable precision livestock nutrition.

2.3.2 Global Development of Nanopremixes as Next-Generation Feed Additives

Over the past two decades, advances in nanotechnology have increasingly influenced the development of mineral and vitamin delivery systems for animal feed. Whereas conventional premixes commonly rely on inorganic salts or organic nutrient forms with variable bioavailability, nanopremixes incorporate nutrients or bioactive compounds into nanoscale particles or nano-enabled delivery systems. These systems may provide increased specific surface area, modified dissolution behavior, enhanced physicochemical stability, and controlled release, potentially improving nutrient utilization under appropriate formulation conditions.

Globally, research on nanopremixes has expanded in parallel with growing efforts to reduce reliance on antibiotic growth promoters (AGPs), improve production efficiency, strengthen gastrointestinal health, and promote sustainable livestock production. Research groups in North America, Europe, Asia, Latin America, and Australia have investigated nano-enabled forms of minerals, vitamins, amino acids, probiotics, phytobiotics, and other functional feed ingredients as potential next-generation feed additives.

The fundamental differences between conventional premixes and nanopremixes can be considered in terms of particle size, specific surface area, dissolution characteristics, surface chemistry, stability, release behavior, and interactions with the gastrointestinal environment. Nanoscale formulations may provide greater interfacial contact with gastrointestinal fluids and, depending on their physicochemical characteristics, may modify interactions with the intestinal mucus layer and epithelial surface. Nevertheless, the extent to which nanoparticles penetrate mucus, interact with membrane transporters, or undergo cellular uptake depends strongly on particle size, morphology, surface charge, surface functionalization, aggregation state, and the composition of the gastrointestinal environment.

Some experimental studies have reported that nano-enabled mineral supplementation can achieve comparable or improved physiological responses at lower inclusion levels than conventional mineral sources. However, the magnitude of any reduction in supplementation requirements is highly dependent on the mineral, animal species, production stage, nanoparticle formulation, dose, and experimental conditions. Therefore, generalized claims that nanopremixes can routinely reduce mineral supplementation by 30–70% should be interpreted cautiously and require validation through comparative dose–response studies. Potential reductions in mineral excretion should likewise be demonstrated through nutrient-balance and environmental-emission assessments.

2.3.2.1 Development in the Poultry Industry

The poultry sector has become one of the most extensively investigated areas for nano-enabled feed additives, partly because the rapid growth rate and high metabolic demands of broiler chickens create strong incentives to improve nutrient-use efficiency.

Numerous experimental studies have investigated nano-zinc oxide (nano-ZnO) as a potential alternative to conventional zinc sources. Reported outcomes include improvements in body weight gain, feed conversion ratio (FCR), intestinal morphology, digestive enzyme activity, antioxidant status, and immune responses under specific experimental conditions. Nano-ZnO has also been investigated for its potential effects on intestinal microbial populations, including pathogenic bacteria such as Escherichia coli and Salmonella, through a combination of direct physicochemical antimicrobial activity and indirect effects associated with intestinal barrier function and host responses. However, the magnitude and consistency of these effects depend on particle characteristics, dietary concentration, exposure duration, and animal health status.

Nano-selenium (nano-Se) has also received substantial attention in poultry nutrition. Selenium nanoparticles have been investigated as an alternative selenium source because their biological behavior differs from conventional inorganic selenium salts such as sodium selenite. Experimental studies in broilers have reported effects on antioxidant defense systems, including glutathione peroxidase (GPx), superoxide dismutase (SOD), and total antioxidant capacity (T-AOC), as well as potential effects on carcass characteristics, immune responses, and oxidative stress under challenging conditions such as heat stress. In breeder poultry, nano-Se supplementation has also been investigated for potential effects on reproductive performance, egg quality, fertility, and hatchability. Nevertheless, the assertion that nano-Se is universally less toxic than sodium selenite is not justified without considering dose, particle characteristics, chemical form, exposure duration, and animal species.

Nano-copper (nano-Cu) has been investigated as a potential alternative to conventional high-dose copper supplementation, particularly copper sulfate. Experimental studies have reported potential effects on antioxidant enzyme activity, energy metabolism, growth performance, feed efficiency, pigmentation, and intestinal microbial populations. The use of lower nano-Cu inclusion levels may also reduce copper accumulation in poultry litter compared with conventional high-dose supplementation, although this potential environmental advantage requires confirmation through comprehensive mineral-balance studies.

Meanwhile, nano-iron has received increasing research attention as a potential strategy for improving iron availability and addressing marginal iron status. Nano-iron formulations have been investigated for their potential effects on hemoglobin synthesis, oxygen transport, iron metabolism, and growth performance, particularly during the early growth phase. Although the evidence base remains smaller than that for nano-zinc and nano-selenium, some experimental studies suggest that appropriately formulated nano-iron may exhibit different dissolution, absorption, and utilization characteristics from conventional ferrous sulfate. Further dose–response, pharmacokinetic, and safety studies are required before firm conclusions can be drawn regarding its superiority over conventional iron sources.

2.3.2.2 Development in the Swine Industry

In swine production, research on nanopremixes has primarily focused on controlling post-weaning diarrhea (PWD), improving intestinal health, and enhancing mineral-use efficiency.

For many years, the swine industry has used pharmacological levels of zinc oxide (ZnO), typically in the range of 2,000–3,000 ppm, to control post-weaning diarrhea in piglets. However, the high level of zinc excretion associated with this practice has raised environmental concerns and has led to restrictions on high-dose ZnO use in several jurisdictions. Consequently, nano-ZnO has been investigated as a potential alternative capable of producing comparable biological responses at substantially lower inclusion levels. Experimental studies have reported that nano-ZnO may support intestinal epithelial integrity, modulate the expression of tight-junction proteins, reduce the abundance or colonization of pathogenic Escherichia coli, influence the composition of the gut microbiota, and improve growth performance in weaned piglets under specific experimental conditions.

Nano-selenium (nano-Se) has also been investigated in pigs for its potential effects on meat quality and antioxidant status. Reported outcomes include reduced lipid peroxidation, improved meat-color stability, enhanced antioxidant defense, and potential benefits for reproductive performance in breeding sows. In addition, nano-copper (nano-Cu) and nano-iron (nano-Fe) have increasingly been evaluated as potential strategies for improving energy metabolism and hematological status while reducing unnecessary mineral excretion. However, the environmental benefits of these approaches depend on dose, mineral source, nanoparticle characteristics, and the resulting nutrient balance.

2.3.2.3 Development in Ruminant Production

In dairy cattle, beef cattle, goats, and sheep, the development of nanopremixes has focused primarily on improving rumen nutrient utilization, reproductive health, antioxidant status, immune function, and milk or meat production.

Nano-selenium is among the most extensively investigated nano-enabled minerals in ruminant nutrition. Supplementation with nano-Se has been associated in experimental studies with increased glutathione peroxidase (GPx) activity, improved antioxidant status, modulation of postpartum immune function, potential improvements in colostrum quality, and reproductive outcomes in dairy cattle. In beef cattle, nano-Se supplementation has also been investigated for its potential effects on growth performance and feed efficiency.

Nano-zinc has been evaluated for its potential role in maintaining epithelial integrity, supporting protein metabolism and immune function, and contributing to hoof health. Nano-copper has been investigated in relation to oxidative enzyme systems, iron metabolism, connective-tissue formation, and general metabolic function. Nano-iron may support hemoglobin synthesis and oxygen metabolism, particularly in young calves with high growth demands.

Nevertheless, the application of nanomaterials in ruminants requires particular consideration of the rumen ecosystem. Nanoparticles may undergo aggregation, dissolution, adsorption, reduction, oxidation, or other chemical and biological transformations in the rumen before reaching the small intestine. These transformations may alter their bioavailability and biological activity. Therefore, further research is needed to characterize nanoparticle–microbiota interactions and determine the extent to which nano-enabled nutrients remain intact or are transformed within the rumen environment.

2.3.2.4 Development in Aquaculture

Aquaculture has emerged as an important area for the development of nano-enabled feed additives because nutrient losses from aquafeeds can directly affect the surrounding aquatic environment. Improving nutrient utilization efficiency is therefore relevant not only to fish and shrimp production but also to the environmental sustainability of aquaculture systems.

Nano-zinc has been investigated in species such as Nile tilapia, common carp, catfish, and various marine fish for its potential effects on growth performance, digestive enzyme activity, protein utilization, antioxidant status, and nonspecific immune responses. Nano-selenium has been studied for its potential to enhance antioxidant defenses, modulate immune responses, increase phagocytic activity, and improve survival following pathogen-challenge experiments.

Nano-iron has been investigated for its potential contribution to erythropoiesis and oxygen-transport capacity, whereas nano-copper has been evaluated for its potential effects on mineral metabolism and host defense against certain bacterial pathogens when administered at appropriate concentrations. However, because aquatic organisms are directly exposed to their surrounding water, the environmental fate, dissolution, aggregation, and potential toxicity of nanoparticles released from uneaten feed and fecal material require careful evaluation.

Recent research has also begun to combine nano-enabled feed additives with encapsulation technologies to regulate mineral release within the gastrointestinal tract. Such approaches may reduce premature nutrient loss, improve nutrient utilization, and potentially decrease the release of excess minerals into the aquatic environment.

2.3.2.5 Current Research Trends in Nanotechnology-Based Feed Additives

Current global research is increasingly moving beyond the use of single mineral nanoparticles toward the development of smart nanopremixes that combine multiple nutrients or bioactive compounds within integrated delivery systems. The objective is to exploit complementary or synergistic biological functions while controlling the release, stability, and bioavailability of individual components.

Several major research directions include:

1. Nano-zinc as a potential alternative to AGPs and high-dose conventional ZnO, with research focusing on improved zinc utilization, intestinal health, antimicrobial activity, and nutrient-use efficiency.

2. Nano-selenium as an emerging antioxidant nutrient source, with potential applications in improving antioxidant status, immune function, reproductive performance, meat and egg quality, and resilience to environmental stressors.

3. Nano-copper for improving mineral utilization, metabolic function, intestinal health, and antimicrobial activity at appropriately controlled inclusion levels, potentially reducing the need for high concentrations of conventional copper sources.

4. Nano-iron for supporting hemoglobin synthesis, oxygen transport, energy metabolism, and growth, particularly in animals with high iron requirements or marginal iron status, while minimizing unnecessary iron excretion.

5. Nano-enabled vitamin delivery systems, including nanoencapsulation of vitamins A, D, E, K, C, and B-complex vitamins. These systems are being investigated to improve stability during feed processing, protect vitamins against oxidation, enhance dispersibility and bioavailability, and enable controlled release within the gastrointestinal tract.

6. Nano-enabled phytobiotics, including nano-curcumin, nano-turmeric extracts, nano-garlic, nano-ginger, nano-cinnamon, nano-oregano, nano-thyme, and other nanoformulated botanical extracts. Nanoencapsulation may improve the aqueous dispersibility, chemical stability, absorption characteristics, and biological activity of phytogenic compounds, including their antimicrobial, anti-inflammatory, antioxidant, and immunomodulatory effects. These systems are therefore being investigated as potential components of strategies to reduce reliance on antibiotic growth promoters in modern livestock production.

Overall, global research indicates that nanopremixes are evolving from being merely alternative forms of mineral supplementation toward more sophisticated platforms for precision animal nutrition. The integration of nano-minerals, nano-enabled vitamins, and nano-phytobiotics may provide opportunities to develop next-generation feed additives with improved delivery efficiency, environmental performance, and compatibility with sustainable livestock production systems.

However, broad commercial implementation still requires standardization of formulations and manufacturing processes, long-term safety evaluation, assessment of tissue deposition and residues in food-producing animals, environmental fate studies, exposure assessment, and harmonization of regulatory frameworks governing nanomaterials in animal feed.

2.3.3 Transition from Conventional Premixes to Nanopremix Feed Additives: Industrial Opportunities, Regulatory Challenges, and Future Research Directions

The development of nanotechnology has stimulated a paradigm shift in animal nutrition, from conventional premix systems toward nano-enabled feed additives designed according to the principles of precision nutrition. This transition represents more than simply reducing the particle size of mineral or vitamin ingredients. It reflects a broader change in how nutrients are formulated, protected, released, absorbed, metabolized, and utilized by animals.

By exploiting selected nanoscale properties—including increased specific surface area, tunable surface chemistry, modified dissolution behavior, and engineered delivery characteristics—nanopremixes are being investigated as a potential technology for improving nutrient-use efficiency while reducing unnecessary nutrient losses from modern livestock production systems.

Conceptually, conventional premixes are formulated to meet nutritional requirements by blending minerals, vitamins, amino acids, enzymes, and other feed additives in micro- or larger particulate forms. However, some of these nutrients may be affected by limited bioavailability, inadequate stability during feed processing and storage, antagonistic interactions among minerals, and incomplete utilization following ingestion. Historically, such limitations have sometimes been addressed by providing supplementation above the estimated physiological requirement as a safety margin. Although this strategy can help compensate for variable nutrient availability, excessive supplementation may increase formulation costs and contribute to greater mineral excretion into the environment.

In contrast, nanopremixes adopt a delivery-efficiency-oriented approach. Rather than relying primarily on increased nutrient inclusion, nano-enabled systems seek to improve the effective utilization of individual nutrients through particle-size engineering, surface engineering, nanoencapsulation, carrier-matrix design, and controlled-release technologies. These strategies can modify dissolution, dispersion, gastrointestinal stability, and release kinetics and may thereby improve the fraction of a nutrient that becomes available for absorption.

Accordingly, nanopremixes have the potential to achieve equivalent physiological outcomes at lower nutrient inclusion levels in some applications. However, this should not be interpreted as a universal reduction in dosage. The appropriate inclusion level must be established through species-specific dose–response studies, bioavailability assessments, nutrient-balance studies, and long-term safety evaluations. The ultimate objective is not simply to reduce particle size or supplementation levels, but to achieve a more precise match between nutrient supply and physiological requirements while minimizing nutrient losses and maintaining animal health, product quality, and environmental safety.

From an industrial perspective, this transition creates opportunities for the development of high-value, multifunctional feed additives capable of integrating nutrient supplementation, controlled delivery, antioxidant protection, intestinal-health support, and targeted biological functions within a single formulation. Nevertheless, commercialization will depend on reproducible manufacturing, robust quality control, cost competitiveness, regulatory compliance, characterization of nanoparticle fate in animals and the environment, and demonstrable benefits under practical production conditions.

2.3.3.1. The Shift Toward Precision Animal Nutrition

The concept of precision animal nutrition has developed in parallel with the increasing demand for production efficiency, animal welfare, food safety, and environmental sustainability. Under this paradigm, the primary objective is no longer to provide animals with nutrients in excess, but rather to ensure that each nutrient is supplied in an appropriate form and utilized as efficiently as possible according to the animal's physiological requirements.

Nanopremixes may represent an important component of this approach because they have the potential to:

· enhance the bioavailability of minerals and vitamins;

· improve nutrient absorption efficiency in the gastrointestinal tract;

· protect active compounds against degradation during gastrointestinal processing;

· enable gradual or site-specific release at targeted locations within the gastrointestinal tract;

· reduce undesirable interactions among mineral components; and

· potentially reduce supplementation levels without compromising biological effectiveness, where supported by dose–response evidence.

This approach is consistent with the development of precision livestock farming (PLF), in which feed formulation and nutritional management are increasingly integrated with sensor technologies, artificial intelligence (AI), the Internet of Things (IoT), and real-time data analytics. Such integration enables nutritional strategies to be adjusted according to animal performance, physiological status, environmental conditions, and production-stage requirements.

The convergence of nanopremix technology with precision nutrition may therefore facilitate a transition from population-level nutrient supplementation toward more targeted and adaptive nutritional management. However, practical implementation requires reliable information on nutrient requirements, animal responses, nanoparticle behavior, and the safety of nano-enabled feed ingredients.

2.3.3.2. Industrial Opportunities for Nanopremixes

From an industrial perspective, nanopremixes have the potential to become an important emerging segment of the feed-additive sector because they may address several major challenges facing modern livestock production.

a. Reducing Reliance on Antibiotic Growth Promoters (AGPs)

Restrictions and bans on the use of antibiotic growth promoters (AGPs) in many countries have increased the demand for alternative feed additives capable of supporting production performance while contributing to strategies for mitigating antimicrobial resistance.

Nano-zinc, nano-selenium, nano-copper, and nanoformulated phytobiotics have been investigated as potential components of AGP-reduction strategies through mechanisms involving antimicrobial activity, antioxidant protection, immunomodulation, and support for gastrointestinal health. Nevertheless, these nano-enabled feed additives should not be considered direct one-to-one replacements for antibiotics because their biological mechanisms and efficacy profiles are fundamentally different. Their role is more appropriately evaluated as part of an integrated strategy for maintaining intestinal health and reducing the need for antimicrobial interventions.

b. Improving Feed-Formulation Efficiency

Although the production of nanoparticles and nano-enabled delivery systems may initially be more expensive than that of conventional mineral sources, improved bioavailability or delivery efficiency could, under appropriate conditions, allow lower inclusion levels to achieve comparable physiological outcomes. Over the long term, such improvements may contribute to lower nutrient supplementation costs, improved feed conversion ratio (FCR), and enhanced economic efficiency.

However, the economic feasibility of nanopremixes cannot be determined solely from their biological efficacy. A complete cost–benefit assessment should also consider raw-material costs, nanoparticle fabrication, encapsulation, quality control, analytical testing, regulatory compliance, storage stability, transportation, and potential environmental benefits.

c. Reducing Environmental Pollution

Excessive excretion of zinc, copper, phosphorus, and other minerals from livestock production can contribute to soil and water contamination. Nano-enabled nutrient-delivery systems may potentially reduce mineral losses when they improve nutrient utilization and allow supplementation levels to be more closely aligned with physiological requirements.

This potential environmental advantage should, however, be demonstrated through nutrient-balance studies, fecal and urinary excretion measurements, soil accumulation studies, and environmental-fate assessments. The presence of nanoparticles does not inherently guarantee lower environmental emissions, because nanoparticulate materials may undergo transformation, aggregation, dissolution, or accumulation in environmental compartments.

d. Integration with Smart Feed Technologies

The next generation of nanopremixes may extend beyond their traditional role as nutrient sources and evolve into multifunctional delivery platforms capable of incorporating minerals, vitamins, probiotics, prebiotics, phytobiotics, enzymes, bioactive peptides, and potentially other biologically active molecules within integrated delivery systems.

This concept creates opportunities for smart feed additives, in which active compounds are released in response to environmental or physiological triggers, such as gastrointestinal pH, enzymatic activity, ionic strength, or residence time. Such systems could potentially provide more precise temporal and spatial delivery of active compounds within the digestive tract.

The integration of nano-enabled feed systems with sensors, AI, IoT, and digital decision-support platforms may further enable adaptive feeding strategies in which nutrient delivery is dynamically adjusted according to animal performance and physiological requirements.

2.3.3.3. Regulatory Challenges

Although research on nanopremixes has expanded rapidly, commercial implementation continues to face significant regulatory challenges. This is largely because nanomaterials may exhibit physicochemical and biological properties that differ from those of the corresponding conventional materials, necessitating comprehensive and substance-specific risk assessment.

In the European Union, the European Food Safety Authority (EFSA) has developed scientific guidance for the characterization and safety assessment of nanomaterials and nano-enabled substances in the food and feed chain. Relevant assessments may include physicochemical characterization, particle size and size distribution, morphology, surface properties, solubility or dissolution behavior, stability, toxicokinetics, toxicity, exposure assessment, consumer safety, user safety, and environmental considerations. For feed additives, the regulatory assessment also involves the scientific framework associated with the FEEDAP Panel, depending on the substance and intended use.

In the United States, the U.S. Food and Drug Administration (FDA), including its Center for Veterinary Medicine (CVM), evaluates animal-food ingredients and products according to their specific characteristics and intended uses. The fact that a material is manufactured at the nanoscale does not, by itself, establish that it is equivalent to the corresponding conventional form. Consequently, relevant assessments may need to consider manufacturing processes, physicochemical characteristics, biological availability, target-animal safety, food safety of products derived from treated animals, exposure, and potential environmental effects.

Several major regulatory challenges remain, including:

1. The absence of a universally harmonized regulatory definition of nanopremixes and nano-enabled feed additives.

2. Limited standardized analytical methods for characterizing nanoparticles within complex feed matrices, particularly for determining particle size distribution, aggregation state, chemical speciation, and dissolution.

3. Insufficient long-term data on chronic toxicity, toxicokinetics, bioaccumulation, and biological transformation for many nanomaterials.

4. Limited validated methods for detecting and quantifying nanoparticle-derived residues or transformation products in animal-derived foods.

5. Regulatory differences among jurisdictions, which may complicate international trade and the global commercialization of nano-enabled feed products.

Accordingly, regulatory authorities generally emphasize a substance-specific and case-by-case risk-assessment approach, in which each nano-enabled material or product is evaluated according to its physicochemical characteristics, manufacturing process, intended function, exposure level, target species, duration of use, biological fate, and potential risks to animals, consumers, users, and the environment.

For the livestock-feed industry, regulatory readiness therefore requires more than demonstrating improved nutrient bioavailability. A commercially viable nanopremix must be supported by a comprehensive evidence package covering identity, composition, manufacturing consistency, physicochemical characterization, efficacy, target-animal safety, consumer safety, environmental safety, residue assessment, exposure characterization, and quality control. This comprehensive approach will be essential for establishing confidence in nano-enabled feed additives and facilitating their responsible integration into modern livestock production systems.

2.3.3.4. Scientific and Technological Challenges

In addition to regulatory considerations, the development of nanopremixes continues to face several scientific and technological challenges that require further investigation.

First, the relationships among particle size, morphological characteristics, surface charge (zeta potential), and bioavailability remain incompletely understood for different minerals and target animal species. Although reducing particle size may enhance dissolution and biological interactions, the relationship is not necessarily linear, and the optimal physicochemical characteristics may differ according to the chemical composition, surface properties, dose, and physiological characteristics of the target species.

Second, interactions between nanoparticles and the gut microbiota remain an active and rapidly developing research area. Some nanoparticles may contribute to the modulation of intestinal microbial communities and potentially support gastrointestinal health. However, at sufficiently high exposure levels, certain nanomaterials may adversely affect beneficial microorganisms or alter microbial community structure and function. Therefore, the effects of nanopremixes on microbiome composition, microbial metabolites, and host–microbiota interactions require systematic evaluation.

Third, the mechanisms governing the biodistribution, biotransformation, and elimination of nanoparticles following absorption require more detailed investigation. Advanced approaches, including multi-omics technologies, molecular imaging, high-resolution microscopy, and nanobioimaging, may provide important insights into the fate of nano-enabled feed components at the cellular, tissue, and systemic levels.

Fourth, the development of large-scale manufacturing processes with consistent product quality under Good Manufacturing Practice (GMP) remains challenging. Particular attention must be given to controlling particle size and size distribution, morphology, surface characteristics, dispersion stability, batch-to-batch reproducibility, storage stability, and production costs. Scaling up laboratory-scale synthesis to industrial production may substantially alter particle characteristics and therefore requires rigorous process validation and quality control.

2.3.3.5. Future Research Directions

Research on nanopremixes is expected to move toward increasingly intelligent, precise, multifunctional, and sustainable nutritional systems. Several research directions are likely to become major priorities during the coming decade.

1. Multicomponent nanopremixes, integrating nanominerals, nanoformulated vitamins, nano-phytobiotics, probiotics, enzymes, and immunostimulatory compounds within a single or coordinated delivery system.

2. Stimuli-responsive nanopremixes, in which active compounds are released in response to specific gastrointestinal conditions, such as changes in pH, temperature, enzymatic activity, ionic strength, or other physiological triggers.

3. Green nanotechnology, emphasizing the use of naturally derived and biodegradable carrier materials, including alginate, chitosan, cellulose, modified starch, plant proteins, and microbial exopolysaccharides. Such approaches may reduce reliance on persistent synthetic materials and improve the environmental profile of nano-enabled feed systems.

4. Precision nanonutrition, integrating nanopremixes with sensor technologies, artificial intelligence, big-data analytics, and precision livestock farming to adjust nutrient delivery according to age, physiological status, production performance, health status, and environmental conditions, potentially in near-real time.

5. Multi-omics approaches, encompassing genomics, transcriptomics, proteomics, metabolomics, and microbiomics, to elucidate the molecular mechanisms underlying animal responses to nanopremix supplementation and to identify biomarkers of efficacy, safety, and individual variability.

6. Long-term safety assessment, including studies of bioaccumulation, toxicokinetics, tissue distribution, transformation, residues in foods of animal origin, effects on the gut microbiota, environmental fate, and Life Cycle Assessment (LCA) to determine the overall sustainability of nano-enabled feed technologies.

Overall, the transition from conventional premixes toward nanopremixes represents a potentially important development in modern animal nutrition. Nano-enabled delivery systems offer opportunities to improve nutrient-use efficiency, reduce the need for high mineral inclusion levels, minimize nutrient losses to the environment, and facilitate the development of multifunctional feed additives compatible with precision livestock production.

Nevertheless, successful industrial implementation will depend on the harmonization of regulatory frameworks, standardization of physicochemical characterization methods, robust demonstration of long-term safety and efficacy, and development of economically viable and environmentally sustainable manufacturing processes. With continued advances in these areas, nanopremixes may become an important component of next-generation animal nutrition and contribute to global food security and more sustainable livestock production.

2.4. Physicochemical Characterization of Nanopremixes as Feed Additives

The performance of nanopremixes as feed additives is determined not only by the composition of the minerals, vitamins, or bioactive compounds incorporated into the formulation but also by the physicochemical characteristics of the constituent nanomaterials. Unlike conventional premixes, which are generally evaluated primarily in terms of nutrient concentration, mixing uniformity, and storage stability, nanopremixes require substantially more comprehensive characterization because their biological behavior may be strongly influenced by particle size, morphology, specific surface area, surface charge, dispersion stability, chemical composition, and nutrient-release behavior within the gastrointestinal tract.

Accordingly, international organizations and scientific bodies, including the International Organization for Standardization (ISO), the Organisation for Economic Co-operation and Development (OECD), and the European Food Safety Authority (EFSA), emphasize the importance of comprehensive physicochemical characterization when evaluating nanomaterials and nano-enabled substances for potential applications in food and feed. Such characterization provides an essential foundation for risk assessment, biological efficacy evaluation, exposure assessment, and batch-to-batch reproducibility in industrial applications.

Physicochemical characterization is also an important component of the Quality by Design (QbD) concept, a systematic approach in which product quality is incorporated into formulation and process design rather than being assessed solely through end-product testing. In nanopremix development, appropriate control of critical physicochemical attributes is essential for determining whether nanoparticles can withstand feed-processing operations, including mixing, storage, pelleting, and transportation, while retaining their intended functionality and delivering active nutrients effectively throughout the gastrointestinal tract.

2.4.1. Particle Size and Size Distribution

Particle size is one of the fundamental parameters in nanopremix characterization. According to ISO terminology, nanoscale materials are generally associated with structures having external dimensions in the approximate range of 1–100 nm. However, nano-enabled feed formulations may exhibit larger hydrodynamic diameters, particularly when nanoparticles are dispersed in aqueous media, form aggregates, or are incorporated into carrier-based delivery systems. Consequently, the distinction between primary particle size and hydrodynamic particle size is important when characterizing nanopremixes.

Particle size can directly influence several biological and physicochemical properties of nano-enabled feed additives, including:

· specific surface area;

· mineral solubility;

· dissolution rate;

· diffusion through the intestinal mucus layer;

· interactions with enterocyte membranes;

· absorption efficiency;

· tissue distribution and biological fate; and

· overall nutrient bioavailability.

As particle size decreases, the surface-to-volume ratio generally increases. Consequently, a greater fraction of atoms or molecules is located at or near the particle surface, potentially increasing surface reactivity and interactions with the surrounding biological environment. However, particle size should not be considered an independent determinant of biological activity because aggregation, agglomeration, surface coating, chemical speciation, dissolution behavior, and protein corona formation can substantially modify the effective biological properties of nanoparticles.

For example, nano-zinc oxide formulations with primary particle sizes in the tens-of-nanometers range have been investigated for their potential to improve zinc utilization relative to conventional ZnO. Similarly, nano-selenium formulations have been studied as alternative selenium sources because their physicochemical properties may influence selenium bioavailability, antioxidant responses, and safety. Nevertheless, such effects are formulation- and dose-dependent and should be demonstrated experimentally rather than assumed solely from nanoscale dimensions.

Particle size and size distribution can be assessed using several complementary analytical techniques, including:

· Dynamic Light Scattering (DLS);

· Nanoparticle Tracking Analysis (NTA);

· Transmission Electron Microscopy (TEM);

· Scanning Electron Microscopy (SEM); and

· Atomic Force Microscopy (AFM).

Each technique provides different types of information and has specific advantages and limitations. DLS primarily determines the hydrodynamic diameter of particles dispersed in a liquid and is particularly useful for assessing colloidal systems and aggregation behavior. NTA tracks the Brownian motion of individual particles and can provide particle-size distributions based on particle-by-particle measurements. In contrast, TEM and SEM provide direct morphological information and estimates of the physical dimensions of individual particles based on microscopic images. AFM can additionally provide three-dimensional surface-topography information at the nanoscale.

For robust nanopremix characterization, reliance on a single analytical technique is generally insufficient. A multimethod characterization strategy combining particle-size measurements with microscopy, surface-charge analysis, chemical characterization, and dispersion-stability assessment provides a more comprehensive understanding of the material's critical quality attributes. Such an approach is particularly important because the particle characteristics measured in the original formulation may change substantially after incorporation into a complex feed matrix or following exposure to gastrointestinal conditions.

2.4.2. Polydispersity Index (PDI)

In addition to the mean particle size, the particle-size distribution is a critical determinant of nanopremix quality. This parameter is commonly expressed as the Polydispersity Index (PDI) and is frequently obtained from Dynamic Light Scattering (DLS) measurements.

The PDI provides an indication of the breadth or heterogeneity of particle-size distribution within a dispersed system. A low PDI generally indicates a relatively narrow particle-size distribution, whereas a high PDI indicates greater heterogeneity and the presence of particles or aggregates with substantially different hydrodynamic sizes.

As a general guide for DLS-based characterization:

PDI value	General interpretation
<0.10	Very narrow size distribution
0.10–0.20	Narrow and relatively homogeneous distribution
0.20–0.30	Moderately heterogeneous but often acceptable for many colloidal systems
>0.30	Broad size distribution
>0.50	Highly heterogeneous dispersion, potentially indicating aggregation or agglomeration

These ranges should be interpreted as general guidelines rather than universal acceptance criteria, because the appropriate PDI threshold depends on the formulation, measurement conditions, particle concentration, dispersing medium, and analytical instrument.

A nanopremix with a relatively low PDI generally exhibits better dispersion uniformity and may show improved physical stability during storage and processing. Conversely, a broad particle-size distribution may increase the likelihood of aggregation, sedimentation, or segregation, potentially affecting nutrient distribution, dissolution behavior, and biological availability.

Therefore, PDI should be evaluated together with particle size, zeta potential, morphology, dispersion stability, and chemical composition to obtain a comprehensive assessment of nanopremix quality.

2.4.3. Nanoparticle Morphology and Surface Structure

Nanoparticle morphology encompasses particle shape, surface texture, porosity, internal architecture, and structural organization. Nanoparticles may exhibit a variety of morphologies, including:

· spherical;

· rod-shaped;

· cubic;

· platelet-like;

· tubular;

· flower-like;

· core–shell; and

· hollow nanoparticles.

In animal-nutrition applications, spherical nanoparticles are frequently investigated because of their relatively uniform geometry and favorable dispersion characteristics. Nevertheless, particle shape should be selected according to the intended function of the delivery system rather than assumed to be universally optimal.

Surface morphology and texture can substantially influence protein adsorption, interaction with the gastrointestinal mucus layer, dissolution behavior, and release kinetics. A relatively smooth surface may contribute to improved dispersion stability, whereas porous or highly structured surfaces can provide greater surface area and potentially enhance the loading capacity of vitamins, phytobiotics, or other bioactive compounds.

Morphological characterization is commonly performed using complementary microscopic techniques, including:

· Scanning Electron Microscopy (SEM);

· Transmission Electron Microscopy (TEM);

· Atomic Force Microscopy (AFM);

· Cryogenic Transmission Electron Microscopy (Cryo-TEM); and

· Focused Ion Beam–Scanning Electron Microscopy (FIB–SEM).

TEM is particularly useful for determining primary particle morphology and nanoscale dimensions, whereas SEM provides information on surface morphology and particle aggregation. AFM can provide three-dimensional surface-topography information, while Cryo-TEM is particularly valuable for examining nanoparticles in hydrated or near-native states. FIB–SEM can additionally provide information about internal structures and cross-sectional morphology.

Because nanoparticle morphology may change during processing, storage, or gastrointestinal exposure, characterization should ideally be performed under conditions relevant to the intended application.

2.4.4. Specific Surface Area

Specific surface area (SSA) is one of the key physicochemical properties underlying the distinctive behavior of nanopremixes. As particle size decreases, the surface-area-to-volume ratio increases, providing a larger interfacial area for interactions with the surrounding medium.

A high specific surface area can contribute to:

· nutrient adsorption;

· interaction with the intestinal mucus layer;

· mineral dissolution;

· release of encapsulated vitamins and bioactive compounds; and

· surface-mediated antimicrobial activity, where applicable.

Specific surface area is commonly determined using the Brunauer–Emmett–Teller (BET) method, typically based on gas adsorption, often using nitrogen. BET analysis provides an estimate of the accessible surface area of a material under the measurement conditions.

For nano-enabled mineral systems such as nano-zinc oxide, an increased specific surface area can enhance contact between the solid phase and gastrointestinal fluids and may consequently increase dissolution kinetics. However, the relationship between specific surface area and biological efficacy is not necessarily linear. Surface chemistry, crystallinity, particle aggregation, dissolution rate, coating materials, and the surrounding feed matrix can all influence the effective surface area available under gastrointestinal conditions.

Accordingly, BET surface area should be interpreted together with particle-size distribution, morphology, aggregation state, chemical composition, and dissolution behavior rather than used as an isolated predictor of bioavailability.

2.4.5. Zeta Potential and Colloidal Stability

In addition to particle size and size distribution, zeta potential is an important parameter for evaluating the electrostatic behavior and dispersion stability of nanopremix systems, particularly for formulations dispersed in liquid media.

Zeta potential represents the electrical potential associated with the slipping plane of particles in a dispersed system. Its magnitude provides an indication of the electrostatic repulsion between particles and can therefore influence their tendency to aggregate.

For many aqueous colloidal systems, the following values are commonly used as approximate indicators of electrostatic stability:

Zeta potential	General interpretation
> +30 mV	Relatively high positive electrostatic stability
+20 to +30 mV	Moderate positive stability
−20 to +20 mV	Relatively low electrostatic stabilization
< −30 mV	Relatively high negative electrostatic stability

These values should not be regarded as universal regulatory or quality specifications. Actual colloidal stability is also affected by ionic strength, pH, temperature, particle concentration, surface coatings, polymeric stabilizers, and the composition of the dispersion medium. In feed applications, the complex composition of the feed matrix may substantially modify the effective surface charge and aggregation behavior.

In addition to its role in colloidal stability, surface charge can influence interactions between nanoparticles and gastrointestinal mucus, digestive proteins, plasma proteins, and cellular membranes. Therefore, optimization of surface charge is an important aspect of nanopremix design, particularly for systems intended to enhance mucoadhesion, gastrointestinal retention, cellular uptake, or controlled delivery.

2.4.6. Solubility and Dissolution Rate of Nanopremixes

One of the potential advantages of nano-enabled feed systems is the improvement of the apparent solubility and dissolution kinetics of poorly soluble nutrient components. In biological systems, the bioavailability of minerals and other poorly soluble compounds is strongly influenced by their ability to dissolve or become available in gastrointestinal fluids before absorption across the intestinal epithelium.

Accordingly, enhanced dissolution may contribute to improved biological utilization of certain nanoformulated minerals, although increased dissolution does not necessarily translate directly into increased systemic bioavailability because absorption is also governed by chemical speciation, transport mechanisms, intestinal physiology, metabolism, and excretion.

According to the Noyes–Whitney equation, dissolution rate is influenced by the surface area of the solid exposed to the dissolution medium, the diffusion coefficient, the thickness of the diffusion boundary layer, and the concentration gradient between the particle surface and the bulk medium. Because nanoparticles generally possess a much greater surface-area-to-volume ratio than larger particles, reduction in particle size can increase the rate of dissolution under appropriate conditions.

At the nanoscale, surface free energy and curvature can also influence the thermodynamic properties of small particles. These effects may alter apparent solubility, although such behavior depends strongly on particle composition, crystal structure, surface chemistry, aggregation state, and the surrounding medium. Therefore, nanoscale size alone should not be assumed to guarantee enhanced solubility.

In nanopremix formulations, improved dissolution may provide several potential biological benefits, including:

· accelerating the release of mineral ions;

· increasing the concentration of soluble or bioaccessible nutrients available for absorption;

· reducing nutrient losses associated with precipitation under certain gastrointestinal conditions;

· improving the utilization efficiency of minerals and other poorly soluble compounds; and

· potentially allowing lower supplementation levels when equivalent biological efficacy has been experimentally demonstrated.

For example, nano-zinc oxide has been investigated because its smaller primary particle size and increased interfacial area may enhance zinc dissolution relative to conventional ZnO under certain gastrointestinal conditions. Likewise, nano-selenium formulations have been studied as alternative selenium-delivery systems because their dissolution, transformation, and biological utilization profiles may differ from those of conventional inorganic selenium sources. However, these effects are formulation-, dose-, species-, and matrix-dependent and therefore require experimental validation.

The dissolution and bioaccessibility of nanopremixes can be evaluated using physiologically relevant media, including:

· Simulated Gastric Fluid (SGF; approximately pH 1–3, depending on the experimental protocol);

· Simulated Intestinal Fluid (SIF; typically near neutral to mildly alkaline pH, depending on the protocol);

· phosphate-buffered solutions;

· simulated ruminal fluid or rumen fermentation media for ruminant applications; and

· species-specific simulated gastrointestinal media for fish and other aquaculture species.

Dissolution studies can subsequently be used to establish relationships among particle size, surface characteristics, carrier composition, gastrointestinal conditions, dissolution kinetics, and nutrient release. Where possible, dissolution data should be complemented by measurements of chemical speciation and bioaccessibility because the total amount of dissolved material does not necessarily represent the fraction that is biologically available for intestinal absorption.

2.4.7. Stabilitas Nanopremix Selama Penyimpanan dan Proses Manufaktur Pakan

Keunggulan fisikokimia dan biologis nanopremix hanya dapat dipertahankan apabila sistem nanopartikel tetap stabil selama seluruh rantai produksi, distribusi, dan penyimpanan. Salah satu tantangan utama dalam pengembangan nanopremix adalah kecenderungan nanopartikel mengalami agregasi (aggregation) atau aglomerasi (agglomeration) akibat tingginya energi permukaan. Perubahan tersebut dapat meningkatkan ukuran partikel efektif, memperlebar distribusi ukuran, menurunkan luas permukaan spesifik, dan pada akhirnya mengubah karakteristik disolusi serta pelepasan bahan aktif.

Stabilitas nanopremix dipengaruhi oleh berbagai faktor, antara lain ukuran dan distribusi partikel, muatan permukaan, pH, kekuatan ionik, kadar air, temperatur, jenis bahan pembawa, serta keberadaan komponen lain dalam matriks pakan. Oleh sebab itu, formulasi nanopremix umumnya memerlukan penggunaan bahan penstabil (stabilizer) atau bahan pembawa yang mampu mempertahankan dispersi dan mencegah interaksi antarpartikel yang berlebihan. Bahan yang dapat digunakan antara lain kitosan, alginat, maltodekstrin, gum arab, pektin, protein whey, gelatin, karboksimetilselulosa (CMC), polietilen glikol (PEG), dan polivinil alkohol (PVA), tergantung karakteristik bahan aktif dan tujuan sistem penghantar.

Stabilitas juga harus dipertahankan selama berbagai tahapan manufaktur pakan, seperti pencampuran (mixing), penggilingan (milling), peletisasi (pelleting), ekstrusi (extrusion), pengeringan (drying), dan penyimpanan. Proses termomekanis tersebut dapat memberikan tekanan terhadap struktur nanopartikel maupun bahan aktif yang dibawanya. Suhu, kadar air, tekanan, waktu tinggal, dan kondisi mekanis selama proses harus diperhitungkan karena dapat memengaruhi ukuran partikel, struktur matriks, aktivitas vitamin, serta stabilitas senyawa bioaktif.

Khusus pada proses peletisasi, kombinasi panas, uap, tekanan, dan gaya geser dapat menyebabkan perubahan pada sistem nanopartikel. Oleh karena itu, nanoenkapsulasi dapat digunakan sebagai salah satu strategi perlindungan untuk mempertahankan stabilitas bahan aktif selama proses manufaktur. Namun, efektivitas perlindungan tersebut harus dibuktikan secara eksperimental melalui perbandingan karakteristik nanopremix sebelum dan sesudah proses produksi.

Evaluasi stabilitas nanopremix dapat dilakukan melalui pengukuran perubahan ukuran partikel, PDI, zeta potential, kadar air, kandungan bahan aktif, aktivitas biologis, serta karakteristik morfologi dan struktur selama periode penyimpanan. Pengujian stabilitas sebaiknya dilakukan pada beberapa kondisi temperatur dan kelembapan untuk memperoleh informasi mengenai umur simpan serta kondisi penyimpanan yang paling sesuai. Dengan demikian, stabilitas nanopremix tidak hanya dinilai berdasarkan keberadaan bahan aktif, tetapi juga berdasarkan kemampuan sistem mempertahankan karakteristik fisikokimia yang menentukan kinerja biologisnya.

2.4.8. Efisiensi Enkapsulasi (Encapsulation Efficiency) dan Kapasitas Pemuatan (Loading Capacity)

Dalam pengembangan nanopremix modern, bahan aktif seperti mineral, vitamin, fitobiotik, atau senyawa bioaktif sering kali tidak diberikan sebagai nanopartikel bebas (free nanoparticles), tetapi dimasukkan ke dalam matriks pembawa untuk membentuk sistem penghantaran yang lebih stabil dan terkontrol. Pendekatan ini dikenal sebagai nanoenkapsulasi.

Dua parameter penting untuk mengevaluasi keberhasilan proses tersebut adalah encapsulation efficiency (EE) dan loading capacity (LC). Encapsulation efficiency menunjukkan proporsi bahan aktif yang berhasil terperangkap atau terasosiasi dengan sistem nanopartikel dibandingkan dengan jumlah bahan aktif yang digunakan pada awal proses. Secara umum, EE dapat dihitung menggunakan persamaan:

dengan merupakan jumlah bahan aktif yang berhasil dienkapsulasi dan merupakan jumlah bahan aktif yang digunakan pada awal formulasi.

Sementara itu, loading capacity menggambarkan jumlah bahan aktif yang terdapat dalam sistem nanopartikel relatif terhadap massa total nanopartikel atau sistem penghantar. Persamaan yang umum digunakan adalah:

Definisi operasional LC perlu dinyatakan secara eksplisit dalam setiap penelitian karena metode perhitungan dapat berbeda antarformulasi.

Nilai EE yang tinggi menunjukkan bahwa proses formulasi mampu mempertahankan sebagian besar bahan aktif di dalam sistem penghantar, sedangkan LC yang tinggi menunjukkan bahwa sistem tersebut mampu membawa bahan aktif dalam jumlah relatif besar tanpa membutuhkan proporsi bahan pembawa yang berlebihan. Kedua parameter tersebut penting dari perspektif teknologi maupun ekonomi karena berhubungan dengan efisiensi proses produksi, jumlah bahan pembawa yang diperlukan, kestabilan formulasi, dan jumlah bahan aktif yang tersedia untuk dilepaskan selama proses pencernaan.

Oleh karena itu, optimasi EE dan LC tidak dapat dilakukan secara terpisah. Sistem dengan EE tinggi tetapi LC rendah belum tentu ekonomis untuk produksi massal, sedangkan LC tinggi dengan stabilitas rendah juga tidak memberikan keuntungan biologis yang optimal. Formulasi nanopremix yang ideal harus memiliki keseimbangan antara efisiensi enkapsulasi, kapasitas pemuatan, stabilitas, kemampuan mempertahankan bahan aktif, dan profil pelepasan yang sesuai dengan target biologis.

2.4.9. Kinetika Pelepasan Nutrien (Nutrient Release Kinetics)

Karakteristik penting lainnya dari nanopremix adalah pola pelepasan bahan aktif selama berada di dalam saluran gastrointestinal. Sistem penghantaran berbasis nanopartikel dapat dirancang untuk mengurangi pelepasan awal yang terlalu cepat (burst release) dan menghasilkan pelepasan yang lebih terkontrol sesuai kondisi fisiologis pada lokasi target.

Dalam sistem penghantaran nutrien, misalnya, matriks polimer dapat dirancang agar relatif stabil pada kondisi lambung tetapi mengalami perubahan struktur atau peningkatan permeabilitas ketika mencapai usus. Mekanisme tersebut memungkinkan sebagian bahan aktif terlindungi selama fase gastrointestinal awal dan kemudian dilepaskan secara lebih efektif pada segmen saluran pencernaan yang memiliki kapasitas absorpsi tinggi.

Pelepasan bahan aktif dapat dikendalikan berdasarkan berbagai stimulus, termasuk pH, aktivitas enzim, kekuatan ionik, kondisi redoks, maupun waktu kontak dengan medium gastrointestinal. Sistem berbasis pH, misalnya, dapat dirancang menggunakan bahan pembawa yang mengalami perubahan kelarutan atau pembengkakan pada kondisi pH tertentu. Sementara itu, sistem responsif terhadap enzim memanfaatkan degradasi matriks oleh enzim pencernaan untuk memicu pelepasan bahan aktif.

Profil pelepasan biasanya dinyatakan sebagai persentase kumulatif bahan aktif yang dilepaskan terhadap waktu. Data tersebut kemudian dapat dianalisis menggunakan beberapa model kinetika, antara lain:

1. Zero-order model, yang menggambarkan pelepasan dengan laju relatif konstan;

2. First-order model, yang menghubungkan laju pelepasan dengan konsentrasi bahan aktif yang masih tersisa;

3. Higuchi model, yang terutama digunakan untuk menggambarkan pelepasan berbasis difusi dari suatu matriks;

4. Korsmeyer–Peppas model, yang dapat membantu mengidentifikasi mekanisme pelepasan berdasarkan hubungan antara fraksi bahan aktif yang dilepaskan dan waktu;

5. Hixson–Crowell model, yang mempertimbangkan perubahan luas permukaan atau ukuran partikel selama proses disolusi.

Pemilihan model kinetika sebaiknya didasarkan pada kesesuaian statistik, seperti nilai , adjusted R², nilai error, serta kesesuaian model dengan mekanisme fisikokimia sistem. Dengan demikian, model dengan nilai tertinggi tidak selalu dapat langsung dianggap sebagai model terbaik apabila tidak sesuai dengan mekanisme pelepasan yang sebenarnya.

Pengujian pelepasan juga sebaiknya menggunakan media yang merepresentasikan kondisi gastrointestinal spesies target. Media dapat mencakup simulated gastric fluid (SGF), simulated intestinal fluid (SIF), cairan rumen buatan untuk ruminansia, maupun media gastrointestinal yang relevan untuk ikan. Pendekatan tersebut memungkinkan evaluasi apakah nanopremix benar-benar mampu mempertahankan bahan aktif pada lokasi yang diharapkan dan melepaskannya pada waktu yang sesuai.

2.4.10. Teknik Karakterisasi Instrumental Nanopremix

Karakterisasi nanopremix membutuhkan kombinasi berbagai teknik analisis karena tidak terdapat satu metode yang mampu menggambarkan seluruh karakteristik fisikokimia nanopartikel secara komprehensif. Kombinasi metode analisis diperlukan untuk memperoleh hubungan antara ukuran, morfologi, muatan permukaan, struktur kimia, kristalinitas, luas permukaan, stabilitas termal, kadar unsur, serta perilaku bahan aktif.

Teknik/instrumen	Parameter atau informasi utama
Dynamic Light Scattering (DLS)	Ukuran hidrodinamik dan PDI
Zeta Potential Analyzer	Muatan permukaan dan indikasi stabilitas koloid
Scanning Electron Microscopy (SEM)	Morfologi dan karakteristik permukaan
Transmission Electron Microscopy (TEM)	Ukuran, bentuk, dan struktur nanopartikel pada resolusi tinggi
Atomic Force Microscopy (AFM)	Topografi permukaan dan karakteristik morfologi tiga dimensi
Fourier Transform Infrared Spectroscopy (FTIR)	Gugus fungsi dan kemungkinan interaksi kimia
X-ray Diffraction (XRD)	Struktur kristal dan derajat kristalinitas
Brunauer–Emmett–Teller (BET)	Luas permukaan spesifik
ICP-OES	Kuantifikasi unsur/mineral
ICP-MS	Analisis unsur pada konsentrasi sangat rendah dan unsur jejak
Thermogravimetric Analysis (TGA)	Stabilitas termal dan perubahan massa terhadap temperatur
Differential Scanning Calorimetry (DSC)	Transisi termal dan interaksi/kompatibilitas komponen

DLS merupakan metode yang banyak digunakan untuk menentukan ukuran hidrodinamik dan PDI nanopartikel dalam suspensi. Namun, hasil DLS harus diinterpretasikan secara hati-hati karena diameter hidrodinamik dapat berbeda dari ukuran geometris yang diamati menggunakan TEM atau SEM. Perbedaan tersebut dapat disebabkan oleh lapisan hidrasi, bahan penstabil, agregasi, maupun kondisi medium pengukuran.

SEM dan TEM memberikan informasi visual mengenai morfologi dan ukuran partikel, sedangkan AFM dapat memberikan informasi mengenai topografi permukaan. FTIR digunakan untuk mengidentifikasi gugus fungsi serta perubahan spektrum yang dapat mengindikasikan interaksi antara bahan aktif dan bahan pembawa. XRD diperlukan untuk mengevaluasi perubahan struktur kristal, terutama ketika proses nanoenkapsulasi menyebabkan perubahan fase atau derajat kristalinitas.

Sementara itu, BET memberikan informasi mengenai luas permukaan spesifik yang sangat relevan terhadap kemampuan adsorpsi dan karakteristik disolusi. Analisis menggunakan ICP-OES atau ICP-MS diperlukan untuk memastikan kandungan mineral atau unsur dalam formulasi, termasuk mendeteksi kemungkinan perubahan kadar selama penyimpanan maupun setelah proses gastrointestinal simulasi. TGA dan DSC selanjutnya dapat digunakan untuk mengevaluasi stabilitas termal dan interaksi antarkomponen dalam sistem nanopremix.

Dengan demikian, karakterisasi instrumental bukan sekadar tahap identifikasi produk, tetapi merupakan fondasi untuk menghubungkan atribut fisikokimia nanopremix dengan stabilitas, pelepasan nutrien, bioavailabilitas, efikasi biologis, dan keamanan. Pendekatan karakterisasi yang komprehensif juga penting untuk memastikan konsistensi antar-batch dan mendukung penerapan prinsip Quality by Design serta Good Manufacturing Practice pada pengembangan nanopremix menuju skala industri.

2.4.7. Stability of Nanopremix during Storage and Feed Manufacturing Processes

The physicochemical and biological advantages of nanopremix can only be maintained if the nanoparticle system remains stable throughout the entire production, distribution, and storage chain. One of the major challenges in nanopremix development is the tendency of nanoparticles to undergo aggregation or agglomeration as a consequence of their high surface energy. These changes may increase the effective particle size, broaden the particle-size distribution, reduce the specific surface area, and ultimately alter the dissolution characteristics and release behavior of the active ingredients.

The stability of nanopremix is influenced by various factors, including particle size and size distribution, surface charge, pH, ionic strength, moisture content, temperature, carrier materials, and the presence of other components within the feed matrix. Therefore, nanopremix formulations generally require the use of stabilizers or carrier materials capable of maintaining particle dispersion and preventing excessive interparticle interactions. Potential stabilizing or carrier materials include chitosan, alginate, maltodextrin, gum arabic, pectin, whey protein, gelatin, carboxymethylcellulose (CMC), polyethylene glycol (PEG), and polyvinyl alcohol (PVA), depending on the characteristics of the active ingredient and the intended delivery system.

Stability must also be maintained throughout various feed manufacturing processes, including mixing, milling, pelleting, extrusion, drying, and storage. These thermomechanical processes may impose considerable stress on the nanoparticle structure and the active compounds they carry. Temperature, moisture content, pressure, residence time, and mechanical conditions during processing must therefore be carefully considered because they may affect particle size, matrix structure, vitamin activity, and the stability of bioactive compounds.

In particular, the combination of heat, steam, pressure, and shear forces during pelleting may induce structural changes in nanoparticle systems. Consequently, nanoencapsulation can be employed as a protective strategy to preserve the stability of active ingredients during feed manufacturing. However, the effectiveness of such protection should be experimentally demonstrated by comparing the physicochemical characteristics of the nanopremix before and after the manufacturing process.

Nanopremix stability can be evaluated by monitoring changes in particle size, polydispersity index (PDI), zeta potential, moisture content, active-ingredient concentration, biological activity, as well as morphological and structural characteristics throughout the storage period. Stability studies should preferably be conducted under multiple temperature and relative-humidity conditions to determine shelf life and identify the most appropriate storage conditions. Thus, nanopremix stability should not be assessed solely on the basis of active-ingredient retention, but also on the ability of the system to maintain the physicochemical attributes that determine its biological performance.

2.4.8. Encapsulation Efficiency and Loading Capacity

In the development of modern nanopremix systems, active ingredients such as minerals, vitamins, phytobiotics, and other bioactive compounds are often not administered as free nanoparticles, but are incorporated into a carrier matrix to form a more stable and controlled delivery system. This approach is known as nanoencapsulation.

Two important parameters for evaluating the effectiveness of this process are encapsulation efficiency (EE) and loading capacity (LC). Encapsulation efficiency represents the proportion of the active ingredient that is successfully entrapped within or associated with the nanoparticle system relative to the total amount of active ingredient initially used during formulation. In general, EE can be calculated using the following equation:

EE (%) = (Amount of active ingredient successfully encapsulated / Initial amount of active ingredient) × 100

where the numerator represents the amount of active ingredient successfully encapsulated and the denominator represents the amount of active ingredient initially used in the formulation.

In contrast, loading capacity (LC) represents the amount of active ingredient incorporated into the nanoparticle system relative to the total mass of the nanoparticles or delivery system. A commonly used expression is:

LC (%) = (Amount of active ingredient loaded / Total mass of nanoparticle system) × 100

The operational definition of LC should be explicitly stated in each study because the calculation method may vary among formulations and delivery systems.

A high EE indicates that the formulation process successfully retains a large proportion of the active ingredient within the delivery system, whereas a high LC indicates that the system can carry a relatively large amount of active ingredient without requiring an excessive proportion of carrier material. Both parameters are important from both technological and economic perspectives because they are associated with production efficiency, the amount of carrier material required, formulation stability, and the quantity of active ingredient available for release during gastrointestinal digestion.

Therefore, optimization of EE and LC should not be considered independently. A system with high EE but low LC may not necessarily be economically viable for large-scale production, whereas a system with high LC but poor stability may not provide optimal biological benefits. An ideal nanopremix formulation should achieve an appropriate balance among encapsulation efficiency, loading capacity, stability, active-ingredient retention, and a release profile compatible with the intended biological target.

2.4.9. Nutrient Release Kinetics

Another important characteristic of nanopremix is the release profile of active ingredients during passage through the gastrointestinal tract. Nanoparticle-based delivery systems can be engineered to minimize excessive initial release or burst release and to achieve more controlled release according to the physiological conditions at the target site.

In nutrient delivery systems, for example, polymeric matrices can be designed to remain relatively stable under gastric conditions but undergo structural changes or increased permeability upon reaching the intestinal environment. This mechanism allows a proportion of the active ingredient to remain protected during the early gastrointestinal phase and subsequently be released more effectively in gastrointestinal segments with high absorptive capacity.

The release of active ingredients can be controlled in response to various stimuli, including pH, digestive enzyme activity, ionic strength, redox conditions, and residence time in the gastrointestinal environment. pH-responsive systems, for example, can be designed using carrier materials that undergo changes in solubility or swelling at specific pH values. Meanwhile, enzyme-responsive systems utilize degradation of the carrier matrix by digestive enzymes to trigger the release of active ingredients.

The release profile is generally expressed as the cumulative percentage of active ingredient released as a function of time. The resulting data can then be analyzed using several kinetic models, including:

1. Zero-order model, which describes release at a relatively constant rate;

2. First-order model, which relates the release rate to the concentration of active ingredient remaining in the delivery system;

3. Higuchi model, which is primarily used to describe diffusion-controlled release from a matrix;

4. Korsmeyer–Peppas model, which can be used to elucidate the release mechanism based on the relationship between the fraction of active ingredient released and time;

5. Hixson–Crowell model, which takes into account changes in particle size or surface area during the dissolution process.

The selection of an appropriate kinetic model should be based on statistical goodness-of-fit parameters, such as R², adjusted R², error estimates, and the consistency of the model with the underlying physicochemical release mechanism. Therefore, a model with the highest statistical fit should not automatically be regarded as the best model if it is inconsistent with the actual release mechanism.

Release studies should also employ media that adequately represent the gastrointestinal conditions of the target species. Such media may include simulated gastric fluid (SGF), simulated intestinal fluid (SIF), simulated ruminal fluid for ruminants, and other physiologically relevant gastrointestinal media for fish. This approach enables researchers to determine whether the nanopremix can effectively protect the active ingredient during the intended gastrointestinal phase and release it at the appropriate time and location.

2.4.10. Instrumental Characterization Techniques for Nanopremix

Comprehensive characterization of nanopremix requires the integration of multiple analytical techniques because no single method can adequately describe all physicochemical characteristics of nanoparticles. A combination of analytical methods is therefore necessary to establish relationships among particle size, morphology, surface charge, chemical structure, crystallinity, specific surface area, thermal stability, elemental composition, and active-ingredient behavior.

Technique/Instrument	Principal Parameter or Information Obtained
Dynamic Light Scattering (DLS)	Hydrodynamic particle size and PDI
Zeta Potential Analyzer	Surface charge and indication of colloidal stability
Scanning Electron Microscopy (SEM)	Particle morphology and surface characteristics
Transmission Electron Microscopy (TEM)	Particle size, shape, and nanoparticle structure at high resolution
Atomic Force Microscopy (AFM)	Surface topography and three-dimensional morphological characteristics
Fourier Transform Infrared Spectroscopy (FTIR)	Functional groups and potential chemical interactions
X-ray Diffraction (XRD)	Crystal structure and degree of crystallinity
Brunauer–Emmett–Teller (BET) analysis	Specific surface area
Inductively Coupled Plasma–Optical Emission Spectrometry (ICP-OES)	Quantification of elements/minerals
Inductively Coupled Plasma–Mass Spectrometry (ICP-MS)	Determination of trace elements and elements at very low concentrations
Thermogravimetric Analysis (TGA)	Thermal stability and mass changes as a function of temperature
Differential Scanning Calorimetry (DSC)	Thermal transitions and component interactions/compatibility

DLS is widely used to determine the hydrodynamic diameter and PDI of nanoparticles in suspension. However, DLS measurements should be interpreted carefully because hydrodynamic diameter may differ from the geometric particle size observed by TEM or SEM. Such differences may result from hydration layers, stabilizing agents, particle aggregation, or the physicochemical characteristics of the measurement medium.

SEM and TEM provide visual information regarding particle morphology and size, whereas AFM can provide detailed information on surface topography. FTIR spectroscopy is used to identify functional groups and spectral changes that may indicate interactions between the active ingredient and carrier material. XRD is required to evaluate changes in crystal structure, particularly when the nanoencapsulation process induces changes in phase composition or degree of crystallinity.

Meanwhile, BET analysis provides information on specific surface area, which is highly relevant to adsorption capacity and dissolution behavior. ICP-OES or ICP-MS analyses are required to quantify minerals or elemental components in the formulation, including the detection of potential changes in elemental concentrations during storage or following simulated gastrointestinal exposure. TGA and DSC can subsequently be employed to evaluate thermal stability and interactions among the components of the nanopremix system.

Thus, instrumental characterization should not be regarded merely as a product-identification step, but rather as a fundamental approach for establishing relationships between the physicochemical attributes of nanopremix and its stability, nutrient release, bioavailability, biological efficacy, and safety. Comprehensive characterization is also essential for ensuring batch-to-batch consistency and supporting the implementation of Quality by Design (QbD) and Good Manufacturing Practice (GMP) principles in the development and scale-up of nanopremix systems for industrial applications.

2.4.11. Relationship between Physicochemical Characteristics and Bioavailability

The physicochemical characteristics of nanopremix interact synergistically to determine its biological effectiveness. Smaller particle sizes generally increase the specific surface area, facilitate dissolution, and may enhance nutrient absorption. A relatively narrow particle-size distribution can improve dispersion stability, whereas an appropriate zeta potential can reduce particle aggregation during storage.

In addition, high encapsulation efficiency can facilitate controlled nutrient release, thereby potentially improving bioavailability and reducing nutrient losses before the active ingredients reach their primary sites of absorption. Particle morphology and surface properties may also influence interactions with the intestinal mucus layer, mucin proteins, and membrane transporters.

These complex interrelationships explain why nanopremix cannot be evaluated solely on the basis of its nutrient content. Instead, its performance should be assessed using a multidisciplinary approach integrating materials science, chemistry, biology, pharmaceutics, and animal nutrition. Such an approach is essential for establishing robust relationships between nanopremix attributes, gastrointestinal behavior, nutrient absorption, biological efficacy, and safety.

2.4.12. Subsection Synthesis

Based on the foregoing discussion, physicochemical characteristics can be considered a fundamental determinant of the performance of nanopremix as a next-generation feed additive. Parameters including particle size, particle-size distribution, morphology, specific surface area, zeta potential, solubility, stability, encapsulation efficiency, and nutrient-release behavior can substantially influence the bioavailability, biological efficacy, and safety of nanopremix formulations in different animal species.

Advances in modern characterization techniques have enabled more comprehensive evaluation of nanopremix systems, thereby supporting the development of formulations with improved stability, efficacy, and batch-to-batch consistency. In the future, the integration of physicochemical characterization with Quality by Design (QbD), computational modeling, and multi-omics approaches is expected to accelerate the development of nanopremix systems that meet the requirements for safety, efficacy, reproducibility, and sustainability in commercial applications.

2.5. Mechanisms of Absorption, Biodistribution, and Bioavailability of Nanopremix in the Gastrointestinal System of Livestock

The development of nanopremix as a feed additive is not determined solely by successful nanoparticle synthesis or improvements in physicochemical properties, but primarily by its ability to enhance nutrient bioavailability within the animal body. Bioavailability refers to the fraction of an ingested nutrient that is absorbed from the gastrointestinal tract, enters systemic circulation, and subsequently becomes available for physiological utilization. In conventional premix systems, a considerable proportion of minerals and vitamins may be lost because of degradation, precipitation, antagonistic interactions with other feed components, or excretion before absorption. In contrast, nanopremix systems are designed to overcome some of these barriers through improved solubility, stability, and delivery efficiency.

In general, the gastrointestinal fate of nanopremix involves several interconnected biological processes: (1) release from the feed matrix, (2) dissolution in gastrointestinal fluids, (3) interaction with the mucus layer, (4) uptake by enterocytes, (5) transport into the blood or lymphatic circulation, (6) biodistribution to target tissues and organs, (7) cellular utilization, and (8) metabolism and excretion. The efficiency of each stage contributes to the overall performance of the nanopremix and determines its potential effects on growth performance, health status, reproductive function, and animal productivity.

One potential advantage of nanopremix over conventional premix systems is its ability to interact with and, depending on particle properties, traverse certain biological barriers that limit nutrient absorption. Small particle size, high specific surface area, and the possibility of surface functionalization can facilitate interactions with the gastrointestinal environment and potentially improve nutrient delivery without necessarily requiring higher supplementation levels. However, the biological fate of nanoparticles is highly dependent on their physicochemical properties, chemical composition, surface characteristics, dose, and animal species. Mineral nanoparticles such as nano-zinc, nano-selenium, nano-copper, and nano-iron have therefore been investigated for their potential to improve nutrient utilization and biological responses compared with conventional mineral sources.

2.5.1. Functional Anatomy of the Gastrointestinal Tract as a Site of Nanopremix Absorption

The effectiveness of nanopremix is strongly influenced by the anatomical and physiological characteristics of the gastrointestinal tract of the target animal species. Although substantial differences exist among poultry, pigs, ruminants, and fish, nutrient absorption generally occurs predominantly across the intestinal mucosa, which provides a large absorptive surface through structural features such as mucosal folds (plicae circulares), intestinal villi, and microvilli (the brush border).

The extensive intestinal absorptive surface facilitates interactions between nutrients or nanoparticle-based delivery systems and enterocytes. At the same time, the mucus layer, which is primarily composed of mucins and other glycoproteins, serves as an important protective barrier over the intestinal epithelium. This mucus layer represents one of the first biological interfaces that nanoparticle-based delivery systems encounter before reaching the epithelial cell membrane.

In poultry, nutrient absorption occurs primarily along the duodenum, jejunum, and ileum, although the relative contribution of each intestinal segment varies according to nutrient type and physiological conditions. In pigs, the small intestine—particularly the jejunum and ileum—is an important site for mineral and vitamin absorption. In ruminants, intestinal absorption occurs predominantly in the small intestine following the extensive physicochemical and microbial transformations that take place within the rumen. In fish, nutrient absorption primarily occurs in the anterior and middle intestinal regions, although gastrointestinal morphology and absorptive capacity vary considerably among species.

These anatomical and physiological differences indicate that nanopremix formulations should be designed according to the target species and, where appropriate, the intended gastrointestinal site of action. Such species-specific design is important for ensuring that nutrient release occurs at a location where absorption and biological utilization can be maximized.

2.5.2. Dissolution and Release of Nanonutrients in the Gastrointestinal Tract

Following ingestion with feed, nanopremix initially undergoes hydration, dispersion, and dissolution within gastrointestinal fluids. This stage is critical because it determines the fraction of nutrients that becomes available for subsequent absorption.

In non-encapsulated nanopremix systems, nanoparticles can directly interact with gastric and intestinal fluids, where mineral components may undergo ionic dissolution and release soluble species. In contrast, nanoencapsulated nanopremix systems can be engineered to regulate nutrient release through mechanisms governed by:

· changes in pH;

· digestive enzyme activity;

· degradation or erosion of the polymeric matrix; and

· diffusion through the carrier matrix or membrane.

For example, alginate-based coatings can provide relative protection under acidic gastric conditions and may undergo swelling, ion exchange, or matrix destabilization under the near-neutral to mildly alkaline conditions encountered in the small intestine, depending on the formulation and cross-linking characteristics. Chitosan, by contrast, exhibits greater solubility under acidic conditions and is therefore frequently combined with alginate or other polymers to develop multilayer or polyelectrolyte-based delivery systems with controlled gastrointestinal release.

Controlled release can help maintain nutrient availability over an appropriate absorptive period and may reduce premature loss of active ingredients during gastrointestinal transit. Compared with rapid or burst release, a properly engineered controlled-release system may improve the temporal and spatial availability of nutrients at the intended absorption site. Nevertheless, the magnitude of any improvement in biological efficiency must be demonstrated experimentally under physiologically relevant gastrointestinal conditions and in the target animal species.

2.5.3. Interaction of Nanoparticles with the Gastrointestinal Mucus Layer

The mucus layer represents one of the major biological barriers that determines the efficiency of nanopremix delivery to enterocytes. Mucus is primarily composed of a network of mucin glycoproteins that forms a viscoelastic gel, with thickness and physicochemical properties varying along different regions of the gastrointestinal tract.

Nanoparticles that are excessively large or possess unfavorable surface properties may become trapped within the mucus layer, thereby limiting their ability to reach the apical surface of enterocytes. In contrast, appropriately sized nanoparticles, particularly those below approximately 100 nm, with suitable surface characteristics may exhibit improved diffusion through the mucus layer. However, mucus penetration is not determined by particle size alone and depends on the interplay between particle surface chemistry and the physicochemical properties of the mucus.

Several factors influence nanoparticle–mucus interactions, including:

· particle size;

· particle morphology;

· zeta potential;

· surface hydrophobicity;

· type and properties of the surface coating or polymeric carrier; and

· mucus viscosity and microstructure.

Surface modification using hydrophilic polymers, such as polyethylene glycol (PEG), or naturally derived polysaccharides can reduce nonspecific adhesion to mucus and facilitate nanoparticle penetration toward the intestinal epithelium. Conversely, positively charged nanoparticles, including chitosan-based systems, may promote mucoadhesion through electrostatic interactions with negatively charged mucin components. Mucoadhesion can prolong the residence time of nanoparticles at the intestinal surface and potentially increase the opportunity for interaction with enterocytes.

The selection between mucus-penetrating nanoparticles and mucoadhesive nanoparticles should therefore be based on the intended delivery mechanism, physicochemical properties of the formulation, target gastrointestinal segment, and animal species. An optimal formulation should achieve an appropriate balance between mucus penetration and epithelial interaction rather than maximizing either property independently.

2.5.4. Mechanisms of Nanopremix Uptake by Enterocytes

After traversing the mucus layer, nanoparticles interact with enterocytes lining the intestinal villi. Conventional mineral nutrients are predominantly absorbed in ionic or molecular forms through specific membrane transporters. In contrast, nanopremix systems may undergo dissolution followed by conventional transporter-mediated uptake, while some nanoparticle formulations may also interact with cells through particle-mediated uptake mechanisms.

a. Passive Diffusion

Mineral ions released from nanoparticles may undergo passive diffusion across biological membranes when concentration and electrochemical gradients permit. The contribution of passive diffusion depends strongly on the chemical form of the released nutrient, membrane permeability, and local gastrointestinal conditions.

b. Membrane Transporters

Following dissolution, mineral ions can enter enterocytes through physiological transport systems. Examples include:

· ZIP4 and members of the ZnT family for zinc homeostasis and transport;

· Divalent Metal Transporter 1 (DMT1) for ferrous iron and other divalent metal ions;

· Copper Transporter 1 (CTR1) for copper; and

· specific transport systems involved in the uptake and metabolism of selenium-containing compounds, particularly seleno-amino acids.

The extent to which nanoparticle formulations alter these transporter-mediated pathways depends on the rate and location of nanoparticle dissolution and the chemical species generated during gastrointestinal processing.

c. Endocytosis

Certain nanoparticle delivery systems may undergo cellular internalization through endocytic pathways. These pathways can include:

· clathrin-mediated endocytosis;

· caveolae-mediated endocytosis;

· macropinocytosis; and

· phagocytosis, particularly in specialized immune cells.

Through these mechanisms, nanoparticles may be internalized partially or, depending on their physicochemical properties, remain associated with the cell surface before releasing their nutrient cargo within intracellular compartments. The extent of intact nanoparticle uptake varies considerably according to particle size, surface chemistry, morphology, aggregation state, and cell type.

d. Microfold (M) Cells

Within Peyer's patches and other gut-associated lymphoid tissues, microfold (M) cells are specialized epithelial cells capable of sampling particulate material from the intestinal lumen and transporting it toward underlying lymphoid tissues. This pathway is particularly relevant to nanoparticle-based systems designed for immunomodulation or oral vaccine delivery.

Accordingly, nanopremix absorption should not be interpreted as a single pathway. Rather, it represents the combined contribution of nutrient dissolution, transporter-mediated uptake, cellular internalization, and, in specific formulations, particulate transport through specialized epithelial pathways.

2.5.5. Factors Affecting Nanopremix Absorption

The absorption efficiency of nanopremix is governed by complex interactions among nanoparticle characteristics, the physiological condition of the animal, and the physicochemical environment of the gastrointestinal tract. The major influencing factors can be broadly classified into three categories.

Nanoparticle-related factors

· particle size;

· particle-size distribution;

· particle morphology;

· specific surface area;

· zeta potential;

· colloidal and dispersion stability;

· type and properties of the carrier material;

· encapsulation efficiency; and

· nutrient-release profile.

Animal-related factors

· age;

· animal species;

· physiological status;

· intestinal health;

· gut microbiota composition and activity; and

· gastrointestinal transit time.

Dietary and environmental factors

· gastrointestinal pH;

· dietary fiber content;

· phytate concentration;

· dietary calcium content;

· interactions with other minerals;

· ambient temperature; and

· physiological or environmental stress.

These factors may interact synergistically or antagonistically and can substantially influence the fate of nanopremix formulations in the gastrointestinal tract. Consequently, responses to nanopremix supplementation may vary among animal species, production stages, physiological states, and husbandry conditions.

2.5.6. Synthesis of Section 2.5

Based on the mechanisms described above, nanopremix absorption represents a multidisciplinary process involving interactions between nanoparticle physicochemical properties and the anatomy, physiology, and gastrointestinal environment of the target animal. Potential advantages of nanopremix systems arise from their ability to enhance dissolution, modulate interactions with the mucus layer, facilitate appropriate cellular uptake pathways, and provide controlled nutrient release at specific gastrointestinal sites.

These mechanisms may improve nutrient bioavailability and utilization compared with conventional formulations under appropriate formulation and dosing conditions. However, enhanced biological performance should not be assumed solely from nanoscale particle size; it must be demonstrated experimentally through comparative assessments of dissolution, absorption, tissue distribution, biological efficacy, and safety.

2.5.7. Biodistribution of Nanopremix Following Gastrointestinal Absorption

Following passage across the intestinal epithelium, nanopremix components may enter systemic circulation either as dissolved nutrient species or, depending on the formulation and physicochemical characteristics, as particulate material. Systemic transport may occur primarily through the hepatic portal circulation or, for certain lipid-associated or sufficiently lipophilic formulations, through the lymphatic circulation.

Mineral ions released through gastrointestinal dissolution are generally transported through the portal circulation to the liver, which serves as a major metabolic and homeostatic organ. In contrast, nanoparticles or bioactive compounds incorporated into lipid-based delivery systems may be transported through intestinal lacteals into the lymphatic system before entering the systemic circulation. Lymphatic transport can partially bypass hepatic first-pass exposure and may therefore influence the systemic disposition of selected bioactive compounds.

Once present in the circulation, nanoparticle distribution is not random but is governed by a combination of physicochemical and biological factors, including:

· particle size;

· particle morphology;

· surface charge;

· protein-corona composition;

· hydrophilic or hydrophobic surface characteristics; and

· interactions with the mononuclear phagocyte system (MPS).

An important phenomenon in nanoparticle biodistribution is the formation of a protein corona, which results from the adsorption of plasma proteins onto the nanoparticle surface. Protein-corona formation can substantially modify the biological identity of nanoparticles and influence their circulation time, recognition by immune cells, cellular uptake, and affinity for particular tissues.

Therefore, the biodistribution of nanopremix cannot be predicted solely from the physicochemical characteristics measured before administration. Nanoparticles may undergo substantial transformations after exposure to gastrointestinal fluids, plasma, proteins, and cellular environments, including changes in aggregation state, surface composition, dissolution behavior, and protein adsorption. These dynamic transformations should be considered when evaluating the absorption, biodistribution, biological efficacy, and safety of nanopremix feed additives.

2.5.8. Distribution of Nanopremix to Target Organs

a. Liver

The liver is one of the primary organs receiving absorbed mineral species following intestinal uptake, particularly through the hepatic portal circulation. In addition to serving as a central metabolic organ, the liver plays essential roles in mineral storage, synthesis of metal-binding proteins, detoxification, and regulation of systemic mineral homeostasis.

For selenium, the liver is an important site for the synthesis and metabolism of several selenoproteins, including glutathione peroxidases (GPx), thioredoxin reductases, and selenoprotein P, which contribute to antioxidant defense and selenium transport. Zinc is required for the catalytic activity or structural function of hundreds of enzymes involved in carbohydrate, protein, and lipid metabolism. Copper is essential for enzymes and proteins such as cytochrome c oxidase, lysyl oxidase, and copper-dependent superoxide dismutase (Cu/Zn-SOD), whereas iron is involved in ferritin-mediated storage, heme biosynthesis, and erythrocyte metabolism.

b. Kidney

The kidneys play a central role in mineral homeostasis, fluid and electrolyte regulation, and the elimination of metabolic waste products. Very small nanoparticles or nanoparticle-derived species may undergo renal filtration depending on their hydrodynamic size and physicochemical properties, whereas larger particles are generally subject to other processes, including dissolution, transformation, or uptake by cells and tissues before elimination.

For nanopremix applications, renal accumulation may differ among nanoparticle types and formulations and is often influenced by particle size, surface properties, dose, and exposure duration. Nevertheless, assessment of renal toxicity remains an important component of safety evaluation, particularly for high-dose or long-term exposure.

c. Spleen

The spleen is an important lymphoid organ containing abundant populations of macrophages and other immune cells. Nanoparticles recognized as foreign particulate materials may be taken up by splenic macrophages as part of the mononuclear phagocyte system (MPS).

At physiologically appropriate exposure levels, such uptake is not necessarily detrimental and may contribute to immune modulation in certain nanoparticle systems. Some formulations have been investigated for their ability to influence macrophage activity, phagocytic responses, and cytokine signaling. However, excessive accumulation or persistent exposure may induce inflammatory responses or oxidative stress, emphasizing the need for long-term safety assessment.

d. Bone and Bone Marrow

Minerals such as zinc, copper, and iron play essential roles in bone development, collagen synthesis, mineralization, and hematopoiesis. Zinc contributes to osteoblast activity, cellular proliferation, and bone matrix metabolism, whereas iron is essential for erythropoiesis through its role in hemoglobin synthesis. Copper contributes to connective tissue formation and collagen and elastin cross-linking through copper-dependent enzymes.

Efficient delivery of essential minerals to bone and bone marrow may therefore be particularly relevant during periods of rapid growth and development. However, tissue distribution should be evaluated experimentally because the biological fate of nanoparticle-derived minerals depends on both nanoparticle properties and the chemical form of the mineral after gastrointestinal processing.

e. Skeletal Muscle

The distribution of mineral nutrients to skeletal muscle is closely associated with growth, protein metabolism, oxidative status, and carcass characteristics. Selenium incorporated into muscle selenoproteins contributes to antioxidant protection and may influence oxidative stability of muscle tissue and meat. Zinc supports protein synthesis, cellular proliferation, tissue repair, and numerous metabolic processes.

In meat-producing animals, adequate mineral retention in skeletal muscle may contribute to nutritional quality and oxidative stability of animal-derived products. However, the extent to which nanoparticle formulations enhance muscle deposition compared with conventional mineral sources should be established through controlled comparative studies.

f. Reproductive Organs

Nano-selenium and nano-zinc have received considerable research attention because of their potential roles in reproductive physiology. In males, selenium and zinc contribute to spermatogenesis, sperm motility, antioxidant defense, and maintenance of sperm DNA and membrane integrity. In females, selenium is involved in antioxidant protection, follicular development, oocyte quality, and reproductive tissue function.

Consequently, the delivery of these minerals to reproductive tissues is of particular interest because mineral status can influence reproductive performance and overall livestock productivity. Nevertheless, reproductive benefits should be assessed in relation to dose, mineral source, bioavailability, and species-specific physiological requirements.

2.5.9. Metabolism of Nano-Zinc, Nano-Selenium, Nano-Copper, and Nano-Iron

Although administered in nanoparticulate form, many mineral nanoparticles undergo dissolution, transformation, or degradation within the gastrointestinal and systemic environments, after which the released mineral species may enter established physiological metabolic pathways. Therefore, the biological effects of nano-minerals reflect both nanoparticle-specific properties and the subsequent fate of the released elemental or molecular species.

a. Nano-Zinc

Nano-zinc formulations may release Zn²⁺ or other zinc-containing species that subsequently participate in physiological zinc transport and homeostasis. Absorbed zinc is regulated by zinc transporters, including members of the ZIP and ZnT families, with ZIP4 playing an important role in intestinal zinc uptake.

Zinc functions as a structural or catalytic component of hundreds of enzymes and proteins, including carbonic anhydrase and alkaline phosphatase. It also participates in transcriptional regulation through zinc-binding domains such as zinc-finger motifs, thereby contributing to cellular differentiation, growth, DNA metabolism, and immune function.

b. Nano-Selenium

Nano-selenium undergoes biochemical transformation into metabolically available selenium species that can ultimately contribute to the synthesis of selenocysteine, the amino acid incorporated into selenoproteins.

These selenoproteins include glutathione peroxidases, thioredoxin reductases, and iodothyronine deiodinases. They contribute to antioxidant defense, redox regulation, and thyroid hormone metabolism. The biological response to nano-selenium therefore depends not only on nanoparticle characteristics but also on its dissolution, transformation, and incorporation into selenium metabolic pathways.

c. Nano-Copper

Following dissolution and metabolic transformation, nano-copper may provide copper species that enter established copper transport and homeostatic pathways. Copper transporter 1 (CTR1) contributes to cellular copper uptake, while intracellular copper chaperones deliver copper to specific cuproenzymes.

Copper is essential for mitochondrial respiration, connective tissue formation, iron metabolism, antioxidant defense, and numerous other physiological processes. Because copper homeostasis is tightly regulated, excessive exposure can potentially lead to oxidative stress and tissue toxicity, emphasizing the importance of dose optimization.

d. Nano-Iron

Nano-iron formulations may undergo dissolution to generate bioavailable iron species, including Fe²⁺ and Fe³⁺, which subsequently enter physiological iron metabolism. Ferrous iron can be transported into enterocytes through divalent metal transporter 1 (DMT1), while systemic iron is transported primarily by transferrin.

Iron is subsequently delivered to tissues such as the bone marrow, where it is required for hemoglobin synthesis and erythropoiesis. It is also incorporated into myoglobin and numerous enzymes involved in cellular respiration and energy metabolism.

2.5.10. Interactions between Nanopremix and the Gut Microbiota

Advances in high-throughput sequencing and multi-omics technologies have demonstrated that the effectiveness of modern feed additives is influenced not only by nutrient absorption but also by their interactions with the gut microbiota. The intestinal microbial community contributes to feed-substrate fermentation, production of short-chain fatty acids (SCFAs), vitamin biosynthesis, bile acid metabolism, maintenance of intestinal barrier function, and regulation of mucosal immunity.

Nanopremix formulations may influence the gut microbiota through several potential mechanisms, including:

1. modifying the availability of essential minerals for commensal microorganisms;

2. inhibiting selected pathogenic microorganisms through antimicrobial activity;

3. supporting intestinal epithelial barrier integrity and tight-junction function;

4. modulating mucosal inflammatory responses; and

5. influencing mucus production and the intestinal microenvironment.

For example, zinc-based nanoparticle formulations have been investigated for their potential to alter the abundance of beneficial bacterial groups and suppress selected pathogenic bacteria, including Escherichia coli, in poultry and swine. Nano-selenium may also influence redox homeostasis within the intestinal environment and thereby contribute indirectly to microbial ecosystem stability.

These interactions are relevant to the concept of the gut–immune axis, which describes the bidirectional relationship among the intestinal microbiota, mucosal immune system, and host metabolism. Thus, the potential benefits of nanopremix may extend beyond direct mineral supplementation to include modulation of the intestinal environment.

However, nanoparticle–microbiota interactions are highly formulation- and dose-dependent. A nanoparticle that is beneficial at one concentration may exert inhibitory or disruptive effects at another. Therefore, microbiome composition, microbial function, metabolite profiles, and intestinal barrier integrity should be evaluated together when assessing the biological effects and safety of nanopremix.

2.5.11. Comparative Bioavailability of Nanopremix and Conventional Premixes

A growing body of research in poultry, swine, ruminants, and aquaculture species indicates that selected nano-mineral formulations can exhibit higher biological availability than conventional mineral sources under specific experimental conditions. Such differences may be reflected by several indicators, including:

· improved intestinal mineral absorption;

· greater tissue retention;

· enhanced activity of mineral-dependent enzymes;

· improved antioxidant status;

· reduced fecal mineral excretion;

· improved feed conversion ratio (FCR);

· increased body-weight gain;

· enhanced immune responses; and

· improved reproductive performance.

The potential increase in bioavailability may allow lower supplementation levels while maintaining comparable or, in some cases, improved biological responses. Nevertheless, the magnitude and consistency of this effect vary considerably according to mineral type, particle size, particle morphology, surface chemistry, formulation technology, animal species, age, physiological status, and dietary composition.

Importantly, higher bioavailability does not necessarily imply greater biological safety. Because enhanced absorption may also increase tissue exposure, nanopremix formulations must be evaluated simultaneously for efficacy, tissue distribution, excretion, toxicity, and potential residues in edible animal products. Comparative assessment should therefore include not only conventional measures of growth and production performance but also mineral balance, tissue retention, toxicokinetic parameters, and long-term safety outcomes.

Overall, the comparative advantage of nanopremix should be defined on the basis of bioefficacy per unit of supplemented nutrient, rather than simply on the basis of higher tissue concentrations or greater apparent absorption. This distinction is particularly important for the development of precision nano-nutrition strategies that seek to maximize nutrient utilization while minimizing unnecessary mineral inputs and environmental losses.

2.5.12. Tissue Retention, Excretion, and Biosafety

An important consideration in the development of nanopremix is to ensure that increased bioavailability does not result in excessive tissue accumulation or an elevated risk of toxicity. After fulfilling their biological functions, mineral species undergo physiological homeostatic processes and may be temporarily stored or bound to proteins such as ferritin, metallothioneins, and other metal-binding proteins. Depending on the mineral species, physiological status, and exposure level, minerals may subsequently be eliminated through biliary, urinary, or fecal pathways.

Toxicokinetic studies indicate that, when administered at nutritionally appropriate doses, nano-zinc, nano-selenium, nano-copper, and nano-iron do not necessarily result in substantially greater residues in meat, milk, eggs, or fish than their conventional counterparts. In some cases, improved bioavailability may permit lower supplementation levels, potentially reducing total mineral excretion into the environment. However, these effects are highly dependent on nanoparticle physicochemical properties, formulation, dose, exposure duration, animal species, and dietary composition and should therefore be demonstrated experimentally rather than assumed.

Accordingly, comprehensive safety assessment of nanopremix should include:

· acute, subchronic, and chronic toxicity;

· biodistribution, tissue retention, and bioaccumulation;

· oxidative stress and inflammatory responses;

· genotoxicity and immunotoxicity;

· residues in foods of animal origin;

· effects on the gut microbiota; and

· potential environmental impacts.

The One Health framework increasingly emphasizes that the safety of nanopremix should be evaluated across interconnected domains, including animal health and welfare, food safety for consumers, occupational safety for workers involved in manufacturing and feed handling, and environmental sustainability. Such an integrated assessment is particularly important because enhanced bioavailability may increase both the beneficial biological effects and, under inappropriate exposure conditions, the potential for tissue exposure.

Synthesis of Section 2.5

Overall, the mechanisms underlying the absorption, biodistribution, and bioavailability of nanopremix indicate that nanotechnology does more than simply increase nutrient availability. It can modify the physicochemical and biological processes governing nutrient dissolution, transport, cellular interaction, tissue distribution, and utilization at the molecular and cellular levels.

Through enhanced dissolution, modulation of mucus interactions, utilization of multiple cellular uptake pathways, targeted or preferential distribution to metabolically relevant tissues, and potential interactions with the gut microbiota, nanopremix systems may improve the efficiency of mineral and vitamin utilization compared with conventional premixes. Nevertheless, the magnitude of these benefits is formulation- and species-dependent and must be established through controlled comparative studies.

Broad industrial implementation will therefore require long-term safety evaluation, standardized physicochemical characterization, validated methods for assessing tissue residues and environmental fate, reproducible manufacturing processes, and greater harmonization of international regulatory frameworks. The future development of nanopremix should consequently balance bioefficacy, safety, environmental performance, and regulatory compliance rather than focusing solely on enhanced bioavailability.

2.6. Synthesis, Formulation, and Manufacturing Technologies for Nanopremix

The development of nanopremix as a next-generation feed additive depends not only on the selection of minerals, vitamins, or bioactive compounds but also on the synthesis, formulation, and manufacturing technologies used to produce the final product. Key physicochemical attributes of nanoparticles—including particle size, size distribution, morphology, crystallinity, colloidal stability, surface properties, and encapsulation efficiency—are strongly influenced by the manufacturing process. Consequently, the selection and optimization of the synthesis technology are critical for obtaining nanopremix formulations with appropriate bioavailability, storage stability, safety, and scalability.

In modern feed manufacturing, nanopremix production must also satisfy several technical requirements, including homogeneous distribution within the feed matrix, compatibility with pelleting or extrusion, stability under thermal and moisture stress, efficient incorporation into complete feeds, and batch-to-batch consistency. In addition, increasing emphasis on sustainability has encouraged the development of more environmentally responsible synthesis strategies, including green nanotechnology, which seeks to utilize renewable or naturally derived materials, reduce the use of hazardous organic solvents, minimize energy consumption, and decrease process-generated waste.

In general, nanopremix production can be conceptually divided into three major stages: (1) nanoparticle synthesis, (2) formulation of the delivery system, and (3) industrial-scale manufacturing and incorporation into feed products.

2.6.1. Top-Down and Bottom-Up Approaches to Nanoparticle Synthesis

Nanoparticle synthesis is generally classified into two principal approaches: top-down and bottom-up. These approaches differ fundamentally in their mechanisms of particle formation and can produce materials with distinct physicochemical characteristics. The selection of an appropriate approach should therefore be based on the properties of the active ingredient, the intended delivery system, target particle characteristics, and manufacturing requirements.

2.6.1.1. Top-Down Approach

The top-down approach produces nanoparticles by reducing larger bulk materials into nanoscale particles through mechanical, physical, or physicochemical processes. Common top-down techniques include:

· high-energy ball milling;

· wet milling;

· jet milling;

· cryogenic milling;

· laser ablation; and

· high-intensity ultrasonication.

The fundamental principle is the progressive reduction of particle dimensions through the application of mechanical or physical energy. Depending on the process conditions, the chemical composition of the starting material can be largely retained, although structural defects, surface modifications, or partial phase transformations may occur.

For example, conventional zinc oxide or copper-containing mineral materials can be subjected to high-energy milling to produce particles within the nanoscale range. Process parameters such as milling time, rotational speed, milling-media composition, solid concentration, temperature, and energy input strongly influence the resulting particle size distribution and morphology.

The major advantages of the top-down approach include:

· relatively straightforward processing technology;

· compatibility with continuous or large-scale manufacturing;

· potential for high production throughput;

· suitability for processing relatively large quantities of mineral materials; and

· compatibility with established powder-processing technologies.

However, several limitations should also be considered, including:

· relatively broad particle-size distributions;

· variable particle morphology;

· possible contamination originating from milling media or equipment;

· relatively high energy requirements; and

· formation of structural defects, lattice strain, or changes in crystallinity caused by mechanical forces.

Because of these characteristics, top-down approaches are particularly relevant to the production of relatively simple nano-mineral systems, especially when the starting material is available as a bulk solid. In contrast, complex nanoencapsulation systems generally require additional formulation or bottom-up processing steps to achieve controlled particle architecture, surface functionality, and efficient incorporation of sensitive bioactive compounds.

Therefore, top-down processing should not be considered universally superior or inferior to bottom-up synthesis. Instead, the most appropriate approach depends on the desired critical quality attributes, active ingredient, target particle size, required surface characteristics, production scale, energy consumption, contamination risk, and intended application in animal nutrition.

2.6.1.2. Bottom-Up Approach

The bottom-up approach involves the construction of nanoparticles from atoms, ions, or molecules through processes of nucleation and crystal growth. Methods belonging to this approach include:

· chemical precipitation;

· co-precipitation;

· sol–gel processing;

· hydrothermal synthesis;

· solvothermal synthesis;

· microemulsion;

· nanoprecipitation; and

· biological synthesis (biosynthesis).

This approach enables more precise control over particle size, thereby producing nanoparticles with a relatively narrow size distribution, uniform morphology, and well-defined crystallinity. In the development of modern nanopremix formulations, bottom-up methods are increasingly favored because they allow the synthesis of nanoparticles with tailored physicochemical characteristics according to specific biological and nutritional requirements.

2.6.2. Green Synthesis of Nanopremix

One of the most rapidly developing approaches over the past decade has been the use of green synthesis as an alternative to conventional chemical synthesis. Green synthesis employs naturally occurring compounds as reducing and stabilizing or capping agents, thereby reducing the use of potentially toxic chemicals and minimizing environmental impacts.

Biological sources commonly used for nanoparticle synthesis include:

· plant extracts;

· polysaccharides;

· proteins;

· amino acids;

· bacteria;

· fungi;

· yeasts; and

· microalgae, such as Arthrospira platensis (Spirulina).

Various secondary metabolites, including polyphenols, flavonoids, tannins, alkaloids, and proteins, can reduce metal ions to form nanoparticles while simultaneously acting as capping agents that limit particle aggregation.

The major advantages of green synthesis include:

· environmental sustainability;

· reduced use of toxic solvents and reagents;

· improved biocompatibility of the resulting nanoparticles;

· potentially enhanced biological safety; and

· compatibility with the principles of green livestock production.

For example, the green synthesis of selenium nanoparticles using extracts of green tea, turmeric, garlic, or Spirulina has been investigated for the production of nanoparticles with enhanced antioxidant properties compared with some conventionally synthesized counterparts. However, the physicochemical characteristics, biological efficacy, and safety of green-synthesized nanoparticles remain strongly dependent on the biological source, synthesis conditions, and post-synthesis processing.

2.6.3. Nanoencapsulation Technology

Most advanced nanopremix formulations are increasingly being developed using nanoencapsulation rather than relying exclusively on free nanoparticles. Nanoencapsulation refers to the process of entrapping or incorporating minerals, vitamins, phytobiotics, or other bioactive compounds within a carrier matrix to form a more stable and controlled delivery system.

The principal functions of nanoencapsulation include:

· protecting active ingredients against oxidation and degradation;

· improving stability during storage;

· reducing nutrient losses during feed processing, particularly pelleting;

· enhancing bioavailability;

· enabling controlled release; and

· reducing the risk of excessive local exposure associated with rapid release.

This technology can improve the stability of nutrients that are particularly sensitive to heat, oxygen, moisture, or light during feed manufacturing and storage. The selection of the encapsulation matrix and processing conditions is therefore critical for maintaining the physicochemical integrity and biological activity of the encapsulated compounds.

2.6.4. Biopolymers as Carriers for Nanopremix

The selection of an appropriate carrier is a critical determinant of the performance of nanoencapsulation systems. Carrier materials should provide adequate encapsulation efficiency, physicochemical stability, biocompatibility, controlled release, and compatibility with feed-processing conditions.

Commonly investigated biopolymer-based carriers include:

Polysaccharides

· alginate;

· chitosan;

· pectin;

· gum arabic;

· carrageenan;

· modified starch; and

· nanocrystalline cellulose.

Proteins

· gelatin;

· whey protein;

· casein;

· zein; and

· soy protein.

Lipid-Based Carriers

· liposomes;

· solid lipid nanoparticles (SLNs); and

· nanostructured lipid carriers (NLCs).

Biodegradable Polymers

· poly(lactic acid) (PLA);

· poly(lactic-co-glycolic acid) (PLGA); and

· polycaprolactone (PCL).

Among these materials, alginate–chitosan systems have been extensively investigated for feed-delivery applications because of their favorable combination of biocompatibility, biodegradability, relatively low toxicity, and pH-responsive behavior. In addition, alginate–chitosan systems can be fabricated using relatively mild ionic gelation processes, making them potentially suitable for the encapsulation of heat-sensitive nutrients and bioactive compounds.

Nevertheless, the selection of a carrier should be based on the physicochemical properties of the active ingredient, the target animal species, the intended gastrointestinal release site, feed-processing conditions, storage requirements, and the overall safety profile of the formulation.

2.6.5. Nanoencapsulation Production Techniques

Various techniques have been developed to produce nanopremix delivery systems with specific particle characteristics, encapsulation efficiencies, and release profiles. The selection of a production method depends on the physicochemical properties of the active ingredient, carrier characteristics, desired particle size, processing requirements, and intended application.

a. Ionic Gelation

Ionic gelation is one of the most widely investigated techniques for the preparation of alginate- and chitosan-based nanoparticles. The process relies on electrostatic interactions and/or ionic cross-linking between oppositely charged polymers or between polymers and multivalent ions.

Major advantages include:

· relatively mild processing temperatures;

· reduced risk of thermal degradation of heat-sensitive vitamins and bioactive compounds;

· limited or no requirement for organic solvents; and

· potentially high encapsulation efficiency.

These characteristics make ionic gelation particularly attractive for the development of biodegradable and gastrointestinal-responsive nanopremix delivery systems.

b. Emulsification

Emulsification involves the formation of dispersed phases such as oil-in-water (O/W) or water-in-oil (W/O) emulsions, which can subsequently be converted into nano-sized delivery systems through appropriate stabilization and processing.

This technique is particularly suitable for lipophilic compounds, including fat-soluble vitamins such as vitamins A, D, E, and K. The final particle size and stability are strongly influenced by the type and concentration of emulsifier, the oil phase, processing energy, and formulation conditions.

c. Nanoprecipitation

Nanoprecipitation involves the mixing of a polymer solution with a suitable antisolvent, resulting in the spontaneous formation of nanoparticles as a consequence of rapid solvent displacement and polymer precipitation.

The technique can produce relatively uniform nanoparticles and is particularly useful for incorporating poorly water-soluble compounds into polymeric delivery systems. Particle size and distribution can be controlled through parameters such as polymer concentration, solvent-to-antisolvent ratio, mixing rate, and formulation composition.

d. Spray Drying

Spray drying is one of the most widely used drying technologies in the food, pharmaceutical, and feed industries. In this process, a nanoparticle dispersion or encapsulation solution is atomized into a stream of heated air, resulting in rapid solvent or water evaporation and the formation of a dry nanopremix powder.

Its major advantages include:

· high production capacity;

· relatively low operating costs at industrial scale;

· continuous processing capability; and

· compatibility with large-scale feed manufacturing.

However, the thermal exposure associated with spray drying must be carefully controlled because excessive temperature or prolonged residence time may adversely affect heat-sensitive vitamins, phytochemicals, proteins, and other bioactive compounds.

e. Spray Chilling

Spray chilling involves atomization of an active ingredient dispersed in a molten lipid or lipid-based carrier followed by rapid cooling, resulting in the formation of solidified particles.

This technique is particularly suitable for lipid-soluble and heat-sensitive compounds because it generally operates at lower thermal exposure than conventional spray drying. The selection of lipid composition and cooling conditions is critical for controlling particle size, encapsulation efficiency, release behavior, and storage stability.

f. Freeze-Drying (Lyophilization)

Freeze-drying, or lyophilization, produces dry nanoparticle formulations through freezing followed by sublimation of ice under reduced pressure. Because the process is conducted at relatively low temperatures, it is particularly useful for preserving thermally sensitive nanoparticles and bioactive compounds.

Freeze-drying can provide excellent long-term stability and may substantially reduce chemical and structural degradation during storage. However, its relatively high energy consumption, lengthy processing time, and high production cost currently limit its application for large-scale industrial nanopremix manufacturing.

Overall, the selection of a nanoencapsulation technique should consider not only particle size and encapsulation efficiency but also the stability of the active ingredient, resistance to feed-processing conditions, gastrointestinal release characteristics, scalability, production cost, and regulatory requirements. Therefore, no single production technology can be considered universally optimal for all nanopremix formulations.

2.6.6. Industrial-Scale Production of Nanopremix

The development of nanopremix formulations does not end at the laboratory scale. To enable commercial application, the production process must satisfy a range of industrial requirements, including:

· high production capacity;

· consistent particle size;

· batch-to-batch uniformity;

· adequate storage stability;

· compatibility with feed-mixing processes; and

· competitive production costs.

Industrial-scale production generally involves the following stages:

1. nanoparticle synthesis;

2. purification;

3. washing;

4. drying;

5. quality characterization;

6. premix formulation;

7. homogeneous blending;

8. packaging;

9. quality control; and

10. distribution.

The implementation of Good Manufacturing Practice (GMP) and Hazard Analysis and Critical Control Points (HACCP) is essential for ensuring product safety, consistency, quality, and traceability. For nanopremix products, these systems should be complemented by appropriate nanomaterial characterization and process controls to ensure that critical physicochemical attributes remain within predefined specifications throughout manufacturing and storage.

2.6.7. Challenges in Nanopremix Production Scale-Up

One of the major challenges in the commercialization of nanopremix is the scale-up process from laboratory development to industrial production. Several problems may arise during this transition, including:

· changes in particle size during large-scale production;

· increased aggregation or agglomeration;

· reduced encapsulation efficiency;

· difficulties in maintaining formulation homogeneity;

· high energy consumption; and

· the need for sophisticated and relatively expensive characterization equipment.

In addition, increasing the production volume can alter nanoparticle formation kinetics and mass- and heat-transfer characteristics. Consequently, process parameters such as agitation rate, precursor concentration, temperature, pH, residence time, mixing intensity, and feed rate may require systematic optimization.

Scale-up should therefore not be regarded simply as an increase in batch volume. Instead, it requires a comprehensive assessment of the relationship between critical process parameters (CPPs) and critical quality attributes (CQAs) to ensure that the physicochemical and biological performance of the nanopremix remains consistent from laboratory to industrial scale.

2.6.8. Future Prospects of Nanopremix Manufacturing Technologies

Advances in manufacturing technologies are expected to drive the development of nanopremix production systems that are increasingly precise, automated, scalable, and sustainable. Several emerging technologies have the potential to transform nanopremix manufacturing, including:

· continuous-flow nanomanufacturing, which enables continuous nanoparticle production with improved process control and batch-to-batch consistency;

· microfluidic synthesis, which provides highly controlled mixing and reaction conditions for precise regulation of nanoparticle size and morphology;

· artificial intelligence (AI) and machine learning (ML) for optimizing formulation composition and manufacturing parameters;

· three-dimensional (3D) printing for the development of customized nutrient-delivery systems; and

· smart nanoencapsulation, in which delivery systems respond to pH, enzymatic activity, temperature, redox conditions, or other physiological stimuli to achieve site-specific or condition-dependent nutrient release.

Furthermore, the integration of Quality by Design (QbD), Process Analytical Technology (PAT), and Industry 4.0 principles is expected to become increasingly important in the manufacture of commercial nanopremix products. These approaches enable real-time monitoring of critical process parameters and quality attributes, thereby improving process consistency, manufacturing efficiency, traceability, and process validation at industrial scale.

The integration of digital technologies with advanced process control may also facilitate the development of data-driven manufacturing platforms in which formulation composition, particle characteristics, processing conditions, and biological performance can be linked through predictive models. Such systems could accelerate process optimization while reducing material waste and manufacturing variability.

Synthesis of Section 2.6

The synthesis, formulation, and manufacturing technologies used for nanopremix production constitute fundamental components of the development of next-generation feed additives. The selection of appropriate synthesis strategies, whether top-down or bottom-up, together with the application of green synthesis, nanoencapsulation technologies, and natural biopolymer carriers such as alginate and chitosan, provides opportunities to develop nanopremix formulations with controlled particle characteristics, enhanced bioavailability, improved stability, and regulated nutrient-release profiles.

At the same time, successful commercialization depends strongly on the ability to achieve economically viable scale-up while maintaining product quality and biological performance. Compliance with Good Manufacturing Practice (GMP) and Hazard Analysis and Critical Control Points (HACCP), together with the implementation of Quality by Design (QbD), Process Analytical Technology (PAT), and digital manufacturing technologies, will be essential for ensuring consistent, safe, traceable, and scalable production.

2.7. Biological Mechanisms of Nanopremix Action at the Molecular and Physiological Levels

The development of nanopremix as a next-generation feed additive is based on the concept that improvements in livestock performance are not solely attributable to enhanced nutrient availability but may also arise from the ability of nanoparticles to modulate biological processes at the molecular, cellular, tissue, and physiological levels. Unlike conventional premixes, which primarily serve as sources of minerals and vitamins, nanopremix formulations possess physicochemical characteristics that can facilitate interactions with cellular membranes, proteins, enzymes, receptors, and intracellular signaling pathways. Consequently, the resulting biological responses may involve alterations in gene expression, enzymatic activity, energy metabolism, immune regulation, and cellular responses to oxidative stress.

At the cellular level, nanoparticles may be internalized through endocytic pathways and, depending on their physicochemical properties and formulation, may undergo dissolution or intracellular processing to release their constituent ions or active compounds. These species can subsequently interact with cellular compartments, including mitochondria, the endoplasmic reticulum, lysosomes, and, in some circumstances, the nucleus. Such interactions may influence multiple signal-transduction pathways involved in cellular growth, differentiation, metabolism, antioxidant defense, and immune responses.

Therefore, the biological efficacy of nanopremix should not be evaluated solely on the basis of the amount of mineral absorbed. Rather, it should also be assessed in terms of how effectively the delivered nutrient is utilized within physiological and molecular pathways, while taking into account dose, chemical form, particle characteristics, exposure duration, and the nutritional status of the target animal.

The biological mechanisms underlying nanopremix action can be considered across several interconnected levels of biological organization, including molecular regulation, cellular function, tissue integrity, physiological responses, and ultimately animal growth, health, reproduction, and productive performance.

2.7.1. Regulation of Gene Expression

One of the mechanisms potentially distinguishing nanopremix from conventional mineral supplementation is its capacity to influence molecular pathways associated with gene expression. Minerals such as zinc, selenium, copper, and iron serve not only as enzyme cofactors but also participate in the regulation of transcription factors, signaling pathways, and cellular homeostasis.

Nano-Zinc and Zinc Finger Proteins

Zinc is an essential structural component of numerous zinc-finger proteins, a diverse group of DNA-binding proteins and transcriptional regulators involved in cellular differentiation, proliferation, protein synthesis, and tissue development. Following the absorption and intracellular utilization of zinc derived from nano-zinc formulations, Zn²⁺ may contribute to the structural and functional integrity of zinc-dependent proteins and transcriptional regulators.

These zinc-dependent mechanisms are associated with the regulation of genes involved in:

· tissue growth;

· protein synthesis;

· carbohydrate metabolism;

· bone development;

· intestinal epithelial integrity and regeneration; and

· immune responses.

In broiler chickens, supplementation with nano-zinc has been investigated in relation to the expression of genes associated with growth and protein synthesis, including IGF-1 (insulin-like growth factor 1), mTOR (mechanistic target of rapamycin), and PCNA (proliferating cell nuclear antigen). Alterations in these molecular markers may be associated with enhanced cellular proliferation, protein synthesis, and growth performance. However, the magnitude and direction of these responses depend on zinc source, dose, particle characteristics, animal age, basal dietary zinc concentration, and overall nutritional status.

Nano-Selenium and Selenoprotein Regulation

Nano-selenium has attracted considerable research interest because selenium is incorporated into a range of biologically important selenoproteins, including:

· glutathione peroxidases (GPx);

· thioredoxin reductases (TrxR);

· selenoprotein P (SELENOP); and

· iodothyronine deiodinases.

These selenoproteins contribute to:

· maintenance of cellular redox homeostasis;

· protection against oxidative damage and lipid peroxidation;

· regulation of thyroid hormone metabolism; and

· modulation of immune function.

The biological effects of nano-selenium are therefore not necessarily attributable to nanoparticles themselves as intact structures. Following gastrointestinal transformation and cellular processing, selenium may enter physiological selenium metabolic pathways and contribute to selenoprotein biosynthesis. The relative bioavailability and biological activity of nano-selenium compared with conventional selenium sources remain dependent on particle characteristics, chemical form, dose, and animal species.

Nano-Iron and Regulation of Iron Homeostasis

Nano-iron may influence molecular pathways associated with iron absorption, transport, storage, and utilization. Important molecular components include:

· divalent metal transporter 1 (DMT1);

· ferroportin;

· ferritin; and

· transferrin receptor.

These proteins are central to the maintenance of systemic iron homeostasis. Following intestinal uptake and intracellular processing, iron is incorporated into regulated transport and storage pathways and can subsequently be delivered to tissues with high iron requirements, particularly the bone marrow for erythropoiesis. Adequate iron availability supports hemoglobin synthesis, oxygen transport, mitochondrial metabolism, and numerous iron-dependent enzymatic reactions.

Thus, the potential advantage of nano-iron supplementation should be evaluated not merely in terms of total iron absorption but also through indicators of iron homeostasis, including tissue iron status, hemoglobin synthesis, transferrin saturation, ferritin concentrations, and the expression of relevant iron-regulatory proteins.

2.7.2. Activation and Modulation of Metabolic Enzymes

Most minerals in nanopremixes function as cofactors for a wide range of metabolic enzymes. Nano-zinc contributes to the activity of more than 300 enzymes, including:

· alkaline phosphatase;

· carbonic anhydrase;

· DNA polymerase;

· RNA polymerase; and

· alcohol dehydrogenase.

Nano-copper serves as a cofactor for several important enzymes, including:

· cytochrome c oxidase;

· lysyl oxidase;

· dopamine β-hydroxylase; and

· Cu/Zn-superoxide dismutase.

Nano-iron supports the activity of enzymes involved in oxidative metabolism, including:

· catalase;

· cytochromes;

· peroxidases; and

· enzymes of the electron transport chain.

Meanwhile, nano-selenium enhances the activity of several selenoenzymes, particularly:

· glutathione peroxidase;

· thioredoxin reductase; and

· methionine sulfoxide reductase.

Enhanced activity of these enzymes may improve energy metabolism, support protein synthesis, and strengthen cellular defense against oxidative stress. However, the magnitude of these effects depends on the chemical form, dose, particle characteristics, bioavailability, and physiological status of the target animal.

2.7.3. Modulation of Cell Signaling Pathways

Molecular studies indicate that nanopremixes may influence several signaling pathways involved in cellular homeostasis, growth, metabolism, stress adaptation, and immune responses. Among the pathways most frequently investigated are the following.

PI3K/Akt/mTOR Pathway

The phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mechanistic target of rapamycin (mTOR) pathway plays a central role in:

· protein synthesis;

· muscle growth;

· cell proliferation; and

· energy metabolism.

Nano-zinc and nano-selenium have been reported to modulate this pathway, potentially promoting anabolic processes and tissue growth under appropriate physiological conditions.

MAPK Pathway

The mitogen-activated protein kinase (MAPK) pathway is involved in:

· cell differentiation;

· cellular responses to stress; and

· tissue regeneration.

Modulation of MAPK signaling may contribute to the adaptive responses of intestinal and other tissues to nutritional and environmental stressors.

Nrf2/Keap1 Pathway

The nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) pathway represents a major cellular defense mechanism against oxidative stress. Nano-selenium and nano-zinc may enhance Nrf2 activation and its translocation into the nucleus, thereby promoting the expression of antioxidant and cytoprotective genes, including:

· glutathione peroxidase (GPx);

· heme oxygenase-1 (HO-1);

· NAD(P)H quinone dehydrogenase 1 (NQO1);

· catalase; and

· superoxide dismutase (SOD).

Activation of the Nrf2 pathway may contribute to improved resilience of livestock to heat stress, infectious challenges, and metabolic stress.

NF-κB Pathway

Nuclear factor kappa B (NF-κB) is a major regulator of inflammatory responses. Nano-selenium, nano-zinc, and nano-formulated phytobiotics may modulate NF-κB signaling and, under appropriate conditions, attenuate the expression of pro-inflammatory mediators such as:

· tumor necrosis factor-alpha (TNF-α);

· interleukin-1 beta (IL-1β);

· interleukin-6 (IL-6); and

· cyclooxygenase-2 (COX-2).

Modulation of excessive intestinal inflammation may help preserve epithelial integrity and support more efficient nutrient utilization.

2.7.4. Enhancement of the Antioxidant System

One of the most consistently reported biological effects of nano-mineral supplementation is the enhancement of antioxidant capacity. Under normal physiological conditions, cellular metabolism generates various reactive oxygen species (ROS), including:

· superoxide radicals;

· hydrogen peroxide; and

· hydroxyl radicals.

When ROS production exceeds the capacity of endogenous antioxidant defenses, oxidative stress occurs. Excessive oxidative stress can result in:

· DNA damage;

· protein oxidation;

· lipid peroxidation; and

· impaired mitochondrial function.

Nano-selenium is particularly relevant to antioxidant defense because selenium is an essential component of several selenoproteins, including glutathione peroxidases and thioredoxin reductases. Nano-zinc contributes to antioxidant defense through its role in the structure and function of Cu/Zn-superoxide dismutase, whereas nano-copper provides copper for the same antioxidant enzyme system. Nano-iron is also associated with catalase function through its heme-containing active site.

Collectively, these minerals may contribute to the maintenance of redox homeostasis and improve the resilience of livestock to various stressors, including:

· heat stress;

· cold stress;

· transport stress;

· infectious challenges;

· mycotoxin exposure; and

· metabolic stress.

Nevertheless, antioxidant effects should be interpreted in a dose-dependent context because excessive exposure to certain metal-based nanoparticles may itself induce oxidative stress.

2.7.5. Regulation of the Immune System

In addition to supporting metabolic processes, nanopremixes may function as immunonutritional interventions by supplying essential minerals that are involved in both innate and adaptive immune responses.

Innate Immunity

Nanopremix supplementation may enhance several components of innate immunity, including:

· macrophage phagocytic activity;

· heterophil activity;

· natural killer (NK) cell activity; and

· lysozyme production.

These responses contribute to the early recognition and elimination of pathogens and help maintain mucosal immune homeostasis.

Adaptive Immunity

Nano-zinc and nano-selenium may support:

· T-lymphocyte proliferation;

· B-lymphocyte differentiation;

· production of immunoglobulins, particularly IgG and IgA; and

· vaccine-induced immune responses.

In poultry, nano-selenium supplementation has been investigated for its potential to enhance antibody responses following vaccination against diseases such as Newcastle disease and avian influenza. However, the magnitude and consistency of these effects depend on mineral dose, formulation, baseline nutritional status, animal age, health status, and vaccination conditions.

2.7.6. Regulation of Intestinal Epithelial Integrity

Nutrient utilization is closely associated with the structural and functional integrity of the intestinal mucosa. Nanopremixes containing bioavailable essential minerals may support the expression and maintenance of tight-junction proteins, including:

· occludin;

· claudins; and

· zonula occludens-1 (ZO-1).

Maintenance of these proteins strengthens the intestinal tight-junction barrier, thereby contributing to:

· reduced paracellular permeability;

· decreased bacterial translocation; and

· improved nutrient absorption.

In addition, nano-zinc supplementation has been associated in some animal studies with improvements in intestinal morphology, including increased villus height and an improved villus height-to-crypt depth (VH) ratio, which are widely used indicators of intestinal absorptive capacity and gut health.

By supporting epithelial barrier integrity and intestinal morphology, nanopremixes may create a more favorable gastrointestinal environment for nutrient digestion, absorption, and immune regulation. However, these effects should be evaluated in relation to the specific nanoparticle formulation, dose, animal species, and underlying intestinal health status.

2.7.7. Regulation of Energy Metabolism

Nano-minerals may enhance the efficiency of cellular energy production through several mechanisms, including:

· activation of the electron transport chain;

· increased ATP synthesis;

· optimization of mitochondrial function;

· enhanced fatty acid oxidation; and

· increased glycogen synthesis.

As a consequence, greater amounts of metabolically available energy may be allocated to essential physiological processes, including:

· growth;

· milk production;

· egg production;

· muscle protein synthesis; and

· reproduction.

The overall effect is expected to improve the efficiency with which dietary nutrients are converted into metabolic energy and subsequently utilized for productive and reproductive functions.

2.7.8. Integration of Molecular Responses with Production Performance

The molecular mechanisms described above ultimately translate into measurable physiological changes at both the individual-animal and herd or flock levels. A growing body of experimental research suggests that nanopremix supplementation may be associated with improvements in several production-related parameters, including:

· feed utilization efficiency and feed conversion ratio (FCR);

· average daily gain (ADG);

· milk, egg, or meat production;

· carcass quality;

· fertility and hatchability;

· antioxidant status;

· disease resistance;

· survival and reduced mortality; and

· reduced mineral excretion into the environment.

Thus, the potential benefits of nanopremixes extend beyond improved nutrient availability. Their biological effects may also arise from the coordinated modulation of molecular pathways involved in homeostasis, metabolism, oxidative balance, immune function, intestinal integrity, and physiological adaptation. The magnitude and consistency of these responses, however, depend on the mineral type, nanoparticle characteristics, dose, formulation, animal species, age, physiological status, and dietary composition.

Synthesis of Section 2.7

The biological mechanisms of nanopremixes indicate that nanotechnology has the potential to shift the paradigm of nutritional supplementation from the provision of essential minerals toward the development of multifunctional biological modulators. Nano-zinc, nano-selenium, nano-copper, nano-iron, nano-formulated vitamins, and nano-formulated phytobiotics may not only improve nutrient bioavailability but also influence gene expression, activate metabolic enzymes, modulate cell-signaling pathways, strengthen antioxidant defenses, support immune responses, maintain intestinal epithelial integrity, and optimize energy metabolism.

Interactions occurring across multiple levels of biological organization—from molecular and cellular processes to tissue function and whole-animal physiology—provide a mechanistic basis for the potential of nanopremixes to improve production efficiency, animal health, and welfare. Nevertheless, these effects should be interpreted within a dose- and formulation-dependent framework, because enhanced bioavailability does not necessarily translate into proportional improvements in biological performance.

2.8. Applications of Nanopremixes in Different Livestock Species

2.8.1. Introduction

The successful application of nanopremixes in the livestock industry depends largely on their ability to produce consistent biological responses across different animal species. Although the fundamental principle underlying nanopremix technology—namely, enhancing nutrient bioavailability through increased surface area, improved absorption efficiency, and controlled nutrient release—is broadly applicable, physiological responses to nano-mineral and nano-vitamin supplementation are influenced by species-specific differences in gastrointestinal anatomy, metabolism, nutrient requirements, physiological status, and production systems.

In recent years, research on nanopremixes has expanded rapidly across poultry, swine, ruminants, and aquaculture species. Research objectives are no longer limited to improving growth performance but increasingly encompass feed-use efficiency, gastrointestinal health, antioxidant status, immune function, reproductive performance, animal-product quality, reduction of mineral excretion into the environment, and resilience to environmental stressors such as heat stress and infectious diseases.

Overall, experimental studies suggest that nano-zinc, nano-selenium, nano-copper, nano-iron, nano-formulated vitamins, and nano-formulated phytobiotics may provide biological advantages over conventional mineral sources under specific formulation and dosage conditions. These findings indicate that nanopremixes have considerable potential to support the concept of precision animal nutrition, in which nutrients are delivered more efficiently, accurately, and sustainably according to the biological requirements of the target animal.

This section reviews the application of nanopremixes across different livestock species based on experimental and field studies and discusses their potential implementation in modern animal production systems.

2.8.2. Application of Nanopremixes in Poultry

2.8.2.1. Broiler Chickens

Broiler chickens are among the most extensively studied animal models for nanopremix research because of their rapid growth rate, high feed conversion efficiency, and sensitivity to changes in dietary nutrient quality. In addition, the broiler industry faces major challenges associated with restrictions on the use of antibiotic growth promoters (AGPs), creating a need for alternative feed additives capable of maintaining productivity while minimizing the risk of antimicrobial resistance.

Effects on Growth Performance and Feed Efficiency

Numerous studies have reported that supplementation with nano-zinc, nano-selenium, nano-copper, or nano-iron may improve several indicators of broiler performance, including:

· average daily gain (ADG);

· feed conversion ratio (FCR);

· protein utilization efficiency;

· nitrogen retention; and

· nutrient digestibility.

These improvements may be associated with several mechanisms, including:

· enhanced mineral bioavailability;

· increased activity of digestive enzymes;

· greater intestinal absorptive surface area; and

· improved gastrointestinal mucosal health.

In some experimental studies, nano-zinc supplementation at levels substantially lower than those used for conventional ZnO has produced growth performance comparable to, or in some cases better than, conventional zinc supplementation. Similarly, nano-selenium has been investigated as a selenium source capable of supporting productive performance at relatively low inclusion levels compared with conventional inorganic selenium sources such as sodium selenite. However, the magnitude of these responses varies considerably among studies and should therefore be interpreted in relation to particle characteristics, chemical form, dose, basal diet composition, animal age, and production conditions.

Effects on Intestinal Morphology

One of the proposed mechanisms underlying improved broiler performance is the enhancement of intestinal mucosal structure and absorptive capacity.

Nanopremix supplementation has been reported in some studies to increase:

· villus height;

· villus height-to-crypt depth (VH) ratio;

· intestinal absorptive surface area;

· goblet cell abundance; and

· intestinal mucosal thickness.

Conversely, excessive crypt depth may be reduced under favorable nutritional conditions, potentially indicating more efficient epithelial turnover and improved allocation of metabolic resources toward productive growth rather than tissue repair.

Improved intestinal morphology can increase the effective surface area available for nutrient absorption and may contribute to better feed utilization and growth performance. Nevertheless, intestinal responses should be evaluated together with histological, molecular, microbiological, and functional indicators because changes in villus morphology alone do not necessarily establish improved nutrient absorption.

Effects on Gut Microbiota

Nano-zinc, nano-copper, and various nano-formulated phytobiotics may exhibit selective antimicrobial activity. Several studies have reported increases in beneficial bacterial populations, including:

· Lactobacillus spp.;

· Bifidobacterium spp.; and

· Faecalibacterium spp.;

accompanied by reductions in potentially pathogenic bacteria, including:

· pathogenic Escherichia coli;

· Salmonella spp.; and

· Clostridium perfringens.

These changes in gut microbial composition may enhance the production of short-chain fatty acids (SCFAs), strengthen intestinal mucosal integrity, and improve nutrient absorption efficiency. However, the effects of nano-minerals on gut microbiota are highly dependent on dose, particle characteristics, mineral source, diet composition, and the initial microbial community.

Effects on the Immune System

Nano-selenium and nano-zinc have been investigated for their potential to enhance several components of immune function, including:

· macrophage activity;

· lymphocyte proliferation;

· immunoglobulin production, particularly IgA and IgG;

· antibody responses to vaccination; and

· expression of anti-inflammatory cytokines.

In chickens exposed to heat stress, nano-selenium supplementation has been reported in several studies to reduce malondialdehyde (MDA) concentrations, a commonly used indicator of lipid peroxidation and oxidative stress, while increasing the activities of antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD). These effects may contribute to improved cellular resilience under environmental stress conditions.

Effects on Carcass Quality

Nanopremixes may also influence several parameters associated with carcass and meat quality, including:

· increased breast meat yield;

· reduced abdominal fat deposition;

· improved water-holding capacity (WHC);

· reduced lipid oxidation; and

· improved color stability during storage.

Nano-selenium supplementation is of particular interest because it may increase selenium deposition in edible muscle tissue, resulting in selenium-enriched meat. Such biofortification may enhance the nutritional value of animal-derived foods and potentially contribute to the development of functional meat products.

2.8.2.2. Laying Hens

In laying hens, nanopremix applications are not limited to improving egg production but also aim to enhance egg quality, reproductive health, and mineral utilization efficiency.

Egg Production and Quality

Several studies have reported that nano-selenium and nano-zinc supplementation may improve:

· hen-day egg production;

· egg weight;

· egg mass;

· feed utilization efficiency;

· albumen quality;

· Haugh unit score;

· eggshell thickness; and

· eggshell strength.

Nano-zinc may contribute to carbonic anhydrase activity, an enzyme involved in the provision of carbonate ions required for calcium carbonate deposition during eggshell formation. Meanwhile, nano-selenium may enhance antioxidant protection in ovarian tissues, potentially supporting reproductive function and maintaining productive performance.

Mineral Fortification of Eggs

One rapidly developing application of nanopremixes is the production of functional eggs through mineral biofortification.

Nano-selenium supplementation may increase selenium deposition in egg yolk without necessarily compromising sensory quality. Selenium-enriched eggs may therefore provide an additional dietary source of selenium for consumers.

Similar approaches are being investigated for the production of:

· zinc-enriched eggs;

· iron-enriched eggs; and

· iodine-enriched eggs using nanoencapsulation-based delivery systems.

Such approaches may provide opportunities to produce value-added animal-derived foods with enhanced micronutrient content.

Reproductive Health

Nanopremixes may support reproductive function through several mechanisms, including:

· improved ovarian follicular development;

· reduced oxidative stress in reproductive tissues;

· modulation of reproductive hormone synthesis; and

· reduced incidence of reproductive dysfunction in aging hens.

Nano-selenium may contribute to the maintenance of granulosa-cell viability and protection against oxidative-stress-induced apoptosis. These effects may help maintain ovarian function and reproductive performance, particularly during periods of increased physiological demand.

2.8.2.3. Broiler Breeder Chickens

In broiler breeders, the primary objectives of nanopremix supplementation are to improve reproductive performance and offspring quality.

Reported benefits include:

· improved fertility;

· increased hatchability;

· improved embryo development;

· reduced embryonic mortality;

· increased day-old chick (DOC) body weight; and

· improved antioxidant status of offspring.

Nano-selenium may contribute to protecting developing embryos against oxidative stress during incubation, whereas nano-zinc may support skeletal development and immune-system maturation. Maternal mineral supplementation may therefore influence not only breeder performance but also the developmental quality and physiological resilience of the offspring.

2.8.2.4. Turkeys, Ducks, Quails, and Other Poultry Species

Although fewer studies have been conducted in poultry species other than chickens, available evidence indicates broadly similar biological responses.

In turkeys, nanopremix supplementation has been investigated for its potential to improve growth efficiency and carcass characteristics. In ducks, nano-selenium and nano-zinc have been reported to support egg quality and resilience to environmental stressors. In quails, nano-mineral supplementation has been associated in some studies with improvements in egg production, eggshell quality, fertility, and reproductive performance.

These findings suggest that the potential biological applications of nanopremixes are not restricted to a single poultry species but may extend to diverse commercial poultry production systems. Nevertheless, species-specific differences in gastrointestinal physiology, nutrient requirements, metabolism, and sensitivity to nanoparticles must be considered when designing formulations and determining supplementation levels.

2.8.2.5. Synthesis of Nanopremix Applications in Poultry

Overall, research in poultry indicates that nanopremixes may provide a range of interconnected benefits, including:

· improved growth performance and feed efficiency;

· improved gastrointestinal morphology and function;

· favorable modulation of the gut microbiota;

· enhanced antioxidant capacity;

· strengthened innate and adaptive immune responses;

· improved carcass and egg quality;

· improved reproductive performance and hatchability; and

· potentially reduced mineral excretion into the environment.

The combination of these potential benefits makes poultry one of the most promising sectors for the application of nanopremix technology. In particular, nanopremixes may contribute to strategies aimed at reducing reliance on antibiotic growth promoters (AGPs) and supporting the implementation of precision poultry nutrition. However, industrial adoption requires rigorous evaluation of efficacy, toxicological safety, product consistency, regulatory compliance, and environmental implications.

2.8.3. Application of Nanopremixes in Swine Production

2.8.3.1. Introduction

The swine industry is one of the livestock sectors that has extensively adopted precision nutrition technologies to improve production efficiency, gastrointestinal health, reproductive performance, and carcass quality. Over the past two decades, interest in nanopremixes has increased substantially, particularly as several jurisdictions have introduced restrictions on the use of pharmacological concentrations of zinc oxide (ZnO) and antibiotic growth promoters (AGPs) because of concerns regarding antimicrobial resistance and environmental contamination.

These developments have stimulated the search for alternative feed additives capable of maintaining productive performance while reducing excessive mineral excretion and minimizing the risks associated with antimicrobial use. Nanopremixes containing nano-zinc, nano-selenium, nano-copper, nano-iron, nano-formulated vitamins, and nano-formulated phytobiotics represent one promising approach because enhanced bioavailability may allow effective nutritional responses at lower supplementation levels than conventional mineral sources.

In swine production, nanopremix applications may encompass the entire production cycle, including suckling piglets, weaned piglets, growing-finishing pigs, sows, and boars. Each production stage has distinct physiological and nutritional requirements; consequently, nanopremix formulations and supplementation strategies should be tailored to the specific developmental stage, production objective, and health status of the animals.

2.8.3.5. Application of Nanopremix in Growing–Finishing Pigs

During the growing and finishing phases, the primary objectives of nanopremix supplementation are to improve nutrient utilization efficiency, accelerate muscle tissue development, maintain gastrointestinal health, and enhance carcass quality. During these stages, the requirements for minerals such as zinc, selenium, copper, and iron increase in association with tissue development, metabolic activity, and protein deposition.

Nano-zinc plays important roles in protein metabolism, DNA synthesis, cell proliferation, and tissue regeneration. Increased zinc availability at the cellular level may support the activity of enzymes involved in muscle growth and intestinal epithelial health. Meanwhile, nano-selenium contributes to the maintenance of antioxidant defense by enhancing the activities of glutathione peroxidase and thioredoxin reductase. The combination of these two minerals may improve nutrient utilization efficiency, particularly under production conditions characterized by high environmental stress.

Nano-copper also plays an important role in energy metabolism and connective tissue formation. Copper is required for the activity of cytochrome c oxidase in mitochondrial respiration and lysyl oxidase in collagen formation and maturation. Accordingly, nano-copper supplementation may improve energy utilization and support body tissue development.

From a production perspective, the expected responses include increased average daily gain (ADG), improved feed conversion ratio (FCR), enhanced nitrogen retention, and increased protein deposition. However, these responses are not necessarily linear with increasing dose. Therefore, nanopremix formulation should take into account the basal mineral content of the diet, physiological status of the animals, other dietary mineral sources, and potential interactions among minerals.

2.8.3.6. Effects of Nanopremix on Carcass and Pork Quality

In addition to promoting growth, nanopremix may influence carcass quality and meat characteristics. Selenium is among the most extensively investigated minerals because of its close association with antioxidant defense in muscle tissue. Improved selenium status may enhance cellular membrane protection against lipid oxidation during the postmortem period and subsequent meat storage.

Nano-selenium may also improve the oxidative stability of meat by enhancing GPx activity and other antioxidant enzymes. This condition may contribute to maintaining meat color, reducing the formation of lipid oxidation products, and preserving water-holding capacity. From an industrial perspective, these characteristics are important because they are directly associated with shelf life, product appearance, fluid loss, and consumer acceptance.

Nano-zinc and nano-copper may also influence protein deposition and lipid metabolism. However, their effects on carcass yield, backfat thickness, loin eye area, and meat composition should be evaluated according to the specific dose and formulation because responses may vary among genetic strains, age groups, sexes, and feeding systems.

2.8.3.7. Application of Nanopremix in Sows

In sows, nanopremix supplementation has strategic importance because nutrient requirements increase substantially during gestation and lactation. Minerals such as zinc, selenium, copper, and iron contribute to maintaining reproductive health, fetal development, milk production, and nutrient transfer from the sow to her offspring.

Nano-selenium may improve the antioxidant status of sows during gestation and lactation, periods characterized by substantially increased metabolic demands. Enhanced antioxidant capacity may help mitigate oxidative stress associated with fetal development, parturition, and milk production.

Nano-zinc contributes to epithelial integrity, immune function, protein metabolism, and tissue repair. Adequate zinc availability in sows is also important for supporting fetal tissue development and mammary gland health. Meanwhile, nano-iron is particularly relevant because iron requirements increase during gestation and lactation as a consequence of maternal blood-volume expansion and the requirements for hemoglobin synthesis in fetuses and piglets.

During lactation, the effectiveness of nanopremix supplementation can be assessed based on sow feed intake, body-weight changes, milk production, body condition, weaning-to-estrus interval, and piglet performance. Thus, nanopremix supplementation in sows is not intended solely to improve maternal health but may also potentially exert effects through maternal programming of offspring development.

2.8.3.8. Application of Nanopremix in Boars

In boars, zinc and selenium are important minerals associated with spermatogenesis, sperm quality, motility, membrane integrity, and protection of sperm DNA against oxidative damage.

Selenium is an essential component of several selenoproteins involved in protecting reproductive cells against oxidative stress. Zinc, in contrast, is associated with sperm chromatin stability, testicular development, and various enzymatic processes required during spermatogenesis.

Nanopremix supplementation may improve sperm concentration and motility, maintain sperm membrane integrity, and reduce the proportion of spermatozoa exhibiting oxidative damage. Improved semen quality in boars has important implications because a single boar may contribute genetically to a large number of offspring through natural mating or artificial insemination.

Nevertheless, nanopremix supplementation in boars should be based on quantitatively determined nutritional requirements. Excessive mineral supplementation does not necessarily improve semen quality and, under certain conditions, may disrupt redox balance and mineral homeostasis.

2.8.3.9. Effects of Nanopremix on the Porcine Immune System

The immune system represents an important biological target of nanopremix supplementation in pigs. Zinc, selenium, copper, and iron are involved in immune-cell development, antioxidant enzyme activity, intercellular communication, and responses to infectious agents.

Nano-zinc may support intestinal epithelial integrity as well as immune-cell function. Nano-selenium contributes to maintaining redox homeostasis during immune activation, thereby allowing inflammatory responses to occur in a more regulated manner. By maintaining antioxidant defense and mucosal integrity, nanopremix may help reduce the physiological consequences of infection and environmental stress.

In weaned piglets, these mechanisms are particularly important because both the immune system and gastrointestinal tract are still undergoing maturation. However, immunomodulatory effects should be distinguished from direct antimicrobial effects. Not all nanoparticles exhibiting antibacterial activity in vitro will produce equivalent effects when administered through feed because the gastrointestinal environment can alter nanoparticle size, surface charge, solubility, and reactivity.

2.8.3.10. Nanopremix and Reduction of Mineral Excretion

One potential advantage of nanopremix in swine production is its ability to improve mineral utilization efficiency and thereby reduce the amount of minerals excreted in feces.

With conventional supplementation, minerals are often provided in excess to ensure that physiological requirements are adequately met. A proportion of the minerals that are not absorbed is subsequently excreted in feces and may enter the environment. The use of mineral sources with higher bioavailability may enable more precise dietary formulation.

Reducing the excretion of zinc, copper, selenium, or other minerals may provide environmental benefits, particularly in high-density livestock production systems. However, the claim that nanopremix supplementation invariably reduces mineral excretion should be substantiated through mass-balance studies comparing mineral intake, tissue retention, and quantitative excretion.

This approach is more consistent with the concept of precision mineral nutrition, in which minerals are supplied according to the actual biological requirements of the animals rather than simply increasing supplementation levels.

2.8.3.11. Synthesis of Nanopremix Applications in Swine Production

Overall, nanopremix applications in swine production have broad potential, ranging from the post-weaning stage to reproductive management. In piglets, the primary objectives are to maintain intestinal integrity, mitigate post-weaning disturbances, and promote growth. During the growing and finishing stages, nanopremix is primarily intended to improve feed efficiency, protein deposition, metabolic health, and carcass quality. In sows and boars, the expected benefits are more closely associated with reproductive health, antioxidant status, gamete quality, and reproductive success.

Nevertheless, the scientific evidence regarding nanopremix applications in pigs should not be generalized excessively. Biological responses are strongly influenced by the chemical form of the mineral, nanoparticle size and physicochemical characteristics, dose, carrier material, manufacturing method, animal age, health status, dietary composition, and housing environment. Therefore, comparisons between nanopremix and conventional mineral sources should be conducted at biologically equivalent doses and should simultaneously assess bioavailability, retention, production performance, and safety.

2.8.4. Application of Nanopremix in Ruminants

Ruminants possess a digestive system that differs fundamentally from that of poultry and pigs because of the rumen, which represents a complex fermentative ecosystem. Consequently, the behavior of nanoparticles within ruminants cannot be assumed to be identical to that observed in monogastric animals.

In cattle, buffaloes, goats, and sheep, some nanoparticulate minerals initially interact with rumen microorganisms before reaching the intestine. Therefore, in addition to their bioavailability to the host animal, nanopremix formulations should also be evaluated in terms of their effects on ruminal fermentation, microbial populations, volatile fatty acid production, microbial protein synthesis, and methane production.

2.8.4.1. Application in Beef Cattle

In beef cattle, nanopremix has the potential to improve growth efficiency by optimizing energy metabolism, protein synthesis, antioxidant defense, and rumen health. Nano-zinc supports epithelial integrity and various enzymatic activities, whereas nano-selenium contributes to maintaining redox homeostasis during growth and periods of stress.

Nano-copper contributes to energy metabolism and connective tissue formation, while nano-iron supports erythropoiesis and oxygen transport. The combination of these minerals may improve ADG, feed efficiency, and carcass quality when provided in formulations appropriately matched to animal requirements.

Under heat-stress conditions, enhanced antioxidant capacity is particularly important because elevated ambient temperatures may increase ROS production and impair feed intake. Nano-selenium may help maintain antioxidant defense, although its effectiveness remains dependent on dose and the animal's basal selenium status.

2.8.4.2. Application in Dairy Cattle

In dairy cattle, nutrient requirements increase substantially during the transition period, early lactation, and peak milk production. Nanopremix may be used to support energy metabolism, udder health, immune function, reproductive performance, and milk quality.

Nano-selenium may support antioxidant defense and immune function, whereas nano-zinc contributes to epithelial integrity, protein metabolism, and immune responses. Optimal mineral availability is also associated with hoof health, reproductive performance, and the ability to sustain milk production.

One potentially important application is the biofortification of milk with selenium or other essential minerals. However, increases in mineral concentrations in milk should always be evaluated together with food-safety considerations, mineral transfer from feed to milk, and the maximum tolerable intake levels for consumers.

2.8.4.3. Application in Goats and Sheep

Goats and sheep represent promising species for nanopremix applications, particularly in tropical and subtropical production systems facing challenges related to mineral deficiencies, heat stress, parasitic infections, and fluctuating forage quality.

Nano-selenium and nano-zinc may improve antioxidant status, immune function, growth, and reproductive performance. In breeding females, appropriate mineral supplementation may support fetal development and colostrum quality. In males, selenium and zinc may contribute to spermatogenesis and semen quality.

However, differences in rumen characteristics and mineral requirements among species must be considered when developing formulations. Dosages developed for cattle cannot be directly applied to goats or sheep without appropriate validation.

2.8.4.4. Nanopremix and Rumen Fermentation

One of the most important considerations in the use of nanopremix in ruminants is its interaction with the rumen microbiota. Nanoparticles may influence bacteria, protozoa, and methanogenic archaea through changes in mineral availability, interactions with cell membranes, or alterations in the redox environment.

From a nutritional perspective, changes in rumen microbial communities may affect fiber degradation, acetate, propionate, and butyrate production, as well as microbial protein synthesis. At the same time, alterations in methanogenic archaeal populations may influence enteric methane production.

These potential effects make nanopremix an interesting approach for improving feed efficiency and mitigating emissions, but such applications must be approached cautiously. A reduction in the population of a particular microbial group does not necessarily translate into improved animal productivity because the rumen ecosystem is characterized by complex metabolic interactions. Evaluation should therefore include fermentation characteristics, nutrient digestibility, gas production, VFA profiles, microbial protein synthesis, animal performance, and safety.

2.8.4.5. Synthesis of Nanopremix Applications in Ruminants

In ruminants, nanopremix has the potential to improve mineral utilization efficiency, antioxidant status, reproductive health, productivity, and the quality of animal-derived products. However, its success depends strongly on the ability of the formulation to preserve the biological function of the nutrients without disrupting the balance of the rumen microbiota.

Therefore, the development of nanopremix for ruminants should adopt a host–rumen microbiome interaction framework. This approach considers nanopremix not merely as a mineral source for the animal but as a component that interacts with the microbial ecosystem before nutrients reach host tissues.

2.8.5. Application of Nanopremix in Aquaculture

Aquaculture has physiological characteristics that differ from those of terrestrial livestock production systems. Minerals and bioactive compounds can be administered through feed, but some may also interact directly with the aquatic environment. Therefore, nanopremix formulations for fish and shrimp must consider not only animal bioavailability but also nanoparticle stability in water and potential effects on non-target organisms.

Nano-zinc, nano-selenium, nano-iron, and various phytobiotic-based nanoparticles have been investigated for their potential to improve growth, antioxidant status, immune responses, disease resistance, and tissue quality in cultured fish.

2.8.5.1. Effects on Growth and Feed Efficiency

In cultured fish, nanopremix may improve growth through enhanced nutrient digestibility, digestive enzyme activity, energy metabolism, and antioxidant status. Common indicators include weight gain, specific growth rate (SGR), feed conversion ratio (FCR), protein efficiency ratio (PER), and survival rate.

Nano-minerals can be administered at relatively low levels because their high surface area and reactivity may enhance biological interactions compared with conventional mineral forms. However, optimal doses must be determined through dose–response studies because increasing the dose does not necessarily result in improved performance.

2.8.5.2. Enhancement of Immunity and Disease Resistance

Nanopremix may function as an immunonutrient in fish by enhancing phagocytic activity, lysozyme activity, complement activity, and antioxidant responses. Selenium and zinc play important roles in maintaining immune function and controlling oxidative stress during infection.

Improved immune status may enhance fish resistance to various pathogens. However, the effectiveness of nanopremix should be distinguished from claims that it can serve as a replacement for antibiotics. Antimicrobial activity of nanoparticles in vitro does not automatically demonstrate therapeutic efficacy in vivo in fish.

2.8.5.3. Environmental Safety in Aquaculture Systems

Unlike terrestrial livestock, some nanoparticles that are not ingested or absorbed may be released directly into the aquatic environment. Therefore, safety assessment of aquaculture nanopremix should include toxicity evaluations involving phytoplankton, zooplankton, environmental bacteria, benthic organisms, and other non-target species.

This approach is important within the frameworks of One Health and One Water, because the safety of aquaculture products cannot be separated from the quality of aquatic ecosystems. A formulation that enhances bioavailability in fish but generates persistent nanoparticle residues in the environment cannot be considered a sustainable solution.

2.8.5.4. Synthesis of Nanopremix Applications in Aquaculture

Overall, nanopremix has potential to support growth, feed efficiency, immune function, and stress resilience in fish and other aquaculture organisms. However, product development must consider the interactions among three major components: nanoparticles, aquatic animals, and the aquatic environment.

Accordingly, the success of aquaculture nanopremix should not be evaluated solely on the basis of growth performance or FCR, but also in terms of tissue residues, excretion, stability in water, toxicity to non-target organisms, and long-term ecological effects.

2.8.6. Comparison of Nanopremix Responses Across Species

Differences in digestive physiology and metabolism result in species-specific responses to nanopremix. Poultry and pigs, as monogastric animals, allow nanoparticles to interact relatively directly with the gastric and intestinal environments. In contrast, ruminants possess the rumen, which represents both a biological barrier and an additional biological target, whereas fish are exposed to an aquatic environment that can influence nanoparticle stability and distribution.

Therefore, the concept of species-specific nanoformulation is becoming increasingly important. An optimal formulation for broilers may not be optimal for dairy cattle or fish. Differences in gastrointestinal pH, transit time, microbiota composition, mineral requirements, metabolism, and feed intake patterns should form the basis for formulation design.

2.8.7. The Principle of Precision Nanonutrition in Animal Production

The development of nanopremix across different animal species is leading toward a new concept that may be described as precision nanonutrition. This concept integrates animal-specific nutritional requirements with nanoparticle physicochemical characteristics, delivery technologies, physiological conditions, and biological targets.

Under this approach, dosage is not determined solely by the mineral concentration in the feed but also considers actual bioavailability, metabolic requirements, health status, age, sex, production stage, and environmental conditions.

The integration of animal sensors, precision feeding, artificial intelligence, machine learning, and omics data has the potential to enable more adaptive nanopremix formulation. Such systems could link the physiological status of animals with their nutrient requirements dynamically, allowing supplementation to be delivered with greater precision.

2.8.8. Synthesis of Section 2.8

Applications of nanopremix in poultry, swine, ruminants, and aquaculture demonstrate the broad potential of nanotechnology to improve nutrient-use efficiency, health, reproductive performance, product quality, and resilience to environmental stress. In poultry, the principal benefits include improvements in growth, carcass and egg quality, immunity, and feed efficiency. In swine, nanopremix primarily shows potential for supporting post-weaning intestinal health, growth performance, meat quality, and reproductive function. In ruminants, major considerations include mineral metabolism, reproductive health, antioxidant status, and interactions with the rumen microbiota. In aquaculture, growth and immune responses must be considered together with aquatic environmental safety.

Nevertheless, evidence regarding the superiority of nanopremix should be interpreted critically. Not all nanoparticles exhibit identical biological behavior, and increased bioavailability does not necessarily translate into improved efficacy or safety. Therefore, nanopremix evaluation should integrate physicochemical characterization, pharmacokinetic or toxicokinetic assessment, bioavailability, production performance, tissue residues, microbiota responses, and environmental impacts.

With this approach, nanopremix can be developed not merely as a substitute for conventional mineral sources but as a precision animal nutrition platform capable of delivering nutrients more efficiently, specifically, safely, and sustainably. Successful implementation will nevertheless depend on rigorous dose validation, manufacturing consistency, standardized nanoparticle characterization, long-term safety assessment, and regulatory harmonization before widespread adoption in the livestock industry.

2.8.3.5. Nano-Copper and Nano-Iron

Nano-Copper

Copper is an essential mineral involved in energy metabolism and connective tissue formation. In nanoparticulate form, copper may exhibit higher bioavailability, enhanced antimicrobial activity, and improved utilization efficiency compared with conventional copper sources.

Nano-copper may enhance:

· oxidative enzyme activity;

· collagen synthesis;

· iron metabolism; and

· growth efficiency.

The use of nano-copper may also allow a reduction in the supplemental dose while maintaining biological efficacy, thereby potentially reducing copper accumulation in livestock manure and minimizing environmental loading.

Nano-Iron

Piglets are particularly susceptible to iron deficiency because they are born with relatively low iron stores and receive only limited amounts of iron from sow's milk. Nano-iron has therefore been investigated as an alternative to conventional iron preparations.

Several studies have reported that nano-iron supplementation can improve:

· hemoglobin concentration;

· erythrocyte count;

· hematocrit;

· oxygen transport capacity; and

· growth performance.

An important potential advantage of nano-iron is its more controlled release of iron, which may reduce the excessive generation of reactive oxygen species (ROS) associated with high-dose iron supplementation. However, the extent of this advantage depends on nanoparticle characteristics, dose, formulation, and the iron status of the piglets.

2.8.3.6. Nano-Vitamins and Nano-Phytobiotics

In addition to minerals, recent studies have increasingly investigated nanopremix formulations containing:

· nano-vitamin A;

· nano-vitamin D;

· nano-vitamin E;

· nano-vitamin C;

· nano-curcumin;

· nano-garlic;

· nano-oregano;

· nano-thyme; and

· nano-ginger.

Nano-formulated vitamins may exhibit improved stability against oxidation and thermal degradation during feed processing, including pelleting. Meanwhile, nano-phytobiotics may provide antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory activities.

Nanoencapsulation can improve the aqueous dispersibility and bioavailability of phytochemicals that otherwise exhibit poor solubility and limited bioavailability, such as curcumin and various essential oils. By improving stability and controlling release, nano-phytobiotic systems may enhance the biological efficacy of these compounds while potentially reducing the required supplementation level.

2.8.3.7. Application of Nanopremix in Sows

In sows, the primary objective of nanopremix supplementation is to support reproductive efficiency and maternal health. Nano-selenium supplementation has been reported to potentially improve:

· the number of piglets born alive;

· birth weight;

· colostrum quality;

· milk immunoglobulin content;

· maternal antioxidant status; and

· postpartum recovery.

Nano-zinc may support placental development and ovarian function through its involvement in enzymatic processes associated with DNA synthesis, cell proliferation, and tissue development.

During lactation, combinations of nano-minerals may increase the transfer of essential minerals into milk, thereby supporting the growth and development of suckling piglets. Nevertheless, the magnitude of these effects depends on the mineral source, dose, basal dietary mineral concentration, sow parity, and physiological stage.

2.8.3.8. Application of Nanopremix in Boars

Male reproductive performance is also strongly influenced by adequate mineral nutrition. Nano-selenium and nano-zinc may improve:

· sperm concentration;

· sperm motility;

· sperm viability;

· sperm membrane integrity; and

· sperm DNA stability.

These improvements are associated, at least in part, with enhanced antioxidant protection in seminal plasma, which helps protect spermatozoa from oxidative damage caused by excessive ROS generation.

Because oxidative stress can impair sperm membrane integrity, mitochondrial function, motility, and DNA integrity, adequate selenium and zinc nutrition may be particularly important for maintaining semen quality. However, excessive mineral supplementation may disrupt redox homeostasis and mineral metabolism; therefore, supplementation should be based on established nutritional requirements rather than on the assumption that higher doses will necessarily improve reproductive performance.

2.8.3.9. Effects on Carcass and Pork Quality

In finishing pigs, nanopremix supplementation may provide several potential benefits for final product quality. Reported or investigated parameters include:

· carcass yield;

· longissimus dorsi muscle area;

· meat color;

· water-holding capacity;

· tenderness;

· oxidative stability; and

· shelf life.

Nano-selenium may play an important role in reducing lipid oxidation by enhancing endogenous antioxidant defenses, thereby slowing rancidity development during meat storage. Improved oxidative stability may contribute to better maintenance of meat color, reduced formation of lipid oxidation products, and improved product quality during refrigerated storage.

However, the effects of nano-minerals on carcass composition and meat quality are not necessarily uniform and may depend on the genetic background, sex, age, feeding system, dietary composition, mineral source, and supplementation level.

2.8.3.10. Environmental Implications

One of the major potential advantages of nanopremix over conventional premixes is the possibility of reducing mineral excretion. Because nano-formulated minerals may have higher biological availability, supplementation levels could potentially be reduced while maintaining adequate mineral status.

Potential environmental benefits include:

· reduced zinc excretion;

· reduced copper excretion;

· lower soil contamination;

· reduced mineral accumulation in agricultural land; and

· potentially lower environmental loading of trace elements.

These considerations are particularly important in intensive pig production systems, where large quantities of manure are generated and repeated land application may result in the accumulation of trace elements. Nevertheless, reductions in mineral excretion should be demonstrated through quantitative mass-balance studies that account for dietary intake, absorption, tissue retention, and fecal and urinary excretion.

2.8.3.11. Challenges in Implementing Nanopremix in the Pig Industry

Despite promising experimental findings, the implementation of nanopremix in commercial pig production still faces several challenges, including:

· relatively high nanoparticle production costs;

· standardization of particle size and physicochemical characteristics;

· stability during feed processing and storage;

· long-term safety validation;

· international regulatory harmonization; and

· market acceptance of nanotechnology-based feed additives.

In addition, larger-scale commercial field trials are required to determine whether findings obtained under controlled experimental conditions can be consistently reproduced under intensive production environments. Such studies should evaluate not only growth performance but also mineral bioavailability, tissue residues, animal health, product quality, environmental emissions, and economic return.

2.8.3.12. Synthesis of Nanopremix Applications in Swine

Overall, current research indicates that nanopremix has considerable potential to improve production efficiency in swine through interconnected mechanisms, including enhanced mineral bioavailability, improved intestinal health, modulation of the gut microbiota, strengthened immune function, enhanced antioxidant capacity, optimized reproductive performance, and improved carcass and meat quality.

Among the various nanopremix components, nano-zinc is one of the most promising candidates for reducing reliance on pharmacological zinc oxide supplementation during the post-weaning period, whereas nano-selenium has considerable potential for improving antioxidant status and reproductive performance. The combination of multiple nano-minerals, nano-vitamins, and nano-phytobiotics in a multicomponent nanopremix formulation is likely to become an important direction for future development in precision swine nutrition.

Nevertheless, the potential advantages of nanopremix should not be interpreted as evidence that all nano-formulations are inherently superior to conventional mineral sources. Their efficacy and safety are strongly dependent on particle size, chemical form, surface properties, dose, carrier system, manufacturing process, and physiological context. Therefore, comparative studies should evaluate nanopremix against conventional sources using biologically equivalent doses and integrated indicators of efficacy, bioavailability, tissue retention, environmental excretion, and safety.

2.8.4. Application of Nanopremix in Ruminants

2.8.4.1. Introduction

Ruminants possess a digestive system that differs fundamentally from that of poultry and pigs because of the rumen, a major fermentation chamber inhabited by a complex microbial community comprising bacteria, protozoa, fungi, and methanogenic archaea. This system enables ruminants to utilize structural carbohydrates as an important energy source but simultaneously creates unique challenges for the delivery of minerals, vitamins, and bioactive compounds.

Some nutrients may undergo transformation, degradation, sequestration, or binding with feed components within the rumen, potentially reducing their availability to the host animal. Consequently, the biological performance of a nanopremix in ruminants cannot be evaluated solely on the basis of its absorption in the gastrointestinal tract; its interactions with the rumen ecosystem must also be considered.

In this context, nanopremix technology offers a potential approach for improving the efficiency of mineral supplementation through enhanced stability, controlled release, and more targeted delivery to the small intestine, which is a major site of nutrient absorption. Nanotechnology also provides opportunities to develop rumen-protected nanopremix systems, which are designed to withstand ruminal fermentation while releasing their active nutrients more efficiently in the abomasum or small intestine.

Research on nanopremix applications in ruminants remains more limited than that in poultry and pigs, although the number of publications has increased substantially over the past decade. Current research has focused on improving feed efficiency, milk production, growth performance, carcass quality, antioxidant status, reproductive function, udder health, and the reduction of enteric methane emissions and mineral excretion into the environment.

Because the rumen is a highly interconnected microbial ecosystem, future development of nanopremix for ruminants should adopt a host–rumen microbiome interaction perspective. This approach recognizes that the biological effects of nanoparticles may arise not only from direct effects on the host animal but also from changes in ruminal microbial communities, fermentation pathways, nutrient transformation, and microbial metabolite production.

2.8.4.2. Specific Challenges of Nanopremix Administration in Ruminants

The successful application of nanopremix in ruminants is strongly influenced by the physicochemical and biological characteristics of the rumen environment. Major challenges include:

· ruminal pH ranging approximately from 5.8 to 7.0;

· highly active microbial fermentation;

· microbial degradation of certain vitamins;

· formation of mineral complexes with phytate or dietary fiber;

· adsorption of minerals onto feed particles; and

· variations in ruminal retention time.

If nanoparticles do not possess adequate stability under ruminal conditions, a substantial proportion of the active payload may be released prematurely, thereby becoming available to ruminal microorganisms or undergoing precipitation before reaching the small intestine.

Therefore, the design of nanopremix formulations for ruminants should consider:

· stability under ruminal fermentation conditions;

· responsiveness to pH changes;

· post-ruminal release; and

· compatibility with the ruminal microbiota.

These characteristics are particularly important for ensuring that the intended nutrient reaches the post-ruminal digestive tract while minimizing unintended disruption of ruminal fermentation.

2.8.4.3. Concept of Rumen-Protected Nanopremix

One of the rapidly developing innovations in ruminant nutrition is the rumen-protected nanopremix, a nutrient delivery system that combines nanotechnology with rumen-protection strategies.

The fundamental principles of this approach are:

1. nanoparticles remain sufficiently stable during their residence in the rumen;

2. the protective coating is resistant to degradation by ruminal microorganisms; and

3. nutrient release occurs after the formulation reaches the abomasum or small intestine in response to changes in pH and digestive enzyme activity.

Various carrier materials have been investigated for rumen-protected delivery systems, including:

· alginate;

· chitosan;

· ethylcellulose;

· rumen-stable lipids;

· rumen-protected proteins;

· modified polysaccharides; and

· lipid–polymer hybrid matrices.

This technology has the potential to improve mineral bioavailability while minimizing unintended interactions with the ruminal microbial ecosystem. However, the effectiveness of rumen protection depends strongly on the physicochemical characteristics of the nanoparticles, coating materials, particle size, feed matrix, and release kinetics.

2.8.4.4. Application in Dairy Cattle

2.8.4.4.1. Milk Production and Composition

In dairy cattle, the primary objective of nanopremix supplementation is to improve nutrient metabolic efficiency so that a greater proportion of available metabolic energy can be directed toward milk synthesis.

Various studies have investigated nano-zinc, nano-selenium, nano-copper, and nano-iron for their potential effects on:

· daily milk yield;

· feed utilization efficiency;

· milk protein content;

· milk fat content;

· lactose concentration; and

· total solids.

These responses may be associated with improved energy metabolism, hepatic function, and the activity of enzymes involved in the synthesis of milk components. Nevertheless, the magnitude and consistency of these effects may vary according to mineral source, nanoparticle characteristics, supplementation dose, basal dietary mineral status, stage of lactation, and environmental conditions.

2.8.4.4.2. Udder Health and Mastitis

Mastitis is one of the diseases with the greatest economic impact on the dairy industry. Adequate mineral nutrition, particularly selenium and zinc, is important for maintaining immune competence and antioxidant defense in mammary tissue.

Nano-selenium and nano-zinc may support:

· neutrophil activity;

· macrophage phagocytic activity;

· glutathione peroxidase activity; and

· antioxidant capacity of mammary tissue.

These effects may help reduce oxidative damage associated with inflammatory responses and thereby contribute to maintaining udder health.

Some studies have also reported reductions in somatic cell count (SCC) following nano-selenium supplementation, suggesting potential improvements in mammary gland health. However, SCC is influenced by multiple factors, including pathogen exposure, milking hygiene, stage of lactation, and management practices; therefore, changes in SCC should not be attributed exclusively to nanopremix supplementation.

2.8.4.4.3. Heat Stress in Dairy Cattle

Heat stress is a major constraint on dairy productivity, particularly in tropical and subtropical production systems. Nanopremix may contribute to improved tolerance to heat stress through several mechanisms, including:

· enhancement of GPx and SOD activity;

· reduction of malondialdehyde (MDA) concentrations;

· modulation of heat shock protein 70 (HSP70) expression; and

· protection of mitochondrial function.

These responses may contribute to the maintenance of metabolic homeostasis and milk production during periods of elevated environmental temperature. However, nanopremix should be considered as a complementary nutritional strategy rather than a substitute for comprehensive heat-stress mitigation measures such as ventilation, shade, cooling systems, and adequate water availability.

2.8.4.5. Application in Beef Cattle

In beef cattle, the primary objectives of nanopremix supplementation are to improve growth efficiency, nutrient utilization, and carcass quality.

Nano-mineral supplementation has been investigated for its potential to improve:

· average daily gain (ADG);

· feed conversion ratio (FCR);

· muscle protein synthesis;

· nitrogen retention;

· longissimus dorsi muscle area; and

· carcass quality.

Nano-zinc may support enzymatic processes involved in protein synthesis and tissue development, whereas nano-selenium may enhance antioxidant protection during the finishing phase, potentially contributing to improved meat quality.

2.8.4.5.1. Meat Quality

Several studies have investigated the effects of nanopremix supplementation on meat quality parameters, including:

· color stability;

· water-holding capacity;

· tenderness;

· oxidative stability; and

· product shelf life.

Nano-selenium may be particularly relevant because enhanced selenium status can increase the activity of endogenous antioxidant enzymes and reduce lipid peroxidation. Consequently, oxidative deterioration and rancidity during storage may be delayed.

Nevertheless, the effects on meat quality should be interpreted in relation to slaughter conditions, postmortem handling, muscle type, storage temperature, dietary composition, and the specific selenium source used.

2.8.4.6. Application in Goats and Sheep

Research on nanopremix applications in goats and sheep has expanded considerably because these species are widely raised in production systems where feed quality and mineral availability may fluctuate substantially.

Supplementation with nano-zinc and nano-selenium has been investigated for its potential to improve:

· average daily gain;

· feed utilization efficiency;

· blood mineral status;

· antioxidant capacity;

· wool quality in sheep; and

· growth performance of young animals.

In dairy goats, nanopremix supplementation has also been investigated for its potential to increase milk production and milk protein concentration.

The biological response, however, may vary between goats and sheep because of differences in ruminal physiology, breed, age, production system, basal diet, and mineral requirements. Therefore, nanopremix formulations should be developed and validated on a species-specific basis rather than directly extrapolated from studies conducted in cattle.

2.8.4.7. Effects on Rumen Fermentation

One of the most extensively investigated aspects of nanopremix application in ruminants is its interaction with the ruminal microbiota. When supplied at nutritionally appropriate levels, nano-minerals may influence ruminal microbial activity through several mechanisms, including:

· stimulation of microbial enzyme synthesis;

· enhancement of fiber degradation;

· improvement of microbial protein synthesis; and

· enhancement of microbial synthesis of B vitamins.

Conversely, excessive supplementation may inhibit certain microbial populations and disrupt the balance of the ruminal ecosystem. Therefore, nanopremix formulation should carefully consider the dose-dependent effects of nano-minerals on ruminal microorganisms and fermentation dynamics.

Volatile Fatty Acid (VFA) Production

Several studies have investigated the potential effects of nano-mineral supplementation on the production of major volatile fatty acids (VFAs), including:

· acetate;

· propionate; and

· butyrate.

An increase in propionate production is particularly important because propionate serves as a major precursor for hepatic gluconeogenesis in ruminants and therefore contributes substantially to glucose supply and energy metabolism.

Efficiency of Microbial Protein Synthesis

Minerals such as zinc, copper, and selenium are required as cofactors for numerous microbial enzymes involved in ruminal metabolism. Improved mineral availability may support microbial growth and protein synthesis, potentially increasing the supply of microbial protein and amino acids to the small intestine.

However, the relationship between nano-mineral supplementation and microbial protein synthesis is dependent on mineral concentration, chemical form, ruminal conditions, and interactions with other dietary components. Consequently, improvements in microbial protein synthesis should be demonstrated through appropriate measurements of microbial nitrogen flow and whole-animal nitrogen balance.

2.8.4.8. Effects on Methane Emissions

One emerging area of research is the potential application of nanopremix technology in supporting low-emission livestock production. Preliminary studies suggest that nano-copper, nano-zinc, and nano-phytobiotics may influence ruminal microbial communities and fermentation pathways, potentially resulting in:

· improved fermentation efficiency;

· reduced hydrogen availability for methanogenesis;

· modulation of methanogenic archaea; and

· reduced enteric methane (CH₄) production.

Although the magnitude and consistency of these effects remain variable, this approach may contribute to broader strategies for mitigating greenhouse gas emissions from ruminant production.

Importantly, reductions in methane emissions should not be assumed solely from changes in microbial abundance. Because ruminal fermentation involves complex metabolic interactions, reliable assessment should include methane yield, feed digestibility, VFA profiles, microbial protein synthesis, animal productivity, and nitrogen utilization.

2.8.4.9. Reproductive Performance in Ruminants

Adequate mineral status is essential for reproductive function in both female and male ruminants. Nano-selenium has been investigated for its potential effects on:

· oocyte quality;

· follicular development;

· corpus luteum function; and

· embryo viability.

Nano-zinc may support DNA synthesis and cell proliferation during embryonic development through its role as a structural and catalytic component of numerous proteins and enzymes.

In males, adequate selenium and zinc status may contribute to:

· sperm motility;

· sperm membrane integrity;

· semen quality; and

· fertility.

These effects are closely associated with antioxidant protection because spermatozoa are particularly susceptible to oxidative damage. Nevertheless, reproductive responses to nano-mineral supplementation depend on basal mineral status, dose, reproductive stage, breed, and overall nutritional management.

2.8.4.10. Safety and Environmental Considerations

Because nano-formulated minerals may exhibit enhanced bioavailability, nanopremix supplementation may potentially allow:

· reduction of supplemental mineral doses;

· reduction in mineral excretion;

· decreased soil contamination; and

· reduced accumulation of trace elements in agricultural soils.

More efficient mineral utilization may also reduce the potential for excessive mineral–mineral interactions within the gastrointestinal tract, although this assumption requires experimental validation.

At the same time, the environmental and food-safety implications of nanopremix require careful evaluation. In particular, research on the absorption, distribution, transformation, and elimination of nanoparticles is needed to determine whether nanoparticulate residues or their transformation products may occur in edible tissues, milk, or other animal-derived products.

Therefore, food-safety assessment should consider not only total mineral concentrations but also the physicochemical form of the mineral, potential nanoparticle residues, tissue distribution, and consumer exposure.

2.8.4.11. Research Challenges

Despite promising experimental findings, several scientific challenges remain to be addressed before nanopremix can be widely adopted in ruminant production. These include:

· maintaining nanoparticle stability under ruminal conditions;

· optimizing rumen-protected nanopremix systems;

· characterizing interactions between nanoparticles and the ruminal microbiota;

· conducting long-term biosafety and toxicological studies;

· standardizing methods for evaluating mineral bioavailability; and

· conducting large-scale field trials under commercial production conditions.

In addition, multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, and metagenomics, are increasingly being applied to elucidate the complex interactions among nanopremix components, ruminal microbiota, host metabolism, and animal performance.

Integration of these approaches may enable the identification of molecular biomarkers associated with mineral utilization, ruminal adaptation, oxidative stress, immune responses, and production efficiency.

2.8.4.12. Synthesis of Nanopremix Applications in Ruminants

Overall, nanopremix technology has considerable potential to improve production efficiency, animal health, and sustainability in ruminant production systems. Enhanced mineral bioavailability, modulation of ruminal fermentation, strengthened antioxidant defenses, improved reproductive function, and the development of rumen-protected delivery systems make nanopremix a promising technological platform for modern ruminant nutrition.

Nevertheless, successful industrial implementation requires a more comprehensive understanding of nanoparticle dynamics within the rumen, including their transformation, interactions with microbial communities, absorption, and post-ruminal fate. Long-term safety validation is also essential, together with the development of formulations capable of maintaining stability during ruminal fermentation while ensuring effective nutrient release in the small intestine.

Accordingly, future research should move beyond simple comparisons of nano- and conventional mineral sources and adopt an integrated framework encompassing nanoparticle characterization, rumen microbiome responses, nutrient bioavailability, animal performance, tissue residues, environmental excretion, and food safety.

2.8.5. Application of Nanopremix in Aquaculture

2.8.5.1. Introduction

Aquaculture is one of the fastest-growing food-producing sectors worldwide and has become a major contributor to global animal-source protein production. Intensification of fish and shrimp farming has substantially increased productivity but has also generated several challenges, including high stocking densities, deterioration of water quality, increased incidence of infectious diseases, environmental stress, and suboptimal feed utilization. Under these conditions, nutritional quality is a critical determinant of production efficiency and animal health.

Conventional premixes containing essential minerals and vitamins have long been incorporated into fish and shrimp feeds. However, the bioavailability of several minerals, particularly zinc, selenium, copper, and iron, may be limited because of interactions with feed components, nutrient leaching into the surrounding water before ingestion, or the formation of poorly absorbable complexes within the gastrointestinal tract. These factors may increase the amount of supplementation required, raise production costs, and increase mineral losses to the aquatic environment.

Nanopremix technology offers a potential approach to addressing these limitations through improved bioavailability, enhanced formulation stability, controlled nutrient release, and more efficient gastrointestinal absorption. In addition to serving as nutrient sources, various nano-minerals and nano-phytobiotics have been investigated for their potential antioxidant, immunostimulatory, and antimicrobial activities, which may support fish and shrimp health.

In recent years, research on nanopremix applications has expanded across a wide range of aquaculture species, including Nile tilapia (Oreochromis niloticus), common carp (Cyprinus carpio), African catfish (Clarias gariepinus), Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), barramundi (Lates calcarifer), whiteleg shrimp (Litopenaeus vannamei), and other marine fish and crustacean species.

2.8.5.2. Characteristics of the Digestive System of Aquatic Organisms

The effectiveness of nanopremix in aquatic organisms is influenced by gastrointestinal physiological characteristics that differ substantially from those of terrestrial livestock.

Important characteristics include:

· relatively short feed transit times in many fish species;

· considerable variation in gastric pH among species;

· mineral absorption occurring predominantly in the anterior and mid-intestine;

· relatively different intestinal mucosal surface characteristics compared with terrestrial mammals; and

· direct exposure of feed particles to the surrounding water before ingestion.

One of the major challenges in aquaculture nutrition is nutrient leaching, particularly the loss of water-soluble vitamins and minerals from feed pellets into the surrounding water. Leaching not only reduces the nutritional value of the feed but may also increase nutrient loading in the culture environment, potentially contributing to water-quality deterioration and eutrophication.

Therefore, nanoencapsulation technology may play an important role in maintaining premix stability until the feed is consumed. Encapsulation systems can potentially reduce premature nutrient release, improve the physical stability of feed additives in water, and facilitate more controlled release within the gastrointestinal tract.

However, the development of nanoencapsulated feed additives for aquaculture should also consider particle stability in water, feed-pellet integrity, ingestion behavior, gastrointestinal release kinetics, tissue accumulation, and potential effects on non-target aquatic organisms.

2.8.5.3. Application of Nanopremix in Nile Tilapia (Oreochromis niloticus)

Nile tilapia is one of the most widely used species as a model for nanopremix research because of its rapid growth, broad environmental tolerance, and high economic value. Various studies have shown that supplementation with nano-zinc, nano-selenium, nano-iron, or multicomponent nanopremixes can improve body weight gain, specific growth rate (SGR), feed conversion ratio (FCR), protein retention efficiency, energy retention efficiency, and survival rate. These improvements are associated with enhanced digestive enzyme activity, improved intestinal morphology, and increased mineral bioavailability.

Effects on the Immune System

Nano-selenium and nano-zinc have been reported to enhance leukocyte phagocytic activity, lysozyme activity, immunoglobulin levels, complement activity, and the expression of innate immune-related genes. Nile tilapia receiving nanopremix supplementation may exhibit greater resistance to bacterial infections caused by pathogens such as Aeromonas hydrophila and Streptococcus agalactiae.

Effects on Antioxidant Status

Nano-selenium supplementation can enhance the activities of glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). Meanwhile, malondialdehyde (MDA) concentrations may decrease, indicating reduced oxidative stress and improved antioxidant defense.

2.8.5.4. Application in Common Carp (Cyprinus carpio)

In common carp, nanopremix supplementation is primarily aimed at improving growth efficiency and disease resistance. Several studies have reported improvements in daily growth, feed utilization efficiency, digestive enzyme activity, antioxidant capacity, and nonspecific immune responses. Nano-zinc may enhance intestinal tissue development, thereby supporting more efficient nutrient absorption.

2.8.5.5. Application in African Catfish (Clarias gariepinus)

Intensive African catfish production is frequently associated with challenges related to deteriorating water quality and high stocking densities. Nanopremix supplementation may improve growth performance, feed efficiency, liver health, renal function, and tolerance to environmental stress. Several studies have also reported increased activities of digestive enzymes, including protease, amylase, and lipase, following nanopremix supplementation.

2.8.5.6. Application in Salmon and Trout

In salmon and trout, research has primarily focused on improving fillet quality, energy metabolism, and health during the grow-out phase. Nano-selenium supplementation may increase selenium deposition in muscle tissue, reduce lipid oxidation, improve fillet color stability, and extend product shelf life. In addition, enhanced antioxidant status may help mitigate oxidative stress associated with temperature fluctuations and transportation.

2.8.5.7. Application in Pacific White Shrimp (Litopenaeus vannamei)

Pacific white shrimp is a high-value aquaculture commodity but is highly susceptible to several important diseases, including White Spot Syndrome Virus (WSSV), Acute Hepatopancreatic Necrosis Disease (AHPND), and vibriosis. Nanopremix has therefore been investigated as part of nutritional strategies aimed at strengthening host defense, particularly because shrimp lack the adaptive immune system characteristic of vertebrates.

Enhancement of Immune Responses

Nano-selenium and nano-zinc may enhance hemocyte activity, phagocytosis, phenoloxidase activity, lysozyme activity, and the expression of antimicrobial-related genes. These responses may contribute to increased resistance to bacterial pathogens, including Vibrio spp.

Effects on Growth Performance

Nanopremix supplementation may improve growth rate, feed efficiency, survival, and exoskeletal quality. Nano-zinc is involved in chitin synthesis and molting processes, whereas nano-copper supports the activity of various enzymes involved in cellular respiration and energy metabolism.

2.8.5.8. Nano-Phytobiotics in Aquaculture

In addition to nano-minerals, a variety of nano-phytobiotics have increasingly been investigated for applications in fish and shrimp production. Compounds and bioactive materials under investigation include nano-curcumin, nano-garlic, nano-ginger, nano-oregano, nano-thyme, nano-propolis, nano-Spirulina, and nano-phycocyanin.

Nanoencapsulation can improve the aqueous dispersibility, solubility, stability, and gastrointestinal delivery of bioactive compounds, particularly those with intrinsically low water solubility or limited bioavailability. Consequently, nanoformulation may enhance the biological activity of phytogenic compounds compared with their conventional forms.

Reported biological effects include enhanced feed intake, increased antioxidant capacity, antibacterial activity, antiviral activity, immunomodulatory effects, and hepatoprotective activity. However, these effects are highly dependent on the specific phytobiotic, nanoparticle characteristics, encapsulation system, dose, administration route, species, and culture conditions. Therefore, findings obtained from one nano-phytobiotic formulation should not automatically be generalized to other formulations or aquaculture species.

2.8.5.9. Effects on Aquaculture Water Quality

An important potential advantage of nanopremix is improved mineral utilization efficiency, which may reduce nutrient losses to the surrounding environment. Consequently, nanopremix supplementation may contribute to reduced mineral leaching, lower accumulation of metals in sediments, reduced water pollution, and improved nutrient-use efficiency. These potential benefits support the development of more sustainable aquaculture systems.

However, the extent to which nanopremix actually improves water quality depends on the physicochemical characteristics of the nanoparticles, dietary inclusion level, feed stability, absorption efficiency, and culture-system conditions. Therefore, claims of reduced environmental contamination should be supported by quantitative measurements of nutrient input, retention, excretion, and environmental fate.

2.8.5.10. Application of Nanopremix in Biofloc and Recirculating Aquaculture Systems (RAS)

The development of modern aquaculture technologies, including biofloc systems and Recirculating Aquaculture Systems (RAS), has increased the demand for highly efficient nutrient utilization. Nanopremix may provide several potential benefits in these systems by reducing nutrient losses, improving feed-use efficiency, decreasing waste loads, supporting beneficial microbial communities, and contributing to greater stability of water quality.

The integration of nanopremix with biofloc technology represents a promising area of research because nutritional supplementation may interact with the microbial community responsible for nutrient recycling within the culture system. Nevertheless, such interactions should be evaluated experimentally because changes in nanoparticle concentration may affect not only cultured organisms but also the microbial communities that regulate nitrogen and organic matter cycling.

2.8.5.11. Challenges and Safety Considerations

Although current research indicates considerable potential for nanopremix applications in aquaculture, several safety-related issues require careful consideration. These include the potential accumulation of nanoparticles in sediments, interactions with planktonic communities, toxicity to non-target organisms, nanoparticle or mineral residues in fish fillets, and potential implications for human food safety.

Accordingly, comprehensive safety assessment should include biodistribution, bioaccumulation, toxicokinetics, ecotoxicological effects, and environmental risk assessment. Particular attention should also be given to the physicochemical transformation of nanoparticles in aquatic environments because particle aggregation, dissolution, surface modification, and interactions with dissolved organic matter may substantially alter their biological activity and environmental fate.

2.8.5.12. Future Research Directions

Future development of nanopremix technology in aquaculture is expected to focus on several emerging areas, including:

· precision aquaculture nutrition based on species-specific nutritional requirements;

· stimuli-responsive nanopremix capable of releasing nutrients in response to changes in pH or enzymatic activity;

· integration with probiotics, prebiotics, and synbiotics;

· development of green-synthesized nanoparticles using plant extracts, microorganisms, or microalgae;

· application of artificial intelligence (AI) and machine learning to optimize feed and nanopremix formulations; and

· application of multi-omics approaches to elucidate interactions among nanopremix components, gut microbiota, metabolism, and immune responses in aquatic organisms.

In addition, nanotechnology is expected to become increasingly integrated into smart aquaculture systems that combine precision nutrition, water-quality sensors, real-time data analytics, and AI-based management. Such integration could enable dynamic adjustment of feed composition and nutrient delivery according to animal performance, environmental conditions, and physiological status, thereby improving productivity and resource-use efficiency.

2.8.5.13. Synthesis of Nanopremix Applications in Aquaculture

Overall, current research indicates that nanopremix has considerable potential to improve the efficiency and sustainability of fish and shrimp production. Enhanced mineral bioavailability, improved feed-use efficiency, increased antioxidant capacity, strengthened immune function, improved gastrointestinal health, enhanced product quality, and potentially reduced nutrient losses to the environment make nanopremix a promising innovation in modern aquaculture nutrition.

Nevertheless, commercial implementation requires rigorous formulation standardization, long-term safety assessment, evaluation of biodistribution and bioaccumulation, and comprehensive ecotoxicological studies. These assessments are essential to ensure that productivity gains are achieved without compromising food safety, animal health, or aquatic ecosystem integrity.

2.8.6. Comparative Analysis of Nanopremix Applications Across Livestock and Aquaculture Species

2.8.6.1. Introduction

The development of nanopremix technologies over the past two decades has introduced a new paradigm in animal nutrition. Although the fundamental rationale of nanopremix—enhancing nutrient bioavailability through particle-size reduction, increased specific surface area, and more efficient delivery systems—is broadly applicable across species, the resulting biological responses can vary substantially. Such differences are influenced by variations in gastrointestinal anatomy and physiology, nutrient requirements, metabolic characteristics, microbiota composition, production systems, and production objectives.

Poultry, swine, ruminants, and aquatic animals face distinct nutritional challenges. In poultry, the principal objectives include improving feed efficiency and developing alternatives to Antibiotic Growth Promoters (AGPs). In swine, nanopremix applications have been investigated particularly for managing post-weaning gastrointestinal disorders and reducing reliance on pharmacological levels of zinc oxide (ZnO). In ruminants, major challenges include maintaining nutrient stability within the rumen and developing effective rumen-protected nanopremix delivery systems. In aquaculture, major concerns include preventing mineral leaching into the culture water, improving immune competence, and enhancing nutrient-use efficiency under intensive production conditions.

Comparative analysis across species is therefore essential for distinguishing common biological responses from species-specific responses. Such information provides an important scientific basis for developing the concept of precision animal nutrition, in which nanopremix formulations are tailored to the physiological requirements, production stage, health status, and environmental conditions of each target species.

Importantly, cross-species extrapolation should be undertaken cautiously. A nanopremix formulation that produces favorable responses in broilers, for example, cannot automatically be assumed to have equivalent efficacy or safety in pigs, cattle, or aquatic organisms. Differences in gastrointestinal conditions, mineral metabolism, microbiome composition, nanoparticle transformation, and exposure pathways must be incorporated into species-specific evaluation and formulation strategies.

2.8.6.2. Comparison of Gastrointestinal Systems and Their Implications for Nanopremix

Gastrointestinal characteristics are among the major factors determining the efficacy and biological fate of nanopremix formulations.

Parameter	Poultry	Swine	Ruminants	Aquaculture
Gastrointestinal structure	Proventriculus–gizzard	Monogastric stomach	Rumen–reticulum–omasum–abomasum	Species-dependent
Major site of absorption	Small intestine	Small intestine	Small intestine (post-ruminal)	Anterior and mid-intestine
Major challenge	Rapid gastrointestinal transit	Post-weaning transition	Rumen fermentation	Nutrient leaching
Nanopremix strategy	High bioavailability	Gut health enhancement	Rumen protection	Water-stable nanoencapsulation

These physiological differences indicate that nanopremix formulation strategies cannot be standardized across species. For example, unprotected nano-zinc may be effectively utilized in poultry and swine, whereas cattle and other ruminants may require rumen-protection strategies to prevent premature transformation, dissolution, or sequestration of the mineral before it reaches the small intestine.

2.8.6.3. Comparison of Nano-Mineral Bioavailability

One of the major proposed advantages of nanopremix is enhanced bioavailability compared with conventional mineral premixes. In general, improvements in mineral bioavailability may be associated with several physicochemical and biological factors, including:

· smaller particle size;

· greater specific surface area;

· increased solubility or dissolution rate;

· enhanced interaction with the intestinal mucosa; and

· more efficient transport across enterocytes.

Based on findings reported across different experimental systems, the relative improvement in bioavailability may be conceptually ranked as follows:

Nano-selenium > nano-zinc ≈ nano-copper > nano-iron > conventional mineral sources

However, this ranking should not be interpreted as a universal quantitative hierarchy because bioavailability depends strongly on particle size, chemical form, surface characteristics, formulation matrix, dose, animal species, dietary composition, and physiological status.

Nano-selenium has frequently demonstrated favorable bioavailability because selenium can be incorporated into selenoproteins involved in antioxidant defense and redox regulation. Nano-zinc has also shown enhanced biological availability in several experimental models, potentially allowing lower supplementation levels while maintaining adequate physiological function. Nevertheless, direct head-to-head comparisons under equivalent biological conditions are required before definitive cross-mineral rankings can be established.

2.8.6.4. Comparison of Effects on Feed Efficiency

Feed-use efficiency is one of the most important economic indicators in intensive animal production. Across different species, nanopremix supplementation has been associated with improvements in:

· nutrient digestibility;

· digestive enzyme activity;

· mineral absorption;

· energy metabolism; and

· protein retention.

Improvements in feed conversion ratio (FCR) have been reported particularly in:

1. broiler chickens;

2. weaned piglets;

3. Nile tilapia; and

4. beef cattle.

The magnitude and consistency of these responses, however, vary substantially among studies and depend on the initial mineral status of the animals, basal diet composition, nanoparticle characteristics, supplementation level, health status, and environmental conditions. Therefore, improved FCR should be evaluated together with nutrient retention, growth performance, and economic efficiency rather than considered as an isolated indicator.

2.8.6.5. Comparison of Effects on Immune Function

Nanopremix supplementation may enhance immune function across different animal production systems, although the predominant physiological responses differ among species.

Poultry

Reported responses include:

· increased antibody titers;

· enhanced lymphocyte activity; and

· improved responses to vaccination.

Swine

The major responses include:

· improved intestinal mucosal health;

· enhanced resistance to post-weaning gastrointestinal disorders; and

· modulation of gut microbial balance.

Ruminants

Potential benefits include:

· improved neutrophil function;

· enhanced mammary gland health; and

· reduced susceptibility to mastitis.

Aquaculture

Reported responses include:

· increased lysozyme activity;

· enhanced phagocytic activity;

· increased hemocyte activity; and

· improved resistance to bacterial infection.

Overall, nano-selenium has demonstrated relatively consistent immunomodulatory effects across several animal species, primarily through its role in selenoprotein synthesis, antioxidant defense, and redox regulation. Nevertheless, the magnitude of the response is highly dependent on selenium status, chemical form, dose, species, and health condition.

2.8.6.6. Comparison of Antioxidant Capacity

Oxidative stress is an important limiting factor for productivity, health, and resilience across diverse animal production systems. Nano-selenium has been particularly investigated for its ability to enhance:

· glutathione peroxidase (GPx) activity; and

· total antioxidant capacity (T-AOC).

Nano-zinc contributes to antioxidant defense primarily through its role in the Cu/Zn-superoxide dismutase (Cu/Zn-SOD) system and through the regulation of cellular redox processes. Nano-copper supports Cu/Zn-SOD activity as well as enzymes involved in oxidative metabolism and energy production. Nano-iron contributes to antioxidant and cellular metabolic processes, including catalase-related activity and mitochondrial respiration.

The most pronounced antioxidant responses have frequently been investigated under conditions associated with elevated oxidative stress, including:

· heat-stressed poultry;

· dairy cattle exposed to high ambient temperatures;

· intensively cultured shrimp; and

· fish maintained at high stocking densities.

These findings suggest that the potential benefits of nano-mineral supplementation may be more apparent under conditions of nutritional challenge, environmental stress, or increased metabolic demand than under optimal husbandry conditions. Consequently, the baseline nutritional and physiological status of the animals should be considered when interpreting the efficacy of nanopremix supplementation.

2.8.6.7. Comparative Effects on Reproductive Performance

Reproductive responses to nanopremix supplementation vary among animal species and production systems.

In breeder chickens, potential benefits include:

· improved fertility; and

· increased hatchability.

In sows, reported outcomes may include:

· increased litter size; and

· improved colostrum quality.

In dairy cattle, potential reproductive benefits include:

· improved oocyte quality; and

· enhanced reproductive efficiency.

In males across different livestock species, nano-mineral supplementation has been investigated for its potential to improve:

· sperm motility;

· sperm viability; and

· sperm DNA integrity.

Among the various minerals investigated, nano-selenium and nano-zinc are among the most extensively studied in relation to reproductive performance. Their effects are primarily associated with antioxidant protection, enzymatic activity, cellular proliferation, and maintenance of reproductive tissue function. However, reproductive responses remain dependent on basal mineral status, dose, animal age, physiological stage, and overall nutritional management.

2.8.6.8. Comparative Effects on Product Quality

Nanopremix supplementation may influence not only production performance but also the quality characteristics of animal-derived foods.

Meat

Potential improvements include:

· color stability;

· water-holding capacity;

· shelf life; and

· oxidative stability.

Eggs

Potential improvements include:

· eggshell thickness;

· Haugh unit;

· selenium concentration; and

· zinc concentration.

Milk

Potential effects include:

· milk protein concentration;

· mineral concentration; and

· oxidative stability.

Fish Fillets

Potential improvements include:

· textural quality;

· selenium concentration; and

· storage stability.

These effects create opportunities for the development of functional animal products through nanopremix-based biofortification. However, nutritional enhancement of animal-derived foods should be evaluated together with consumer safety, mineral transfer efficiency, residue profiles, and the applicable maximum intake limits for essential trace elements.

2.8.6.9. Comparative Environmental Impacts

One of the proposed advantages of nanopremix technology is improved mineral-use efficiency, which may reduce the quantity of minerals excreted into the environment.

Aspect	Conventional Premix	Nanopremix
Supplemental dose	Relatively high	Potentially lower
Bioavailability	Moderate	Potentially higher
Mineral excretion	Relatively high	Potentially lower
Pollution risk	Relatively high	Potentially lower
Nutrient-use efficiency	Moderate	Potentially higher

Potential reductions in zinc, copper, and other trace-mineral excretion could contribute to improved environmental sustainability in intensive livestock production systems.

Nevertheless, these environmental benefits should not be assumed solely from the use of nanoparticulate mineral sources. They should be demonstrated through quantitative mass-balance studies that simultaneously evaluate mineral intake, absorption, tissue retention, fecal and urinary excretion, and environmental fate.

2.8.6.10. Technology Readiness Level (TRL)

When evaluated in terms of industrial implementation readiness, nanopremix technology may exhibit different levels of maturity across species.

Species	Indicative Technology Readiness
Broiler chickens	Relatively high
Laying hens	Relatively high
Pigs	High to moderate
Dairy cattle	Moderate
Beef cattle	Moderate
Goats and sheep	Moderate to emerging
Aquaculture species	Moderate to high, depending on application

Poultry represents one of the sectors with relatively strong prospects for early commercialization because of the large volume of research, the highly standardized nature of intensive production systems, and the continuing demand for nutritional strategies that can reduce reliance on antibiotic growth promoters (AGPs).

However, TRL classifications should be regarded as indicative rather than universal, because technology readiness depends on the specific nanoparticle, formulation, target species, production objective, manufacturing process, safety evidence, regulatory status, and commercial validation.

2.8.6.11. Common Cross-Species Challenges

Although the available evidence is promising, several challenges remain common across animal species.

Technological Aspects

Key technological challenges include:

· standardization of nanoparticle size and physicochemical properties;

· stability during storage;

· mixing homogeneity;

· scalability of manufacturing; and

· batch-to-batch consistency.

Regulatory Aspects

Major regulatory challenges include:

· harmonization of international standards;

· standardized characterization methods;

· establishment of appropriate safety-assessment frameworks; and

· development of regulatory criteria specific to nano-enabled feed additives.

Biosafety Aspects

Critical biosafety considerations include:

· biodistribution;

· bioaccumulation;

· residues in edible animal products;

· chronic toxicity;

· nanoparticle transformation and persistence; and

· potential effects on microbiota and the environment.

Economic Aspects

Economic considerations include:

· production costs;

· cost–benefit analysis;

· scalability;

· economic return under commercial conditions; and

· industry and consumer acceptance.

2.8.6.12. Integration with Precision Livestock Nutrition

Recent developments suggest that nanopremix technology could become an important component of Precision Livestock Nutrition (PLN), an approach in which nutrient supply is tailored to the physiological requirements of animals according to species, age, production stage, health status, environmental conditions, and real-time performance data.

Within such a framework, nanopremix formulations would no longer necessarily be standardized across all animals or production stages. Instead, they could be dynamically adjusted through integration with:

· feed-intake sensors;

· animal-activity sensors;

· metabolic biosensors;

· Internet of Things (IoT) technologies;

· artificial intelligence (AI);

· machine learning;

· big-data analytics; and

· digital farming technologies.

Such integration could enable more dynamic adjustment of nano-mineral supplementation according to physiological and environmental conditions, potentially improving nutrient-use efficiency, reducing nutrient losses, and supporting animal health.

In the longer term, integration of nanopremix technology with digital phenotyping, precision feeding, and predictive analytics may enable adaptive nutrient delivery systems capable of responding to changes in animal performance and physiological status.

2.8.6.13. Global Nanopremix Development Roadmap (2025–2045)

Based on current research trends and technological developments, the future development of nanopremix technology may be conceptualized into several phases. This roadmap should be regarded as a prospective framework rather than a definitive prediction.

Phase I (2025–2030): Formulation Optimization

Key priorities include:

· standardization of nanoparticle size and physicochemical characteristics;

· development of biopolymer-based nanoencapsulation systems;

· optimization of controlled-release formulations; and

· validation of bioavailability across animal species.

Phase II (2030–2035): Integration of Multifunctional Feed Additives

Potential developments include:

· combinations of nano-minerals, nano-vitamins, probiotics, and phytobiotics;

· organ- or site-specific nutrient delivery systems;

· multifunctional nanopremix formulations; and

· broader implementation in poultry and pig production systems.

Phase III (2035–2040): AI-Based Precision Nutrition

Expected technological directions include:

· individualized or group-specific nanopremix formulation;

· integration of biological sensors with real-time production data;

· AI-assisted optimization of nutrient requirements; and

· development of smart-feed systems capable of adapting nutrient release according to the physiological and environmental status of animals.

Phase IV (2040–2045): Precision Nano-Nutrition Ecosystem

The longer-term development trajectory may involve:

· integration of nanopremix technology with genomics, metabolomics, microbiomics, and digital livestock technologies;

· development of low-emission livestock production systems;

· integration of real-time animal and environmental monitoring;

· closed-loop precision feeding systems; and

· development of One Health and One Nutrition frameworks linking animal health, human health, food safety, and environmental sustainability within an integrated nutrition system.

Under this prospective ecosystem, nanopremix would no longer function merely as a more bioavailable source of minerals or bioactive compounds. Instead, it could become one component of an integrated precision nano-nutrition platform, in which formulation, delivery, monitoring, and response assessment are dynamically connected.

Nevertheless, the transition toward such systems will depend on substantial advances in nanoparticle standardization, toxicological evaluation, regulatory harmonization, manufacturing scalability, digital infrastructure, and long-term validation under commercial production conditions.

2.8.6.14. Synthesis of Section 2.8

Comparative analysis indicates that the biological benefits of nanopremixes are generally consistent across different livestock species, although the magnitude of the response is influenced by species-specific physiological characteristics. Nano-zinc, nano-selenium, nano-copper, nano-iron, nano-vitamins, and nano-phytobiotics have generally been reported to improve nutrient bioavailability, feed efficiency, antioxidant capacity, immune function, gastrointestinal health, reproductive performance, and the quality of animal-derived products, while simultaneously reducing mineral excretion into the environment. The major differences among species are associated with the specific physiological challenges that must be addressed, such as the need for rumen-protected nanopremixes in ruminants and the prevention of nutrient leaching in aquaculture.

Overall, the current body of scientific evidence positions nanopremixes as one of the most promising innovations in modern animal nutrition. The integration of nanotechnology with precision livestock nutrition, artificial intelligence, multi-omics, and smart farming is expected to provide a foundation for the development of next-generation livestock nutrition systems that are more efficient, sustainable, and aligned with the principles of One Health.

CHAPTER 3. SAFETY, TOXICITY, REGULATION, AND ONE HEALTH ASPECTS OF NANOPREMIXES

3.1. Introduction

The rapid development of nanotechnology in animal nutrition has created substantial opportunities to improve nutrient utilization efficiency, livestock productivity, the quality of animal-derived products, and the sustainability of livestock production systems. Research discussed in the preceding chapter indicates that nanopremixes can enhance the bioavailability of minerals and vitamins, improve feed conversion efficiency, strengthen immune function, enhance antioxidant capacity, and reduce mineral excretion into the environment. Nevertheless, the commercial implementation of nanopremixes is determined not only by their biological efficacy but also by considerations related to safety, toxicity, regulatory acceptance, and potential impacts on human health and the environment.

Unlike conventional premixes, nanopremixes possess unique physicochemical characteristics, including particle sizes generally within the nanoscale range, high specific surface area, high surface energy, and enhanced capacity to interact with biomolecules at the molecular level. These characteristics may provide advantages in terms of absorption and bioavailability but also raise concerns regarding potential differences in toxicological profiles compared with microparticulate or conventional mineral forms. In this context, the classical toxicological principle that “the dose makes the poison” becomes more complex for nanomaterials because biological effects are determined not only by dose but also by particle size, shape, morphology, surface charge, chemical composition, solubility, aggregation state, and surface coating.

Safety evaluation of nanopremixes is particularly important because nanoparticles administered through feed may interact with the gastrointestinal tract, undergo systemic absorption, distribute to various organs, undergo biotransformation, and subsequently be excreted or retained in specific tissues. Consequently, safety assessment cannot be restricted to effects on the target animal alone. It must also consider the potential presence of residues in animal-derived foods, including meat, milk, eggs, and fish; effects on the gut microbiota; the potential for bioaccumulation within food chains; and environmental risks associated with the excretion of nanoparticles through feces and urine.

In recent years, international organizations and standard-setting bodies, including the European Food Safety Authority (EFSA), U.S. Food and Drug Administration (FDA), Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), International Organization for Standardization (ISO), and Codex Alimentarius Commission (CAC), have developed scientific guidance and frameworks for the safety and risk assessment of nanomaterials in food and feed. These frameworks emphasize that nanomaterial safety evaluation should be conducted comprehensively using a tiered risk-assessment approach, beginning with physicochemical characterization and progressing, where appropriate, to in vitro toxicity testing, in vivo toxicity studies, toxicokinetic assessment, biodistribution, bioaccumulation, genotoxicity, immunotoxicity, and environmental impact assessment.

At the same time, growing global attention to the One Health concept has broadened the scope of nanopremix safety assessment. This concept recognizes animal health, human health, and environmental health as interconnected components of a single system. Therefore, the successful implementation of nanopremixes should not be evaluated solely on the basis of improvements in livestock productivity, but also on their ability to safeguard food safety, minimize environmental contamination, and support sustainable livestock production systems.

This chapter provides a comprehensive discussion of nanopremix safety, encompassing the fundamentals of nanotoxicology, molecular and cellular mechanisms of toxicity, factors influencing the safety of nano-minerals, biodistribution and bioaccumulation, gastrointestinal and gut microbiota safety, residues in animal-derived food products, risk assessment, developments in international regulatory frameworks, and implications within the One Health framework. Accordingly, this chapter aims to provide a robust scientific foundation for the safe, effective, and responsible development and implementation of nanopremixes in modern livestock production.

3.2. Fundamental Concepts of Nanotoxicology

3.2.1. Definition of Nanotoxicology

Nanotoxicology is a branch of toxicology that investigates the interactions between nanomaterials and biological systems and the resulting biological effects at the molecular, cellular, tissue, organ, organismal, and ecosystem levels. This field has emerged in response to the expanding application of nanotechnology across diverse sectors, including medicine, pharmaceuticals, food science, agriculture, animal production, cosmetics, and industry.

Unlike conventional toxicology, which generally evaluates the effects of chemical substances primarily on the basis of their composition and dose, nanotoxicology recognizes that the biological properties of nanomaterials are determined not only by their chemical composition but also by their physicochemical characteristics. Two nanoparticles with identical chemical compositions may exhibit markedly different toxicological profiles if they differ in particle size, shape, surface area, or surface modification. Consequently, the safety assessment of nanopremixes requires an interdisciplinary paradigm integrating materials science, cell biology, physiology, pharmacology, toxicology, and environmental science.

In the context of animal nutrition, nanotoxicology seeks to address several fundamental questions, including:

· Are nanoparticles administered through feed safe for the gastrointestinal tract of livestock?

· What proportion of the administered nanoparticles is absorbed into the systemic circulation?

· Which organs constitute the principal targets for nanoparticle biodistribution?

· Do nanoparticles bioaccumulate in tissues intended for human consumption?

· Does long-term exposure result in chronic toxic effects?

· What are the consequences of nanoparticle excretion for the environment and for soil and aquatic microorganisms?

Answers to these questions provide an important scientific basis for the development of international regulatory frameworks governing the use of nanomaterials in animal feed.

3.2.2. Differences between Conventional Toxicology and Nanotoxicology

The fundamental difference between conventional toxicology and nanotoxicology lies in the parameters that determine the biological effects of a material.

For conventional substances, toxicity is primarily influenced by:

· exposure dose;

· duration of exposure;

· route of exposure; and

· compound metabolism.

In contrast, nanomaterials are influenced by several additional parameters that can substantially determine their biological behavior and toxicological profile, including:

· particle size;

· particle-size distribution;

· particle shape;

· specific surface area;

· surface charge or zeta potential;

· solubility;

· propensity for aggregation or agglomeration;

· surface coating;

· core composition; and

· stability in biological media.

For example, zinc oxide nanoparticles with a nominal particle size of approximately 20 nm may exhibit substantially different bioavailability and biological activity from micrometer-scale ZnO, despite having the same chemical composition. Similarly, amorphous and crystalline forms of nano-selenium may exhibit different toxicokinetic profiles because of differences in crystal structure and selenium-ion release kinetics.

Therefore, the safety assessment of nanopremixes cannot be based solely on the total mineral content. Instead, it requires comprehensive characterization of the relevant physicochemical properties of the nanoparticles, together with an evaluation of how these properties influence their biological fate, efficacy, and potential toxicity.

3.2.3. Physicochemical Characteristics Determining the Safety of Nanopremixes

The safety of a nanopremix is strongly influenced by the physicochemical characteristics of its constituent nanoparticles. Several key parameters should be thoroughly characterized prior to biological evaluation, including the following:

1. Particle Size

Particle size is one of the most important determinants of nanoparticle biological behavior. As particle size decreases, the specific surface area generally increases, thereby enhancing interactions with cell membranes, proteins, and other biomolecules. However, extremely small nanoparticles (<10 nm) may also exhibit greater cellular and subcellular penetration, potentially increasing their toxicological effects.

2. Particle Size Distribution and Polydispersity Index (PDI)

Particle size distribution influences the physical homogeneity and stability of a nanopremix formulation. A nanopremix with a PDI value below approximately 0.3 is generally considered to have a relatively narrow particle-size distribution, which may contribute to more consistent bioavailability and release profiles than systems with a broad particle-size distribution. Nevertheless, PDI should be interpreted in conjunction with the mean particle size, measurement technique, dispersion medium, and sample preparation conditions.

3. Particle Shape and Morphology

Nanoparticles may exhibit various morphologies, including spherical, rod-shaped, cubic, platelet-like, or porous structures. Particle shape and morphology influence interactions with biological membranes, cellular uptake, phagocytic processes, biodistribution, and intracellular trafficking. Consequently, morphological characteristics should be considered alongside particle size when assessing the biological safety of nanopremixes.

4. Surface Charge (Zeta Potential)

Surface charge, commonly assessed through zeta potential measurements, plays an important role in nanoparticle colloidal stability and interactions with biological membranes. Nanoparticles with relatively high positive or negative zeta-potential values generally exhibit greater resistance to aggregation under appropriate dispersion conditions. However, highly charged surfaces may also promote stronger interactions with oppositely charged cellular membranes and extracellular biomolecules, potentially affecting cellular uptake and biological responses.

5. Specific Surface Area

A high specific surface area increases the capacity of nanoparticles to adsorb biological molecules. At the same time, it may enhance the formation of a protein corona, namely a dynamic layer of proteins and other biomolecules that adsorb onto the nanoparticle surface after exposure to biological fluids. The protein corona can alter the biological identity of nanoparticles and consequently influence their cellular uptake, biodistribution, immune recognition, and biological responses.

6. Solubility and Ion Release Kinetics

For nanominerals, biological effects are determined not only by the nanoparticulate form itself but also by the ions released through dissolution. For example, excessive or rapid release of Zn²⁺ or Cu²⁺ may increase the risk of oxidative stress and cellular injury, whereas controlled dissolution and ion release may improve nutrient utilization while minimizing the potential for toxicity. Therefore, dissolution behavior and ion-release kinetics under physiologically relevant gastrointestinal conditions should be incorporated into nanopremix safety assessments.

---

3.2.4. Molecular and Cellular Mechanisms of Nanopremix Toxicity

3.2.4.1. Introduction

The use of nanopremixes as feed additives offers several potential biological advantages, particularly by enhancing the bioavailability of minerals and vitamins. However, the physicochemical properties that contribute to their enhanced biological effectiveness may also influence interactions with biological systems at the molecular and cellular levels. Therefore, understanding the mechanisms underlying nanopremix toxicity is fundamental to the development of safe products and to compliance with international regulatory requirements.

It is important to emphasize that the presence of nanoparticles does not inherently imply toxicity. Many studies indicate that nano-zinc, nano-selenium, nano-copper, nano-iron, and biopolymer-based nanoparticles can exhibit acceptable safety profiles when administered within nutritionally relevant dosage ranges. Toxic effects are more likely to occur when exposure substantially exceeds physiological requirements, when nanoparticles possess unfavorable physicochemical characteristics, or when chronic exposure occurs without adequate mechanisms of biotransformation and elimination.

Unlike the toxicity of conventional mineral forms, which is often primarily associated with excessive ion exposure or accumulation, nanopremix toxicity may involve a combination of physical, chemical, and biological mechanisms. These interactions occur dynamically from the moment nanoparticles enter the gastrointestinal tract until they reach potential systemic or tissue targets, resulting in complex biological responses.

3.2.4.2. Initial Interactions of Nanoparticles with Biological Systems

The first stage following oral administration of a nanopremix involves contact between the nanoparticles and biological fluids within the gastrointestinal tract. Within seconds to minutes, the nanoparticle surface may adsorb a wide range of biomolecules, particularly:

· albumin;

· immunoglobulins;

· mucoproteins;

· apolipoproteins;

· digestive enzymes;

· phospholipids; and

· glycoproteins.

The resulting biomolecular layer is commonly referred to as the protein corona, which can substantially modify the biological identity of the nanoparticle.

The protein corona influences several biological characteristics of nanoparticles, including:

· cellular recognition;

· efficiency of endocytosis;

· biodistribution;

· immune responses;

· systemic circulation and retention; and

· elimination.

The composition and dynamics of the protein corona are strongly influenced by:

· particle size;

· surface charge;

· hydrophobicity;

· surface coating; and

· the surrounding biological environment.

Consequently, nanoparticles with identical chemical compositions may exhibit different biological behaviors when exposed to different biological environments and consequently form distinct protein coronas.

3.2.4.3. Cellular Internalization of Nanoparticles

Nanopremix nanoparticles that reach the intestinal mucosal surface may enter cells through several cellular uptake pathways.

3.2.4.3.1. Endocytosis

Endocytosis represents one of the major mechanisms involved in nanoparticle internalization and includes several distinct pathways.

a. Clathrin-mediated endocytosis

Clathrin-mediated endocytosis is an important pathway for the cellular internalization of many nanoparticles, particularly those within the tens-to-low-hundreds-of-nanometers range. Following internalization:

· an early endosome is formed;

· the endosomal compartment undergoes maturation and may subsequently fuse with lysosomes;

· a fraction of the nanoparticles may undergo degradation or dissolution; and

· another fraction may undergo intracellular trafficking or, depending on the nanoparticle characteristics, escape into the cytosolic compartment.

b. Caveolae-mediated endocytosis

Caveolae-mediated uptake occurs in various cell types, including:

· enterocytes;

· endothelial cells; and

· hepatocytes.

This pathway can facilitate intracellular trafficking that differs from conventional lysosomal processing and, for certain nanoparticle systems, may increase the probability of avoiding rapid lysosomal degradation and reaching specific intracellular compartments.

c. Macropinocytosis

Macropinocytosis is a non-selective cellular uptake mechanism that can internalize relatively large particles and extracellular fluid. The process generates large intracellular vesicles known as macropinosomes, which can transport nanoparticles into the cell.

d. Phagocytosis

Phagocytosis occurs predominantly in professional phagocytic cells, including:

· macrophages;

· neutrophils; and

· dendritic cells.

Phagocytosis constitutes an important component of the innate immune system for recognizing and eliminating foreign particulate materials, including certain nanoparticle populations

3.2.4.4. Reactive Oxygen Species (ROS) Generation

One of the most extensively investigated mechanisms underlying nanoparticle-induced toxicity is the generation of reactive oxygen species (ROS). ROS include:

· superoxide anion (O₂•⁻);

· hydroxyl radical (•OH);

· hydrogen peroxide (H₂O₂); and

· singlet oxygen (¹O₂).

At physiological concentrations, ROS function as important cell-signaling molecules and participate in normal cellular processes, including proliferation, differentiation, immune responses, and redox signaling. However, excessive ROS production can overwhelm cellular antioxidant defenses and lead to oxidative stress.

Sources of ROS Generation

Nanoparticles may enhance ROS generation through several mechanisms, including the following:

1. Metal Ion Release

Some metal-containing nanoparticles can undergo dissolution and release biologically active metal ions. For example:

· nano-Cu → Cu²⁺;

· nano-Zn → Zn²⁺.

The released ions can participate in redox reactions and disrupt cellular redox homeostasis. The extent of ion release depends on particle size, surface characteristics, chemical composition, solubility, and the surrounding biological environment.

2. Disruption of the Mitochondrial Electron Transport Chain

Nanoparticles may interfere with mitochondrial respiratory complexes, thereby increasing electron leakage during oxidative phosphorylation. Leaked electrons can react with molecular oxygen to generate superoxide anion (O₂•⁻), which can subsequently contribute to the formation of other ROS.

3. Activation of NADPH Oxidase

In immune cells, particularly macrophages and neutrophils, exposure to certain nanoparticles may activate NADPH oxidase, resulting in increased ROS production as part of the innate immune response. Although this process can contribute to antimicrobial defense, excessive or prolonged activation may promote oxidative injury.

3.2.4.5. Oxidative Stress

Oxidative stress occurs when ROS generation exceeds the capacity of endogenous antioxidant defense systems to neutralize or control reactive species. Persistent oxidative stress can consequently damage cellular biomolecules and disrupt normal cellular functions.

Lipid Damage

ROS can attack cellular membranes through a process known as lipid peroxidation. This process generates a variety of reactive aldehydes and other secondary oxidation products, including:

· malondialdehyde (MDA); and

· 4-hydroxynonenal (4-HNE).

MDA and 4-HNE are widely used as biomarkers of lipid peroxidation and oxidative cellular injury and may therefore provide useful indicators in nanoparticle toxicology studies.

Protein Damage

ROS can oxidize several amino acid residues and functional groups, including:

· sulfhydryl groups;

· methionine residues; and

· tyrosine residues.

Protein oxidation may result in:

· reduced enzymatic activity;

· alterations in protein conformation and structure; and

· protein misfolding or aggregation.

These alterations can interfere with cellular metabolism and impair essential biochemical pathways.

DNA Damage

Excessive ROS generation may also damage genomic DNA through:

· oxidation of nucleobases;

· DNA strand breaks; and

· formation of potentially mutagenic lesions.

Persistent or inadequately repaired DNA damage may contribute to genotoxicity, genomic instability, and altered cellular function.

3.2.4.6. Mitochondrial Dysfunction

Mitochondria are important cellular targets in nanoparticle-induced toxicity because of their central role in energy metabolism and redox homeostasis. Potential mitochondrial disturbances include:

· loss of mitochondrial membrane potential;

· impaired ATP production;

· increased mitochondrial ROS generation;

· release of cytochrome c; and

· activation of apoptotic signaling pathways.

Because mitochondria are central to cellular energy metabolism, sustained mitochondrial dysfunction can impair multiple cellular processes and, under severe conditions, promote cell death.

3.2.4.7. Activation of Inflammatory Pathways

Nanoparticles may activate several intracellular signaling pathways associated with inflammation. The magnitude and nature of the response depend strongly on nanoparticle composition, physicochemical properties, dose, exposure duration, and the biological context.

NF-κB Pathway

Activation of the nuclear factor kappa B (NF-κB) pathway can induce the transcription of multiple pro-inflammatory mediators, including:

· tumor necrosis factor-alpha (TNF-α);

· interleukin-1 beta (IL-1β);

· interleukin-6 (IL-6); and

· cyclooxygenase-2 (COX-2).

Excessive or persistent activation of NF-κB may contribute to chronic inflammatory responses and tissue injury.

NLRP3 Inflammasome

Certain nanoparticles may also activate the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome. Activation of this multiprotein complex promotes the maturation and secretion of pro-inflammatory cytokines, particularly:

· IL-1β; and

· IL-18.

Excessive or sustained inflammasome activation may contribute to chronic inflammation and tissue damage. However, the ability of a specific nanoparticle to activate the NLRP3 inflammasome depends on its physicochemical properties and the cellular context.

3.2.4.8. Apoptosis

When cellular damage becomes irreversible or exceeds the capacity of cellular repair mechanisms, cells may undergo programmed cell death (apoptosis). Nanoparticle-induced apoptosis can involve the intrinsic mitochondrial pathway, characterized by several molecular events, including:

· increased expression or activation of Bax;

· reduced expression or activity of Bcl-2;

· release of cytochrome c from mitochondria;

· activation of caspase-9; and

· subsequent activation of caspase-3.

Under nutritionally relevant exposure conditions, substantial activation of apoptotic pathways is generally not expected for well-characterized and appropriately formulated nano-mineral systems. However, excessive exposure, unfavorable particle characteristics, or prolonged accumulation may increase apoptotic signaling, particularly in metabolically active tissues such as:

· hepatocytes;

· enterocytes; and

· renal cells.

3.2.4.9. Autophagy

In addition to apoptosis, nanoparticles may modulate autophagy, an intracellular quality-control mechanism involved in maintaining cellular homeostasis. Autophagy contributes to:

· recycling damaged or dysfunctional organelles;

· degradation of abnormal or aggregated proteins; and

· maintenance of cellular metabolic homeostasis.

At moderate levels, autophagy may represent an adaptive and protective response that enables cells to eliminate damaged cellular components and recover from stress. However, persistent or dysregulated autophagy may contribute to cellular dysfunction and, under certain conditions, may be associated with autophagy-associated cell death.

Therefore, changes in autophagic activity should be interpreted within the broader context of cellular stress, apoptosis, mitochondrial function, and the specific physicochemical properties of the nanoparticle.

3.2.4.10. Genotoxicity

Genotoxicity refers to the ability of an agent to induce damage to genetic material, including DNA and chromosomes. Nanoparticle-associated genotoxicity may arise through several direct and indirect mechanisms, including:

· excessive ROS generation and oxidative DNA damage;

· disruption of the mitotic spindle;

· direct or indirect interactions with DNA; and

· impairment of DNA repair mechanisms.

Genotoxicity is commonly evaluated using a combination of standardized experimental approaches, including:

· Comet assay;

· Micronucleus assay;

· Ames test; and

· chromosomal aberration assay.

The interpretation of genotoxicity data for nanomaterials requires particular caution because nanoparticle-specific properties may interfere with conventional assay systems and potentially produce false-positive or false-negative results. Therefore, complementary assays and appropriate nanoparticle controls are recommended.

Available evidence indicates that several nano-selenium and nano-zinc formulations administered within nutritionally relevant exposure ranges do not necessarily induce significant genotoxic effects. However, safety cannot be generalized to all nano-selenium or nano-zinc products because biological responses depend on particle size, morphology, surface chemistry, dissolution behavior, coating, dose, exposure duration, and the biological matrix. Consequently, genotoxicity should be evaluated on a case-by-case basis for each specific nanopremix formulation.

3.2.4.11. Immunotoxicity

Nanoparticles may influence the immune system through two broadly different types of responses: immunostimulation and immunosuppression.

Immunostimulation

At nutritionally relevant exposure levels, appropriately formulated nanoparticles may support immune function through mechanisms such as:

· activation of macrophages;

· enhancement of phagocytic activity; and

· enhancement of vaccine-induced immune responses.

These immunomodulatory effects represent some of the desired biological outcomes of nanopremix supplementation, particularly when nano-minerals function as highly bioavailable sources of essential trace elements.

Immunosuppression

At excessive exposure levels, however, nanoparticles may adversely affect immune function, potentially resulting in:

· reduced lymphocyte proliferation;

· impaired macrophage function; and

· persistent or dysregulated inflammatory responses.

Therefore, dose optimization and exposure control are critical determinants of the immunological safety of nanopremixes. The distinction between beneficial immunomodulation and adverse immunotoxicity depends on nanoparticle characteristics, dose, exposure duration, biological context, and the physiological status of the animal.

3.2.4.12. Alterations in Gene Expression (Transcriptomic Response)

Advances in transcriptomic technologies, particularly RNA sequencing (RNA-seq), have demonstrated that exposure to nanomaterials can modulate the expression of genes involved in antioxidant defense, inflammation, epithelial barrier integrity, and mineral metabolism.

Genes and pathways that may be affected include:

Antioxidant Defense

· GPX1

· GPX4

· SOD1

· CAT

· NFE2L2 (encoding nuclear factor erythroid 2-related factor 2, Nrf2)

Inflammatory Response

· TNF

· IL6

· IL1B

· IFNG

Tight Junction and Epithelial Barrier Function

· OCLN

· CLDN1

· TJP1 (encoding zonula occludens-1, ZO-1)

Mineral Transport and Homeostasis

· SLC39A4 (encoding ZIP4)

· SLC30A1 (encoding ZnT1)

· SLC11A2 (encoding divalent metal transporter 1, DMT1)

· SLC40A1 (encoding ferroportin)

Transcriptomic approaches provide a sensitive means of identifying molecular responses to nanopremix exposure and may help identify potential molecular biomarkers of safety, biological activity, and early toxicity that are not readily detectable using conventional clinical or histopathological parameters alone. However, changes in gene expression should be interpreted in conjunction with functional, biochemical, histological, and toxicokinetic endpoints.

3.2.4.13. Hormesis in Nanopremixes

An important concept in toxicology and nanotoxicology is hormesis, referring to a biphasic biological response in which a substance may produce beneficial or adaptive effects at relatively low exposure levels but adverse effects at higher levels.

In the context of nanopremix supplementation, the response may be conceptually represented as follows:

· nutritionally appropriate dose → beneficial physiological response;

· moderate dose → adaptive cellular response;

· excessive dose → adverse or toxic response.

This relationship may produce a biphasic dose–response curve. The hormetic concept may help explain why a nano-mineral such as nano-selenium can enhance antioxidant defenses, including glutathione peroxidase (GPx) activity, within an appropriate nutritional range, whereas excessive selenium exposure may disrupt redox homeostasis and promote oxidative stress.

Nevertheless, hormesis should not be assumed for every nanoparticle or nanopremix formulation. Its occurrence depends on the specific nanomaterial, dose, exposure duration, biological endpoint, and physiological context.

3.2.4.14. Synthesis of the Molecular Mechanisms of Toxicity

Overall, the toxicity of nanopremixes results from complex interactions between the physicochemical characteristics of nanoparticles and the biological responses of host cells. The formation of a protein corona, cellular internalization, ROS generation, oxidative stress, mitochondrial dysfunction, activation of inflammatory signaling pathways, apoptosis, autophagy, and alterations in gene expression represent major mechanisms that may influence nanoparticle safety.

However, current evidence indicates that appropriately designed formulations of nano-zinc, nano-selenium, nano-copper, and nano-iron administered within nutritionally relevant exposure ranges may exhibit favorable safety profiles in specific animal models. In some circumstances, these nano-minerals may even enhance antioxidant defense and cellular homeostasis. Nevertheless, safety should not be generalized solely on the basis of the mineral type or nanoscale designation.

Thus, the safety profile of a nanopremix is more appropriately determined by the integrated effects of formulation design, physicochemical characteristics, dose, exposure duration, route of administration, dissolution behavior, biological transformation, and target species, rather than by particle size alone.

3.2.5. Factors Influencing the Safety and Toxicity of Nanopremixes

3.2.5.1. Introduction

The safety of a nanopremix cannot be determined solely by the type of mineral or vitamin incorporated into the formulation. Numerous studies have demonstrated that nanoparticles with identical chemical compositions may produce different biological responses when their physicochemical characteristics, formulation properties, or exposure conditions differ. Consequently, the safety assessment of nanopremixes has increasingly shifted from a substance-based assessment toward a material-specific risk assessment, in which the unique characteristics of each nanomaterial are explicitly considered.

In animal nutrition, the safety profile of a nanopremix results from complex interactions among the intrinsic properties of the nanoparticles, the biological characteristics of the target animal, the feed matrix, the physicochemical conditions of the gastrointestinal tract, and the magnitude and duration of exposure. These factors collectively determine how nanoparticles undergo nano–bio interactions, gastrointestinal transformation, absorption, distribution, biotransformation, and elimination.

Understanding these determinants is essential for designing nanopremixes with an optimized benefit–risk profile, in which enhanced nutrient bioavailability can be achieved without disproportionately increasing toxicological risks or adverse environmental effects.

3.2.5.2. Physicochemical Factors of Nanoparticles

Physicochemical characteristics are major determinants of nanoparticle biological behavior. These properties influence nanoparticle stability, dissolution, biodistribution, interactions with biological interfaces, cellular uptake, and potential toxicity.

3.2.5.2.1. Particle Size

Particle size is among the most extensively investigated determinants in nanotoxicology. In general, decreasing particle size can result in:

· increased specific surface area;

· increased surface energy;

· enhanced dissolution rates for certain nanominerals; and

· increased opportunities for interactions with and, in some circumstances, penetration across biological membranes.

However, extremely small nanoparticles may also have greater potential to cross biological barriers and undergo systemic distribution, depending on their composition and surface characteristics.

Particle size should therefore not be interpreted as an independent determinant of toxicity. A conceptual size-dependent pattern may be described as follows:

· >200 nm → generally lower potential for intestinal absorption as intact particles;

· 50–200 nm → potentially favorable for certain oral delivery applications;

· 10–50 nm → potentially high biological availability, depending on composition and formulation;

· <10 nm → potentially greater systemic distribution and tissue penetration.

These ranges should be regarded as general conceptual categories rather than universal safety thresholds, because gastrointestinal absorption, biodistribution, and toxicity depend on multiple interacting factors.

Accordingly, nanopremix formulations may be engineered within specific nanoscale ranges to achieve an appropriate balance between biological efficacy, stability, and safety. The optimal particle size should ultimately be established experimentally for each specific nanomaterial and intended application.

3.2.5.2.2. Particle Size Distribution

Particle size distribution, rather than mean particle size alone, is an important determinant of nanoparticle behavior and formulation consistency.

A relatively narrow particle-size distribution may contribute to:

· more uniform mineral release;

· more predictable bioavailability;

· greater formulation consistency; and

· improved reproducibility of biological responses.

Conversely, a broad particle-size distribution may produce heterogeneous biological behavior because different particle fractions can exhibit different dissolution rates, cellular uptake characteristics, biodistribution patterns, and toxicological profiles.

The Polydispersity Index (PDI) is commonly used as an indicator of particle-size distribution in dynamic light-scattering measurements. As a general interpretive framework:

· PDI <0.20 → relatively narrow and highly uniform distribution;

· PDI 0.20–0.30 → relatively narrow distribution and generally acceptable colloidal uniformity;

· PDI >0.40 → broad and heterogeneous distribution, potentially indicating reduced formulation uniformity or increased aggregation.

However, PDI values should not be interpreted as universal indicators of safety or stability. Their significance depends on the analytical method, sample concentration, dispersion medium, measurement conditions, and the physicochemical nature of the nanoparticle system.

3.2.5.2.3. Particle Shape and Morphology

Nanoparticles may exhibit various shapes and morphologies, including:

· spherical;

· rod-shaped;

· cubic;

· plate-like;

· tubular; and

· porous structures.

Particle shape can influence:

· the extent of contact with cell membranes;

· phagocytic uptake efficiency;

· endocytic pathways; and

· biological circulation and residence time.

For nanopremix applications, spherical nanoparticles are often preferred because they are generally easier to manufacture and may provide relatively uniform physicochemical and biological behavior. In addition, compared with certain elongated or fiber-like nanostructures, appropriately designed spherical nanoparticles may present a lower potential for persistent physical interactions with cells and tissues. Nevertheless, the safety profile of a nanoparticle cannot be determined solely by its shape, as particle size, surface chemistry, dissolution behavior, aggregation state, and exposure conditions also play critical roles.

3.2.5.2.4. Specific Surface Area

Specific surface area increases substantially as particle size decreases.

A high specific surface area may provide several advantages, including:

· increased dissolution;

· enhanced adsorption of biomolecules; and

· improved nutrient bioavailability.

However, an excessively high specific surface area may also:

· increase reactive oxygen species (ROS) generation;

· accelerate the release of metal ions; and

· enhance protein corona formation.

Therefore, specific surface area should be optimized to maximize the nutritional benefits of nanoparticles while minimizing the potential for adverse biological effects.

3.2.5.2.5. Surface Charge (Zeta Potential)

Surface charge is an important determinant of the colloidal stability of nanoparticles and their interactions with biological membranes.

As a general colloidal-stability guideline:

· zeta potentials greater than approximately +30 mV are often associated with relatively high electrostatic stability;

· zeta potentials lower than approximately −30 mV are likewise generally associated with relatively high electrostatic stability; and

· zeta potentials close to neutrality, particularly within approximately −10 to +10 mV, may increase the tendency toward aggregation.

Positively charged nanoparticles can interact strongly with negatively charged cell membranes, potentially enhancing cellular uptake. However, excessively positive surface charge may also increase the risk of:

· cytotoxicity;

· hemolysis; and

· inflammatory responses.

Accordingly, nanopremix formulations may be engineered with near-neutral or mildly charged surfaces to achieve an appropriate balance between colloidal stability, biological interaction, and safety. The optimal surface charge, however, is formulation- and application-dependent and should therefore be established experimentally rather than based on a universal threshold.

3.2.5.3. Chemical Composition of Nanoparticles

The chemical composition of the nanoparticle core (core composition) is a major determinant of its biological behavior, dissolution characteristics, and potential toxicity.

Nano-Selenium

Nano-selenium has been investigated extensively as a source of selenium because of its high biological activity and, in some formulations, a relatively favorable safety profile compared with certain conventional selenium sources. Its potential advantages include:

· antioxidant activity;

· relatively favorable biocompatibility within nutritional dose ranges; and

· the potential for controlled selenium release.

Nevertheless, the biological and toxicological properties of nano-selenium depend strongly on its physicochemical characteristics, including particle size, elemental or compound form, surface coating, aggregation state, and dose.

Nano-Zinc

Nano-zinc, particularly zinc oxide nanoparticles, may provide:

· high zinc bioavailability;

· immunomodulatory activity; and

· antimicrobial activity.

However, excessive dissolution and release of Zn²⁺ may disrupt cellular zinc homeostasis and increase oxidative stress. Therefore, the rate and extent of zinc-ion release are important determinants of both efficacy and safety.

Nano-Copper

Nano-copper may exhibit:

· strong antimicrobial activity; and

· high biological availability of copper.

However, excessive exposure to Cu-containing nanoparticles or the excessive release of Cu²⁺ may promote pro-oxidant reactions and cellular oxidative damage. Consequently, the nutritional benefits of nano-copper must be balanced against its potential dose-dependent toxicity.

Nano-Iron

Nano-iron can contribute to iron supplementation and support hematopoiesis and cellular iron metabolism.

However, excessive release of Fe²⁺ may promote Fenton-type reactions, thereby increasing the generation of hydroxyl radicals and other reactive oxygen species. Thus, iron nanoparticle formulations require careful control of dissolution kinetics and dosage.

3.2.5.4. Surface Coating and Functionalization

One of the most important developments in nanopremix design is the application of surface coatings and surface functionalization.

Nanoparticle coatings may be composed of:

· chitosan;

· alginate;

· pectin;

· dextran;

· gelatin;

· proteins;

· lipids;

· polyethylene glycol (PEG); and

· naturally derived polysaccharides.

Surface coatings can provide several functional advantages, including:

· improving colloidal stability;

· reducing aggregation;

· controlling excessive ion release;

· enhancing biocompatibility; and

· reducing undesirable immune interactions.

In addition, surface functionalization can be used to modify the interaction of nanoparticles with biological barriers and potentially facilitate more controlled nutrient delivery to specific sites of absorption.

For orally administered nanopremix, the coating material may also determine the stability of the nanoparticles under gastrointestinal conditions, their interaction with digestive enzymes and mucus, and the extent to which the nanoparticles remain intact or undergo dissolution. Consequently, coating selection should be based not only on technological stability but also on gastrointestinal fate, toxicological characteristics, and regulatory acceptability.

3.2.5.5. Solubility and Ion-Release Kinetics

Not all nanoparticles remain in particulate form after entering the gastrointestinal tract. Depending on their chemical composition and physicochemical properties, nanoparticles may undergo:

· dissolution;

· ion release; and

· chemical transformation.

The safety and efficacy of nanopremix are therefore influenced by the dynamic equilibrium between:

· intact nanoparticles; and

· dissolved or bioavailable mineral ions.

Excessively rapid ion release may result in:

· oxidative stress;

· disruption of mineral homeostasis; and

· cytotoxicity.

Conversely, excessively slow dissolution may limit mineral bioavailability and reduce the nutritional effectiveness of the formulation.

Therefore, ion-release kinetics represents a critical design parameter in the development of nano-mineral feed additives. An optimal formulation should provide sufficient nutrient availability while preventing excessive systemic exposure to free metal ions.

3.2.5.6. Dose and Duration of Exposure

The fundamental toxicological principle that biological effects are dose-dependent remains highly relevant to nanopremix.

Dose

In general, the relationship between nanopremix dose and biological response can be conceptualized as follows:

· nutritional dose → generally within the range intended to meet physiological requirements;

· optimized dose → expected to provide maximum nutritional benefit with an acceptable safety margin; and

· excessive dose → increased potential for adverse biological effects and toxicity.

This dose-dependent phenomenon may, in some cases, exhibit a hormetic or biphasic dose–response relationship, in which low or nutritional exposure produces beneficial adaptive responses whereas excessive exposure may result in adverse effects.

Consequently, the establishment of an appropriate dose range is essential for maximizing the benefit–risk profile of nanopremix.

Duration of Exposure

Exposure duration is generally classified into:

· acute exposure;

· subchronic exposure; and

· chronic exposure.

Acute exposure typically refers to a short-term exposure following a single or limited number of administrations, whereas subchronic and chronic exposure involve repeated administration over substantially longer periods.

Most studies evaluating nanopremix in livestock have focused on short-term or production-cycle-scale exposure, whereas evidence regarding long-term, multigenerational exposure remains comparatively limited. Therefore, chronic toxicity, reproductive and developmental effects, tissue accumulation, potential residues in edible tissues, and environmental consequences require further investigation before widespread long-term application of nanopremix can be considered fully characterized from a safety perspective.

3.2.5.7. Species and Animal Biological Factors

Responses to nanopremix supplementation may vary substantially among animal species because of differences in:

· gastrointestinal anatomy;

· gut microbiota;

· metabolism; and

· absorptive physiology.

For example:

· poultry have a relatively short gastrointestinal transit time;

· pigs exhibit several physiological and anatomical similarities to humans;

· ruminants are exposed to the unique physicochemical and microbial environment of the rumen; and

· fish are exposed to interactions between feed components and the surrounding aquatic medium.

In addition to species-specific characteristics, other biological factors that may influence the safety and biological response to nanopremix include:

· age;

· sex;

· physiological status;

· health status; and

· stress conditions.

These factors may alter gastrointestinal transit, nutrient absorption, metabolism, immune responses, and the disposition of nanoparticles, thereby contributing to inter-individual and interspecies variability in nanopremix safety and efficacy.

3.2.5.8. Interactions with the Feed Matrix

Nanopremix is not administered as an isolated material but is incorporated into a complex feed matrix containing multiple nutritional and non-nutritional components.

Feed constituents such as:

· phytate;

· dietary fiber;

· proteins;

· lipids;

· tannins; and

· polysaccharides

may influence:

· nanoparticle aggregation or agglomeration;

· dissolution;

· ion-release kinetics; and

· nutrient bioavailability.

These interactions may substantially alter the physicochemical behavior and gastrointestinal fate of nanoparticles. For this reason, safety and efficacy assessments should, whenever possible, be conducted using the complete feed formulation rather than solely with purified nanoparticle suspensions. Such an approach provides a more realistic representation of the conditions encountered during practical animal feeding.

3.2.5.9. Interactions with the Gut Microbiota

The gut microbiota is increasingly recognized as an important determinant of nanopremix safety and biological activity.

Nanoparticle–microbiota interactions may involve:

· modulation of microbial community composition;

· alterations in microbial metabolism;

· formation of new microbial metabolites; and

· microbial transformation of nanoparticles or their dissolved constituents.

At nutritional exposure levels, nano-zinc and nano-selenium may influence microbial community structure and potentially contribute to the maintenance of intestinal microbial homeostasis. However, excessive exposure may disturb microbial community balance and potentially lead to dysbiosis.

Therefore, assessment of nanopremix safety should not be restricted to conventional toxicological endpoints but should also consider changes in microbial diversity, community structure, functional activity, and host–microbiota interactions.

3.2.5.10. Environmental and Management Factors

Several external and management-related factors may also influence the stability, efficacy, and safety of nanopremix, including:

· storage temperature;

· humidity;

· feed pelleting conditions;

· oxidative processes during storage;

· drinking-water quality; and

· raw-material quality.

The physical and chemical stability of nanopremix during storage is particularly important because particle aggregation or agglomeration may alter particle size distribution, dissolution behavior, bioavailability, and potentially the biological response.

Processing conditions such as pelleting temperature, pressure, moisture, and residence time may also modify the physicochemical characteristics of nanoparticles. Consequently, nanopremix should be evaluated not only as a freshly prepared material but also in its final commercial feed form and following relevant processing and storage conditions.

3.2.5.11. Variability in Nanoparticle Synthesis Methods

The synthesis method used to produce nanoparticles can substantially influence their final physicochemical and biological characteristics.

Common approaches include:

· chemical synthesis;

· physical synthesis;

· biological or green synthesis;

· bacterial-mediated biosynthesis;

· fungal-mediated biosynthesis; and

· plant-extract-mediated biosynthesis.

Green-synthesized nanoparticles may, in some cases, exhibit favorable biocompatibility because naturally derived biomolecules associated with their surfaces can function as stabilizing or capping agents. These biomolecular coatings may influence particle aggregation, surface reactivity, dissolution, cellular interactions, and biological responses.

However, the assumption that green synthesis is inherently safer should be avoided. The safety profile of biologically synthesized nanoparticles remains dependent on particle size, morphology, surface chemistry, residual synthesis components, batch-to-batch reproducibility, dissolution behavior, and exposure dose. Therefore, green synthesis should be considered a potentially advantageous manufacturing strategy rather than a guarantee of reduced toxicity.

3.2.5.12. Interrelationships among Determinants: An Integrated Safety Framework

The safety of nanopremix is not determined by a single factor but by the interaction of multiple physicochemical, biological, nutritional, and environmental parameters.

Conceptually, these relationships can be represented as follows:

Physicochemical Characteristics of Nanoparticles
↓
Particle size • Shape • Surface charge • Solubility • Surface coating
↓
Interactions with Biological Fluids
↓
Protein Corona Formation
↓
Absorption and Biodistribution
↓
Interactions with Target Cells and Tissues
↓
Molecular and Cellular Responses
↓
Biological Outcomes
↓
Nutritional Benefit or Adverse Effects/Toxicity

This framework provides the conceptual basis for the Safe-by-Design Nanopremix approach, in which safety, efficacy, and sustainability are incorporated into nanopremix development from the earliest stages of formulation and material engineering.

Under this approach, nanoparticle properties are deliberately optimized to achieve the desired nutritional function while minimizing unnecessary systemic exposure, adverse cellular interactions, tissue accumulation, food-chain transfer, and environmental release.

3.2.5.13. Synthesis of the Subsection

Overall, nanopremix safety is determined by a complex interplay among nanoparticle physicochemical characteristics, chemical composition, synthesis method, surface coating, dose, duration of exposure, target species, physiological condition of the animal, feed matrix, gut microbiota, and environmental factors.

Among these determinants, particle size, surface charge, solubility, and ion-release kinetics are particularly important in determining the balance between nutritional efficacy and potential toxicity. Nevertheless, no single physicochemical parameter can independently predict the safety of all nanomaterials. A comprehensive assessment should therefore consider the complete physicochemical and biological profile of each specific nanopremix formulation.

Accordingly, the development of next-generation nanopremix should extend beyond the objective of improving nutrient bioavailability and incorporate the principles of Safe-by-Design. This approach aims to engineer nanoparticle properties from the outset to maximize biological benefits while minimizing potential risks to livestock, consumers, and the environment.

3.3. Biodistribution, Toxicokinetics, Bioaccumulation, and Elimination of Nanopremix

3.3.1. Introduction

The safety of nanopremix as a feed additive is determined not only by the physicochemical characteristics and intrinsic toxicity of nanoparticles but also by their biological fate following oral administration. After entering the gastrointestinal tract, nanoparticles undergo a series of biological processes collectively described by the ADME framework (Absorption, Distribution, Metabolism, and Excretion). These processes determine the fraction of nanoparticles or their dissolved constituents that reaches systemic circulation, the organs and tissues in which they are distributed, the extent to which they undergo transformation, their residence time in the body, and their eventual routes of elimination.

In pharmacology and toxicology, the study of the fate of a substance within an organism is generally referred to as toxicokinetics. For nanomaterials, this concept is further refined through the study of nanotoxicokinetics, because the biological disposition of nanoparticles is strongly influenced by particle size, specific surface area, surface charge, shape, aggregation state, dissolution behavior, protein corona formation, and interactions with the immune system and gut microbiota.

Consequently, nanoparticles with identical chemical compositions may exhibit substantially different absorption, biodistribution, transformation, and elimination profiles when their physicochemical properties differ.

For the livestock industry, understanding the biodistribution of nanopremix has several important implications. First, biodistribution determines biological efficacy because nanoparticles or their bioavailable constituents must reach relevant target tissues to exert their intended physiological effects. Second, biodistribution is directly relevant to food safety, because the potential presence of nanoparticle-derived materials or mineral residues in meat, milk, eggs, and fish depends on their absorption, tissue distribution, transformation, and elimination. Third, toxicokinetic information is important for regulatory decision-making because safety assessment of novel nanomaterials may require information on absorption, distribution, metabolism or transformation, and excretion.

Several studies indicate that nano-minerals administered as nutritional supplements may undergo substantial transformation within the gastrointestinal tract before entering systemic circulation. Nano-selenium, nano-zinc, nano-copper, and nano-iron may undergo partial dissolution, resulting in absorption of dissolved mineral species, while a fraction may remain in particulate form and potentially undergo cellular uptake through endocytic mechanisms. The relative contribution of intact nanoparticles versus dissolved ions depends strongly on the chemical composition, dissolution kinetics, particle size, surface properties, gastrointestinal conditions, and formulation of the nanopremix.

Following systemic absorption, nanoparticles or nanoparticle-derived species may be distributed to tissues such as the liver, spleen, kidneys, bone marrow, skeletal muscle, reproductive tissues, and immune organs. The extent and persistence of tissue distribution depend on nanoparticle-specific properties, dose, exposure duration, animal species, physiological condition, and the capacity of tissues to transform, sequester, or eliminate the material.

Although some studies indicate relatively efficient elimination of certain nano-mineral-derived species through urine, bile, and feces, the possibility of tissue retention or accumulation following repeated long-term exposure remains an important area of investigation. Therefore, toxicokinetic evaluation of nanopremix should extend beyond measurements of mineral concentrations in blood and include tissue biodistribution, biological half-life, clearance kinetics, elimination pathways, tissue retention, and potential transfer to edible animal-derived products.

This subsection therefore examines the biological fate of nanopremix from gastrointestinal absorption and systemic distribution to target organs, transformation and metabolic processes, potential bioaccumulation, and elimination through major excretory pathways. These considerations provide an important scientific basis for evaluating food safety, establishing appropriate exposure limits where applicable, and developing nanopremix formulations consistent with the principles of Safe-by-Design and One Health.

3.3.2. Basic Concepts of Nanopremix Toxicokinetics

Toxicokinetics describes the relationship between the administered dose and the concentration of a substance in the body over time. In the context of nanopremix, this concept is more complex because nanoparticles may undergo physical, chemical, and biological transformations throughout their journey within the body.

In general, the biological fate of nanopremix can be described as follows:

Dietary ingestion
↓
Dispersion in the gastrointestinal tract
↓
Interactions with mucus and biological proteins
↓
Absorption across the intestinal mucosa
↓
Systemic distribution through the blood and lymphatic systems
↓
Transient accumulation in target organs
↓
Biotransformation and release of mineral ions
↓
Excretion through urine, bile, feces, milk, or eggs

Unlike small molecules, nanoparticles may also undergo:

· aggregation;

· agglomeration;

· protein corona formation;

· phagocytic uptake by the reticuloendothelial system (RES);

· transformation into ionic species or organic complexes.

Therefore, the toxicokinetic parameters of nanopremix should be evaluated using a multidisciplinary approach and advanced analytical techniques, including inductively coupled plasma mass spectrometry (ICP-MS), single-particle ICP-MS (spICP-MS), transmission electron microscopy (TEM), scanning electron microscopy (SEM), laser ablation ICP-MS, and isotope tracing and imaging techniques.

3.3.3. Gastrointestinal Absorption of Nanopremix

Absorption represents the first critical stage determining the biological effectiveness of nanopremix. Following ingestion, nanopremix undergoes several sequential processes, including:

1. disintegration of the formulation;

2. dispersion of nanoparticles;

3. formation of a protein corona;

4. interaction with the intestinal mucus layer;

5. penetration of the intestinal mucosa; and

6. internalization by enterocytes.

Some nano-minerals undergo dissolution and release mineral ions, whereas others may enter enterocytes through several pathways, including:

· clathrin-mediated endocytosis;

· caveolae-mediated endocytosis;

· macropinocytosis; and

· transport through M cells within Peyer's patches.

The efficiency of nanopremix absorption is influenced by several factors, including:

· particle size;

· surface charge;

· type of surface coating;

· solubility;

· gastrointestinal pH;

· feed composition;

· the presence of phytate and dietary fiber; and

· intestinal mucosal integrity.

In poultry and pigs, absorption occurs predominantly in the duodenum and jejunum, whereas in ruminants, absorption efficiency is strongly influenced by the ability of the nanopremix to remain stable and biologically available within the fermentative environment of the rumen. In fish and shrimp, absorption is affected by feed retention time in the gastrointestinal tract and the stability and transformation of nanoparticles in the aquatic environment.

3.3.4. Biodistribution of Nanopremix

Following translocation across the intestinal mucosa, nanoparticles may enter the systemic circulation through the portal blood circulation or lymphatic system. Their subsequent distribution is determined by particle size, protein corona characteristics, tissue affinity, and the ability of nanoparticles to cross biological barriers.

The organs and tissues most frequently involved in nanoparticle distribution include:

· liver;

· spleen;

· kidneys;

· bone marrow;

· lungs;

· skeletal muscle;

· adipose tissue;

· reproductive organs; and

· immune tissues.

Liver

The liver is one of the primary organs exposed to absorbed nanoparticles because it receives blood directly from the gastrointestinal tract through the portal vein. Kupffer cells play an important role in the recognition, uptake, and processing of nanoparticles through phagocytosis.

Kidneys

The kidneys serve as a major route of elimination for soluble mineral species and, depending on their physicochemical characteristics, for very small nanoparticles. Nanoparticles within the renal filtration range may undergo glomerular filtration, whereas other particles may be taken up by proximal tubular cells.

Spleen

The spleen is an important component of the reticuloendothelial system and contributes to the clearance of foreign particulate materials from the circulation. Transient accumulation of nanoparticles in the spleen is therefore commonly observed in nanoparticle biodistribution studies.

Skeletal Muscle

Distribution to skeletal muscle has important implications for food safety because muscle tissue constitutes a major edible component of meat-producing animals. Available evidence generally indicates that tissue deposition of nano-minerals in skeletal muscle is relatively limited when administered at nutritionally appropriate doses. Nevertheless, tissue-specific accumulation should be evaluated for each nanomaterial and exposure scenario.

3.3.5. Biodistribution According to Nano-Mineral Type

Different nano-minerals exhibit distinct toxicokinetic and biodistribution profiles.

Nano-Selenium

Nano-selenium may undergo metabolic transformation into selenium intermediates, including selenide, which subsequently contribute to the biosynthesis of selenoproteins such as glutathione peroxidase (GPx), thioredoxin reductase, and selenoprotein P. Tissue distribution has been reported primarily in the liver, kidneys, spleen, and reproductive tissues, although the extent of deposition depends on particle characteristics, dose, and exposure duration.

Nano-Zinc

Nano-zinc may be distributed to the liver, pancreas, bone, skin, and reproductive tissues. A substantial proportion of zinc is regulated through binding to proteins such as metallothionein, which plays a central role in zinc homeostasis and intracellular metal regulation.

Nano-Copper

Nano-copper may show substantial hepatic distribution because copper metabolism is closely regulated by hepatic uptake and hepatobiliary transport pathways. Biliary excretion represents an important physiological route for copper elimination.

Nano-Iron

Nano-iron can contribute to iron availability for erythropoiesis in the bone marrow, whereas excess iron may be stored primarily as ferritin or, under conditions of iron overload, hemosiderin in tissues such as the liver and spleen.

3.3.6. Bioaccumulation of Nanopremix

Bioaccumulation refers to an increase in the concentration of a substance within biological tissues when the rate of uptake exceeds the rate of elimination.

In nanopremix, bioaccumulation may be influenced by:

· particle size;

· frequency of administration;

· duration of exposure;

· animal species;

· hepatic and renal function; and

· the metabolic characteristics of the mineral.

Available evidence suggests that, at nutritionally appropriate doses, nano-selenium and nano-zinc generally undergo physiological utilization and homeostatic regulation, thereby limiting sustained tissue accumulation. However, prolonged exposure to doses substantially exceeding physiological requirements may increase mineral deposition in organs such as the liver, kidneys, or spleen.

Because bioaccumulation is highly material- and dose-dependent, conclusions regarding the absence of accumulation should not be generalized across all nano-minerals or animal species.

3.3.7. Biotransformation of Nanopremix

Nanopremix materials do not necessarily remain in their original nanoparticulate form after entering the gastrointestinal tract or systemic circulation. Biotransformation may involve:

· dissolution into mineral ions;

· complexation with proteins;

· oxidation or reduction;

· conjugation with biomolecules; and

· sequestration or storage through mineral-binding proteins.

For example, nano-selenium may undergo metabolic transformation into selenium intermediates, including selenide, which can subsequently be incorporated into selenocysteine and various selenoproteins. These transformations are important because the biological activity and toxicity of a nano-mineral may arise from both the nanoparticulate form and the ionic or molecular species generated during dissolution and metabolism.

3.3.8. Elimination of Nanopremix

Elimination represents the final stage of nanopremix toxicokinetics. Potential routes of elimination include:

· urine;

· feces;

· bile;

· milk;

· eggs;

· intestinal mucus and epithelial shedding; and

· gills in aquatic animals.

For most nano-minerals, elimination occurs through a combination of urinary, fecal, and hepatobiliary pathways. However, the predominant route varies according to the mineral, its chemical form, particle characteristics, degree of dissolution, and physiological regulation.

For example:

· nano-zinc → primarily through feces and, to a lesser extent, urine;

· nano-selenium → through urine and feces, with biliary excretion also contributing depending on its chemical form;

· nano-copper → predominantly through the hepatobiliary pathway and feces; and

· nano-iron → primarily through physiological recycling and sequestration, with very limited active excretion under normal conditions.

Efficient elimination is a critical determinant of systemic exposure and is important for minimizing the potential for long-term tissue accumulation. Accordingly, assessment of nanopremix safety should consider not only total mineral concentrations in biological matrices but also the chemical and particulate forms present, their residence time in tissues, and their respective elimination pathways.

3.3.9. Factors Affecting Biodistribution and Elimination

Several major factors influence the biodistribution and elimination of nanopremix, including:

· nanoparticle size;

· particle shape and morphology;

· surface coating;

· surface charge;

· protein corona characteristics;

· animal species;

· age;

· physiological status;

· disease status; and

· feed composition.

In addition, inflammatory conditions may increase vascular permeability and consequently alter the tissue distribution and accumulation of nanoparticles in specific organs. Alterations in hepatic and renal function may also substantially affect nanoparticle clearance, systemic exposure, and residence time within tissues.

3.3.10. Techniques for Evaluating Biodistribution

Advances in analytical technologies have enabled increasingly accurate and comprehensive characterization of nanopremix biodistribution.

Commonly employed techniques include:

· ICP-MS (Inductively Coupled Plasma–Mass Spectrometry);

· single-particle ICP-MS (spICP-MS);

· ICP-OES (Inductively Coupled Plasma–Optical Emission Spectroscopy);

· TEM coupled with EDX (Transmission Electron Microscopy with Energy-Dispersive X-ray Spectroscopy);

· laser ablation ICP-MS;

· synchrotron X-ray fluorescence imaging; and

· isotope tracing or labeling using stable isotopes or radioisotopes.

These complementary analytical approaches can provide information not only on total elemental concentrations but, where technically feasible, also on elemental speciation and physical form (particulate versus ionic), particle size, tissue localization, spatial distribution, and the dynamics of biological transformation. The integration of elemental analysis with particle-specific techniques is particularly important because measurement of total mineral concentration alone cannot reliably distinguish intact nanoparticles from dissolved ionic species.

3.3.11. Implications for Food Safety

Biodistribution data have direct implications for the safety assessment of foods of animal origin. Key parameters requiring evaluation include:

· potential residues in meat;

· transfer into milk;

· deposition in eggs;

· accumulation in fish fillets;

· appropriate withdrawal periods; and

· establishment of Maximum Residue Limits (MRLs) or other applicable regulatory residue criteria.

Available evidence suggests that nano-minerals administered at nutritionally appropriate doses may generally result in limited tissue deposition or residues of toxicological concern. However, this conclusion cannot be generalized to all nanomaterials, formulations, animal species, or exposure conditions. Each new nanopremix formulation therefore requires product-specific evaluation of toxicokinetics, tissue distribution, transformation, persistence, and residues before regulatory authorization.

3.3.12. Synthesis of the Subsection

The biodistribution and toxicokinetic behavior of nanopremix result from dynamic interactions between the physicochemical properties of nanoparticles and the biological characteristics of the target animal. Following ingestion, nanopremix may undergo gastrointestinal transformation and absorption, systemic distribution to specific organs and tissues, biotransformation into biologically active or inactive species, and elimination through urine, feces, bile, or other physiological pathways.

At recommended nutritional doses, nano-selenium, nano-zinc, nano-copper, and nano-iron may exhibit toxicokinetic profiles compatible with efficient nutrient utilization without substantial persistent tissue accumulation. Nevertheless, these observations should not be generalized across all nano-minerals or formulations. Product-specific safety assessment remains essential because changes in particle size, surface coating, chemical form, synthesis method, dissolution behavior, dose, and exposure duration may substantially modify biodistribution, biological transformation, tissue residence time, and elimination.

3.4. Safety of Nanopremix for the Gastrointestinal Tract, Gut Microbiota, and Immune System

3.4.1. Introduction

The gastrointestinal tract is the first major biological system to interact with nanopremix following dietary administration. Consequently, gastrointestinal safety represents one of the most important components of toxicological evaluation and risk assessment. Unlike pharmaceutical agents that are often administered over relatively short periods, nanopremix may be incorporated into animal diets and consumed continuously throughout the production cycle. Therefore, the long-term interactions between nanoparticles and the intestinal mucosa, gut microbiota, gut-associated lymphoid tissues, and local immune system require comprehensive evaluation.

Over the past decade, the concept of gut health has emerged as a major pillar of modern animal nutrition. The gastrointestinal tract is no longer regarded merely as an organ responsible for nutrient digestion and absorption, but rather as a complex biological ecosystem comprising three major components: the intestinal epithelial barrier, the gut microbiota, and the mucosal immune system, including the gut-associated lymphoid tissue (GALT). These components interact dynamically to form a gut microbiota–immune axis, which plays a central role in maintaining intestinal homeostasis, digestive efficiency, resistance to pathogens, and regulation of inflammatory responses.

In the context of nanopremix, enhanced mineral and vitamin bioavailability may support intestinal function and immune competence. However, the physicochemical characteristics of nanoparticles may also influence microbial community composition, epithelial permeability, microbial metabolite production, and innate immune signaling. Therefore, the safety assessment of nanopremix should extend beyond conventional toxicological endpoints to include indicators of gut health, mucosal integrity, microbiota composition and function, and immune status.

Experimental studies in poultry, pigs, ruminants, and aquaculture species indicate that appropriately formulated nanopremix may exert beneficial effects on gastrointestinal health. Nano-zinc, nano-selenium, nano-copper, nano-vitamins, and various nano-phytobiotics have been reported under specific experimental conditions to improve intestinal villus morphology, support tight-junction integrity, enhance mucin production, reduce colonization by selected pathogenic microorganisms, and modulate mucosal immune responses. Conversely, exposure to concentrations substantially exceeding physiological requirements may disrupt microbial homeostasis (dysbiosis), increase oxidative stress, and promote mucosal inflammation.

This subsection systematically examines the interactions between nanopremix and the gastrointestinal tract, encompassing the intestinal mucus layer, epithelial barrier, gut microbiota, microbial metabolites, and mucosal immune system, as well as their implications for animal health and the long-term safety of nanopremix administration.

3.4.2. Interaction of Nanopremix with the Gastrointestinal Mucosa

Following entry into the intestinal lumen, nanoparticles first interact with the intestinal mucus layer. Intestinal mucus consists predominantly of mucin glycoproteins, phospholipids, secretory immunoglobulin A (IgA), antimicrobial peptides, and other immune-related components.

The mucus layer performs several important physiological functions, including:

· protecting the intestinal epithelium from mechanical and chemical damage;

· limiting invasion by pathogenic microorganisms;

· maintaining hydration of the epithelial surface;

· regulating the diffusion and transport of nutrients toward enterocytes; and

· providing a habitat and physicochemical environment for portions of the commensal microbiota.

Nanoparticles with sufficiently small dimensions and appropriate surface characteristics may diffuse through the mucus layer without causing substantial disruption of its structure. In contrast, highly aggregating nanoparticles or particles with strongly positive surface charge may interact extensively with mucin, potentially reducing their diffusion through the mucus layer and increasing localized exposure at the epithelial surface.

Several studies suggest that coating nanoparticles with biopolymers such as chitosan, alginate, pectin, or other naturally derived polysaccharides can modify their interaction with the mucus layer and potentially improve their compatibility with the intestinal environment. However, the effects of a particular coating remain dependent on its physicochemical properties, coating density, gastrointestinal conditions, and nanoparticle composition. Therefore, coating strategies should be evaluated on a formulation-specific basis rather than assumed to provide uniform safety benefits across all nanomaterials.

3.4.3. Effects on Intestinal Epithelial Integrity

The intestinal epithelium constitutes a major biological barrier that regulates the movement of nutrients, water, electrolytes, and potentially harmful external substances across the intestinal wall.

Epithelial integrity is maintained in part by tight-junction complexes, which include proteins such as:

· occludin (OCLN);

· claudins (CLDNs);

· zonula occludens-1 (ZO-1); and

· junctional adhesion molecules (JAMs).

At nutritionally appropriate doses, nano-zinc and nano-selenium have been reported in experimental studies to support the expression and/or integrity of tight-junction-associated proteins, thereby contributing to maintenance of the intestinal barrier. Improved tight-junction integrity may reduce excessive intestinal permeability and help limit the development of intestinal barrier dysfunction, commonly referred to as “leaky gut,” which has been associated with inflammatory responses and impaired production performance.

Conversely, exposure to excessively high concentrations of certain nanoparticles may increase epithelial permeability through oxidative stress, membrane damage, mitochondrial dysfunction, or disruption of tight-junction proteins. Such findings highlight the importance of dose optimization, exposure duration, nanoparticle characterization, and formulation-specific safety assessment in the development of nanopremix.

3.4.4. Effects on Intestinal Morphology

Changes in intestinal morphology represent one of the most sensitive indicators for evaluating the biological effects of nanopremix. Commonly assessed histomorphometric parameters include:

· villus height;

· crypt depth;

· villus height-to-crypt depth ratio (VH);

· absorptive surface area; and

· goblet cell number.

Most experimental studies have reported that supplementation with nano-zinc, nano-selenium, and nano-vitamins can increase villus height and the VH ratio in broiler chickens, weaned pigs, Nile tilapia, and Pacific white shrimp. These morphological improvements are associated with an increased absorptive surface area and enhanced nutrient absorption efficiency.

In addition, an increased number of goblet cells may contribute to enhanced mucus production, thereby strengthening mucosal protection against enteric pathogens. Nevertheless, the magnitude and direction of these effects depend on the nanoparticle formulation, dose, duration of exposure, animal species, basal diet, and prevailing gastrointestinal conditions.

3.4.5. Effects on Gut Microbiota

3.4.5.1. Gut Microbiota as a Biological Target of Nanopremix

The gut microbiota is a complex community of microorganisms—including bacteria, archaea, fungi, protozoa, and viruses—that inhabits the gastrointestinal tract and interacts dynamically with the host.

Major physiological functions of the gut microbiota include:

· fermentation of complex carbohydrates;

· synthesis of certain vitamins and other bioactive metabolites;

· production of short-chain fatty acids (SCFAs);

· modulation of host immune responses; and

· protection against colonization by pathogenic microorganisms.

Nanopremix may influence the gut microbiota through at least two principal mechanisms:

1. Indirect nutritional modulation, whereby improved host mineral and vitamin status supports intestinal homeostasis and a more favorable microbial ecosystem; and

2. Direct antimicrobial activity, particularly in the case of nano-zinc and nano-copper, depending on their physicochemical characteristics and luminal concentrations.

The biological consequences of these interactions are highly dependent on dose. At nutritionally appropriate concentrations, nanopremix may support a favorable host–microbiota relationship, whereas excessive exposure may exert non-selective antimicrobial effects and disrupt microbial homeostasis.

3.4.5.2. Modulation of Gut Microbial Composition

Studies using 16S rRNA gene sequencing have indicated that appropriately formulated nanopremix may alter the relative abundance of specific microbial taxa. In some experimental settings, supplementation has been associated with increased proportions of potentially beneficial microorganisms, including:

· Lactobacillus spp.;

· Bifidobacterium spp.;

· Faecalibacterium spp.; and

· Ruminococcus spp.

Conversely, populations of certain potentially pathogenic microorganisms, including enteropathogenic Escherichia coli, Salmonella spp., Clostridium perfringens, and Campylobacter jejuni, may decrease following supplementation with selected nano-minerals at appropriate doses.

Such microbial shifts may contribute to improved intestinal function, enhanced nutrient utilization, and reduced susceptibility to enteric disturbances. However, these effects should not be interpreted as universal, because responses vary according to animal species, age, diet composition, nanoparticle characteristics, dose, and baseline microbiota.

3.4.5.3. Risk of Dysbiosis

Although many experimental studies indicate potentially beneficial effects of nanopremix on gut microbial communities, excessive supplementation may result in dysbiosis, defined as disruption of the normal composition, diversity, or functional balance of the gut microbiota.

Potential consequences of dysbiosis include:

· reduced microbial diversity;

· expansion of opportunistic microorganisms;

· impaired microbial fermentation;

· increased intestinal inflammation; and

· reduced nutrient absorption efficiency.

Such effects are of particular concern when nano-copper or nano-zinc is administered at concentrations substantially exceeding nutritional requirements, because their antimicrobial activity may affect both pathogenic and commensal microorganisms.

Therefore, assessment of nanopremix safety should incorporate microbiome-related endpoints, including microbial diversity, community structure, functional capacity, and relevant microbial metabolites, rather than relying solely on conventional clinical or histopathological parameters.

3.4.6. Effects on Microbiota-Derived Metabolites

Gut microbial activity generates numerous metabolites that play important roles in intestinal physiology and host health. Among the most extensively studied are:

· acetate;

· propionate; and

· butyrate.

These metabolites are collectively referred to as short-chain fatty acids (SCFAs).

SCFAs exert multiple biological functions, including:

· serving as energy substrates, particularly for colonocytes;

· supporting the expression and integrity of tight-junction proteins;

· lowering luminal pH and thereby creating conditions that may inhibit the proliferation of certain pathogenic bacteria;

· modulating intestinal epithelial function; and

· regulating immune responses, including the differentiation and activity of regulatory T cells.

Several experimental studies suggest that selected nanopremix formulations may increase SCFA production by promoting the growth or activity of SCFA-producing microorganisms. An increase in butyrate production may be particularly beneficial because butyrate serves as an important energy source for colonocytes and contributes to maintenance of epithelial barrier integrity.

However, changes in SCFA concentrations should be interpreted in conjunction with microbial community composition and host physiological responses, because an increase or decrease in an individual metabolite does not necessarily indicate an overall improvement or deterioration in gut health.

3.4.7. Effects on the Mucosal Immune System

The gastrointestinal immune system is largely organized within the gut-associated lymphoid tissue (GALT), which constitutes a major component of the intestinal mucosal immune system.

Important components of GALT include:

· Peyer's patches;

· the lamina propria;

· isolated lymphoid follicles; and

· intraepithelial lymphocytes.

These structures provide an integrated defense system that continuously monitors luminal antigens while maintaining tolerance toward commensal microorganisms and dietary components.

Nano-selenium and nano-zinc have been reported in experimental animal studies to enhance several aspects of mucosal immune function, including:

· macrophage activity;

· production of secretory immunoglobulin A (sIgA);

· lymphocyte proliferation; and

· expression of antimicrobial peptides.

In addition, appropriately dosed nanopremix may influence cytokine balance by enhancing anti-inflammatory signaling, such as interleukin-10 (IL-10), while reducing excessive production of pro-inflammatory mediators, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) under certain stress or inflammatory conditions.

These immunomodulatory effects may contribute to improved mucosal defense and intestinal homeostasis. Nevertheless, immune stimulation should be distinguished from nonspecific immune activation, and the interpretation of cytokine changes should consider dose, exposure duration, baseline immune status, pathogen challenge, and the specific physicochemical characteristics of the nanopremix.

Overall, the effects of nanopremix on the gastrointestinal tract are best understood as a dynamic interaction among nanoparticle characteristics, intestinal barrier function, microbial ecology, microbial metabolites, and mucosal immunity. A nutritionally optimized nanopremix may therefore contribute to improved gut health, whereas excessive or poorly characterized exposure may compromise microbial and epithelial homeostasis.

3.4.8. The Gut–Microbiota–Immune Axis

The gut–microbiota–immune axis describes the functional interrelationship among the intestinal epithelium, gut microbiota, and mucosal immune system. These components operate as an integrated biological network that maintains intestinal homeostasis and contributes to systemic health.

Nanopremix may influence these three components simultaneously through a cascade of biological interactions:

Nanopremix
↓
Enhanced nutrient bioavailability
↓
Improved intestinal epithelial integrity
↓
Modulation of gut microbiota
↓
Increased production of short-chain fatty acids (SCFAs)
↓
Modulation of gut-associated lymphoid tissue (GALT)
↓
Enhanced systemic immune competence
↓
Improved animal health and production performance

This conceptual framework helps explain why the biological effects of nanopremix may extend beyond improved mineral absorption to broader effects on intestinal health, immune function, and resistance to disease. However, the magnitude and direction of these effects depend on nanoparticle characteristics, dose, animal species, dietary composition, and the baseline physiological and microbial status of the host.

3.4.9. Species-Specific Responses

Responses to nanopremix vary among animal species because of differences in gastrointestinal anatomy, digestive physiology, microbiota, metabolism, nutrient absorption, and production systems.

In poultry, nanopremix supplementation has been associated in experimental studies with increased villus height, reduced colonization by Clostridium perfringens, improved intestinal function, and enhanced feed efficiency.

In pigs, particularly during the post-weaning period, nanopremix may support intestinal mucosal function, reduce the incidence or severity of diarrhea under certain experimental conditions, and contribute to stabilization of the gut microbial community.

In ruminants, the principal challenge is the ruminal environment, where fermentation processes can modify nanoparticle stability, dissolution, and biological availability. Consequently, rumen-protected nanopremix formulations may be required to deliver selected nutrients to the post-ruminal gastrointestinal tract while minimizing undesirable transformation within the rumen.

In aquaculture species, nanopremix may influence intestinal barrier integrity, microbial homeostasis, nutrient utilization, and resistance to selected bacterial pathogens, including Vibrio spp. However, the aquatic environment introduces additional considerations, such as nanoparticle stability, dissolution, aggregation, and potential release into the surrounding water.

These differences indicate that nanopremix formulations should be tailored to the target species, production stage, physiological requirements, gastrointestinal environment, and intended biological outcome rather than being applied as a universal formulation.

3.4.10. Implications for the Replacement of Antibiotic Growth Promoters (AGPs)

One of the potentially important applications of nanopremix is its incorporation into integrated strategies aimed at reducing reliance on antibiotic growth promoters (AGPs).

Through a combination of improved intestinal barrier integrity, modulation of gut microbiota, enhanced immune competence, and, for selected nano-minerals, antimicrobial activity, nanopremix may contribute to maintaining animal health and production performance with reduced dependence on routine antimicrobial use.

However, the term “replacement” should be interpreted cautiously. Nanopremix should not be regarded as a direct substitute for therapeutic antibiotics used to treat clinically significant bacterial infections. Rather, nanopremix may constitute one component of a broader antimicrobial stewardship and disease-prevention strategy, together with effective biosecurity, vaccination, appropriate nutrition, hygiene, environmental management, prudent antimicrobial use, and good animal husbandry.

This distinction is particularly important because antimicrobial activity observed in vitro does not necessarily translate into clinical efficacy in vivo, and excessive use of antimicrobial nano-minerals could itself exert selective pressure on microbial populations.

3.4.11. One Health Perspective

Within the One Health framework, gastrointestinal health in food-producing animals has implications that extend beyond individual animal productivity.

Improved gastrointestinal health through appropriately designed nanopremix may potentially:

· reduce the need for routine antimicrobial use;

· contribute to mitigation of antimicrobial resistance (AMR);

· reduce intestinal carriage and shedding of selected zoonotic pathogens;

· improve the microbiological safety of food products of animal origin; and

· improve nutrient utilization and potentially reduce nutrient losses through animal excreta.

Accordingly, the development of safe and effective nanopremix may provide benefits not only for livestock productivity but also for public health and environmental sustainability.

Nevertheless, these potential One Health benefits should be demonstrated through integrated evidence rather than assumed solely from improvements in animal performance. Evaluation should encompass antimicrobial-use patterns, resistance-selection potential, pathogen shedding, food safety, environmental exposure, and long-term ecological effects.

3.4.12. Synthesis of the Subsection

The gastrointestinal safety of nanopremix is determined by the balance between enhanced nutrient bioavailability and preservation of intestinal ecosystem homeostasis. Current experimental evidence indicates that appropriately formulated nano-zinc, nano-selenium, nano-vitamins, and selected nano-phytobiotics administered at nutritionally appropriate doses may support epithelial integrity, increase villus development, maintain tight-junction function, modulate the gut microbiota toward a potentially favorable profile, enhance the production of short-chain fatty acids (SCFAs), and strengthen mucosal immune responses.

Conversely, excessive exposure may disrupt microbial homeostasis, impair epithelial integrity, increase oxidative stress, and promote intestinal inflammation. Therefore, Safe-by-Design, dose optimization, species-specific formulation, and long-term safety evaluation remain essential prerequisites for the development of next-generation nanopremix products.

3.5. Residues of Nanopremix in Food Products of Animal Origin and Consumer Safety

3.5.1. Introduction

Food safety is one of the most critical considerations in the development of nanopremix as a feed additive. Although the primary objective of nanopremix supplementation is to improve nutrient utilization and animal productivity, its successful implementation at commercial scale ultimately depends on demonstrating that the use of nanomaterials does not result in residues that pose unacceptable risks to consumers. Accordingly, evaluation of nanopremix residues in food products of animal origin represents an essential component of food-safety risk assessment and regulatory authorization.

In food-safety science, the term residue generally refers to the remaining parent compound, transformation product, or metabolite present in animal tissues or products following exposure through feed, drinking water, or veterinary medicinal products. In the context of nanopremix, residues may occur as intact nanoparticles, dissolved mineral species, transformed particulate forms, or biologically incorporated mineral species generated after nanoparticles undergo transformation within the animal. Consequently, residue assessment for nanopremix is more complex than conventional analysis of total mineral concentrations alone.

The development of nanotechnology introduces additional challenges to food-safety assessment. For conventional mineral supplements, the primary concern is often the total concentration of elements such as Zn, Se, Cu, or Fe. For nanopremix, it is additionally important to determine whether these elements remain in particulate form, have undergone dissolution into ionic species, or have been incorporated into physiological proteins and metabolic pathways, such as selenoproteins, metallothioneins, ferritin, and hemoglobin. Chemical speciation and physicochemical form can substantially influence bioavailability, biological activity, toxicity, and consumer exposure.

Experimental studies in poultry, pigs, ruminants, and aquaculture species generally indicate that nano-zinc, nano-selenium, nano-copper, and nano-iron administered at nutritionally appropriate supplementation levels do not necessarily produce tissue concentrations of toxicological concern in meat, milk, eggs, or edible fish tissues. In some cases, the greater nutrient-use efficiency of nanopremix may permit lower supplementation levels, potentially reducing mineral excretion and environmental loading. However, such conclusions cannot be generalized to all nanomaterials or formulations. Each nanopremix product requires product-specific assessment because particle size, chemical form, synthesis method, surface coating, dissolution behavior, and aggregation state may substantially influence tissue distribution and retention.

International regulatory and scientific organizations, including the European Food Safety Authority (EFSA), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO), and the Codex Alimentarius Commission (CAC), provide scientific and regulatory frameworks relevant to the evaluation of residues and consumer exposure associated with substances used in food-producing animals. Depending on the regulatory classification and intended use of a particular nanomaterial, the required assessment may include tissue-residue concentrations, depletion kinetics, potential bioaccumulation, transformation products, and estimates of dietary exposure.

This subsection examines the concept and characterization of nanopremix residues, pathways of transfer into food products of animal origin, modern analytical approaches, findings from different livestock and aquaculture species, consumer-risk assessment, and implications for the development of international food-safety standards.

3.5.2. Concept of Nanopremix Residues

In the context of nanopremix, residues can be conceptually classified into three major categories:

3.5.2.1. Residues of Intact Nanoparticles

These refer to nanoparticles that retain, at least to a measurable extent, their particulate structure and relevant physicochemical characteristics after undergoing gastrointestinal and systemic biological processes.

Their presence is of particular interest because particulate nanomaterials may exhibit biological behavior that differs from that of their corresponding dissolved ionic forms.

3.5.2.2. Residues of Dissolved Mineral Species

Many nano-minerals undergo partial or substantial dissolution within the gastrointestinal tract, resulting in the formation of mineral ions or other dissolved species, such as:

· Zn²⁺;

· selenium-containing ionic or molecular species;

· Cu²⁺; and

· Fe²⁺/Fe³⁺.

These species may subsequently enter conventional physiological mineral-transport and homeostatic pathways.

Importantly, selenium should not be represented solely as Se²⁻ in biological systems because selenium undergoes complex redox and metabolic transformations and may occur as multiple inorganic and organic selenium species. Therefore, selenium speciation should be considered when evaluating residues and biological fate.

3.5.2.3. Biologically Incorporated Mineral Species

Mineral elements released from nanoparticles may subsequently become incorporated into physiological proteins and metabolic pathways. Examples include:

· glutathione peroxidases and other selenoproteins for selenium;

· metallothioneins and zinc-dependent proteins for zinc;

· metallothioneins and copper-binding proteins for copper; and

· ferritin, transferrin, and hemoglobin-associated iron pools for iron.

Once incorporated into normal physiological pathways, the element should not automatically be interpreted as an intact nanoparticle residue. Consequently, residue assessment should distinguish between the nanoparticulate form, dissolved chemical species, and physiologically incorporated element whenever analytical methods permit.

3.5.3. Pathways of Nanopremix Transfer to Food Products of Animal Origin

The transfer of nanopremix-derived constituents from feed to edible animal products is governed by the processes of ADME (Absorption, Distribution, Metabolism, and Excretion).

The general pathway can be summarized as follows:

Nanopremix in Feed
↓
Gastrointestinal Transformation and Absorption
↓
Systemic Circulation
↓
Distribution to Organs and Tissues
↓
Mineral Metabolism and Biotransformation
↓
Deposition or Incorporation into Tissues
↓
Food Products of Animal Origin

Potentially relevant edible products and tissues include:

· skeletal muscle and meat;

· liver;

· kidney;

· milk;

· eggs;

· fish;

· shrimp; and

· other edible tissues, depending on the target species.

The extent of transfer is influenced by several factors, including:

· type and chemical form of the nano-mineral;

· particle size and size distribution;

· supplementation dose;

· duration of exposure;

· animal species;

· age and physiological status;

· feed composition;

· absorption efficiency; and

· rates of tissue turnover and elimination.

3.5.4. Residues in Meat

Meat represents an important category of food products of animal origin and therefore requires careful evaluation when assessing the consumer safety of nanopremix.

Experimental studies indicate that:

· nano-zinc may increase physiologically relevant zinc concentrations in skeletal muscle without necessarily causing excessive accumulation when administered at appropriate nutritional levels;

· nano-selenium may increase selenium deposition in edible tissues and promote incorporation into organic selenium compounds, potentially enhancing the nutritional value of meat;

· nano-iron may contribute to maintenance of physiological iron status and tissue iron stores without necessarily producing toxicologically relevant accumulation at appropriate supplementation levels; and

· nano-copper generally exhibits relatively limited retention in skeletal muscle because copper homeostasis is strongly regulated through hepatic uptake, intracellular binding, and biliary excretion.

Overall, when nanopremix is administered within nutritionally appropriate ranges, mineral concentrations in edible muscle are generally expected to remain within physiologically regulated ranges. Nevertheless, tissue-specific residue studies remain necessary for each nanopremix formulation because the relationship between nanoparticle exposure, total elemental concentration, chemical speciation, and particulate persistence cannot be assumed to be identical across products.

For consumer-safety assessment, therefore, measurement of total mineral concentration should ideally be complemented, where technically feasible, by characterization of chemical speciation and particulate versus dissolved fractions. This distinction is particularly important for nanomaterials because total elemental analysis alone cannot establish whether the measured element originated from intact nanoparticles, dissolved ions, or normal physiological mineral pools.

3.5.5. Residues in the Liver and Kidneys

The liver and kidneys are among the most important tissues examined in residue and biodistribution studies of nano-minerals because of their central roles in mineral metabolism, storage, transformation, and excretion.

The liver serves as a major site of mineral metabolism and temporary storage and plays an important role in the biotransformation and systemic clearance of absorbed nanomaterials and their dissolution products. Consequently, tissue concentrations of certain nano-minerals may be higher in the liver than in skeletal muscle. The extent of hepatic retention, however, depends strongly on the chemical form of the mineral, particle size, dissolution behavior, dose, exposure duration, and species.

The kidneys play an important role in the elimination of soluble mineral species and very small particles that are capable of renal filtration. Some nano-minerals or their dissolution products may therefore undergo transient renal retention before being eliminated in urine. At nutritionally appropriate exposure levels, such retention may be limited and reversible; however, prolonged exposure to excessive doses may increase renal mineral burden and should therefore be evaluated through tissue concentration, histopathology, and functional biomarkers.

Importantly, measurement of total elemental concentrations in liver and kidney does not by itself establish whether the retained material remains in nanoparticulate form. Consequently, residue studies should, whenever analytically feasible, distinguish between particulate, ionic, and biologically incorporated forms.

3.5.6. Transfer into Milk

In dairy animals, potential transfer of nano-minerals into milk is an important consideration for consumer safety. Following gastrointestinal absorption, minerals may undergo dissolution, transport, binding to proteins, incorporation into metabolic pathways, and subsequent secretion into milk.

Experimental studies indicate that nano-selenium can increase selenium concentrations in milk, frequently through incorporation into biologically relevant selenium-containing compounds and selenoproteins. Nano-zinc may also influence the physiological zinc concentration of milk, although the magnitude of this effect depends on dose, animal species, lactation stage, baseline mineral status, and the chemical form of the supplemented zinc.

For most essential mineral supplements, the presence of the element in milk does not necessarily indicate the presence of intact nanoparticles. Therefore, total elemental analysis should be complemented, where technically feasible, by particle-specific and speciation analyses to determine the chemical and physical form of the transferred material.

At present, evidence supporting substantial transfer of intact nano-minerals into milk at nutritionally appropriate supplementation levels remains limited. Nevertheless, the absence of demonstrated risk should not be interpreted as evidence that all nano-formulations are inherently safe. Product-specific studies remain necessary, particularly for formulations with novel surface coatings, low dissolution rates, or prolonged systemic persistence.

3.5.7. Transfer into Eggs

In laying poultry, nano-mineral supplementation may alter the concentration and biological form of minerals deposited into eggs. Egg deposition is influenced by intestinal absorption, systemic mineral homeostasis, hepatic metabolism, ovarian transfer, and the duration and level of supplementation.

Nano-selenium has attracted particular interest because dietary supplementation can increase selenium concentrations in egg yolk and albumen and may enhance the antioxidant capacity and oxidative stability of eggs. Much of the selenium deposited in eggs is expected to occur in organic or protein-associated forms following normal selenium metabolism rather than as intact nanoparticles.

Nano-zinc may contribute to physiological zinc availability and may influence eggshell quality, embryonic development, and mineral metabolism. However, the biological significance of increased zinc deposition depends on the supplementation level and the baseline zinc status of the laying hens.

Thus, increased mineral concentration in eggs should not automatically be interpreted as evidence of nanoparticle accumulation. Comprehensive residue assessment should distinguish between total elemental concentration, chemical speciation, and, where technically possible, the presence of intact nanoparticles.

3.5.8. Residues in Aquaculture Products

In fish and shrimp production, residue assessment presents additional challenges because aquatic animals are continuously exposed to their surrounding water, which may serve as a secondary pathway for nanoparticle exposure.

Key tissues and edible products requiring evaluation include:

· muscle or fillet;

· liver or hepatopancreas;

· kidney, where anatomically applicable;

· gills; and

· whole-body tissue in small aquaculture species.

Studies of nano-selenium and nano-zinc supplementation have generally reported improvements in mineral status and physiological responses without necessarily producing excessive tissue accumulation when supplementation is maintained within nutritionally appropriate ranges. However, the magnitude and persistence of tissue deposition vary considerably according to nanoparticle characteristics, dose, exposure duration, species, water chemistry, and feed composition.

Aquaculture therefore requires an integrated residue and environmental assessment. Unabsorbed nanoparticles excreted through feces or released into the culture water may undergo aggregation, dissolution, sedimentation, or transformation and subsequently interact with microorganisms and other aquatic organisms. Consequently, food-safety evaluation should be linked to environmental exposure assessment within a broader One Health framework.

3.5.9. Maximum Residue Limits and Other Regulatory Residue Criteria

A Maximum Residue Limit (MRL) generally refers to the maximum concentration of a residue legally permitted in food commodities when established by the relevant regulatory authority. The regulatory meaning and applicability of MRLs, however, differ among substances, jurisdictions, and regulatory frameworks.

For essential minerals such as zinc, copper, iron, and selenium, conventional safety assessment has historically focused primarily on total elemental exposure and physiological requirements rather than on a nanoparticle-specific MRL framework. This creates an important regulatory challenge for nano-enabled feed additives because total elemental concentration alone cannot establish whether an element is present as a dissolved ion, an organic metabolite, a protein-bound species, or an intact nanoparticle.

Accordingly, the safety assessment of nanopremix should increasingly incorporate speciation analysis and, where scientifically and analytically feasible, particle-specific measurements. These approaches can provide information regarding:

· total elemental concentration;

· ionic and soluble fractions;

· organically bound fractions;

· nanoparticulate fractions;

· particle size distribution; and

· tissue localization.

Risk characterization should integrate these data with toxicological reference values, dietary exposure estimates, animal consumption patterns, and appropriate uncertainty or safety factors. For essential nutrients, approaches based solely on conventional ADI concepts may not always be sufficient because both deficiency and excessive exposure can produce adverse effects.

3.5.10. Withdrawal Period

A withdrawal period is the period that must elapse between the final administration of a regulated veterinary medicinal product and the collection or slaughter of animals for food production, in order to ensure that residues remain within applicable regulatory limits.

The concept should be applied cautiously to nutritional nanopremixes. The fact that a mineral is an essential nutrient does not automatically exclude the need for residue or tissue-depletion studies. Regulatory requirements depend on the legal classification of the product, the nature of the active substance, the intended use, the formulation, and the jurisdiction in which authorization is sought.

For a conventional nutritional mineral for which systemic exposure remains within physiological ranges and no nanoparticle-specific hazard has been demonstrated, a conventional pharmacological withdrawal period may not be required. Nevertheless, this determination should be supported by appropriate safety and residue data.

Conversely, a novel nanomaterial, a substantially modified mineral formulation, or a formulation with prolonged tissue retention may require specific depletion studies to establish the time course of disappearance from edible tissues and other food products.

3.5.11. Analytical Methods for Nanopremix Residues

Accurate assessment of nanopremix residues requires analytical methods capable of distinguishing total elemental concentrations from the physical and chemical forms of the element. No single analytical technique is sufficient for all residue questions; therefore, a multimodal analytical strategy is generally preferable.

3.5.11.1. Total Mineral Analysis

Common methods for quantifying total elemental concentrations include:

· ICP-MS (Inductively Coupled Plasma–Mass Spectrometry);

· ICP-OES (Inductively Coupled Plasma–Optical Emission Spectroscopy); and

· Atomic Absorption Spectroscopy (AAS).

These techniques provide highly sensitive measurements of elemental concentrations but generally do not, by themselves, determine whether the measured element originated from intact nanoparticles, dissolved ions, or biologically incorporated mineral species.

3.5.11.2. Nanoparticle-Specific Analysis

Where particle-specific information is required, complementary methods may include:

· single-particle ICP-MS (spICP-MS);

· TEM coupled with EDX (TEM–EDX);

· SEM coupled with EDX (SEM–EDX); and

· Nanoparticle Tracking Analysis (NTA), where the physicochemical characteristics of the sample permit its application.

These approaches can provide information on particle presence, size distribution, morphology, and elemental composition, although each technique has specific detection limits, matrix effects, and analytical constraints.

3.5.11.3. Chemical Speciation Analysis

Speciation analysis is particularly important for essential nano-minerals because biological effects are strongly influenced by chemical form. Relevant approaches include:

· HPLC–ICP-MS;

· field-flow fractionation coupled with ICP-MS (FFF–ICP-MS); and

· synchrotron-based X-ray absorption or fluorescence techniques.

The integration of elemental, particle-specific, and speciation analyses enables investigators to determine whether an element detected in an edible tissue is present predominantly as an intact nanoparticle, dissolved ionic species, protein-associated form, or other biologically transformed species.

3.5.12. Consumer Exposure and Risk Characterization

Residue concentrations in edible tissues should ultimately be translated into estimates of human dietary exposure. Consumer risk assessment should consider:

1. concentration of the relevant element or nanomaterial in the edible commodity;

2. consumption rate of the food product;

3. frequency and duration of exposure;

4. chemical and physical form of the residue;

5. toxicological reference values or other appropriate health-based guidance values;

6. exposure from other dietary sources; and

7. uncertainty associated with analytical measurements and interspecies extrapolation.

A useful conceptual framework is:

Animal exposure → tissue deposition → residue depletion → food consumption → human exposure → hazard characterization → risk characterization

This approach is particularly important for essential minerals because the relationship between exposure and adverse effects is often nonlinear. Both inadequate and excessive intake may be detrimental, and the relevant safety margin therefore depends on the physiological requirement, chemical form, bioavailability, and total dietary exposure.

3.5.13. Integrated Assessment of Consumer Safety

The safety of nanopremix cannot be determined solely from the concentration of total minerals detected in edible tissues. A scientifically robust assessment should integrate toxicokinetics, biodistribution, transformation, tissue depletion, particle characterization, chemical speciation, dietary exposure, and toxicological hazard assessment.

For nano-selenium, nano-zinc, nano-copper, and nano-iron, the essential-nutrient status of the constituent elements provides an important physiological context, but it does not eliminate the need to evaluate the properties of the nano-formulation itself. In particular, particle size, surface coating, dissolution rate, aggregation behavior, dose, and duration of exposure may alter biological fate and consumer exposure.

Therefore, the conclusion that a nanopremix is safe for consumers should be based on product-specific evidence rather than extrapolation from the safety profile of the corresponding conventional mineral.

3.5.14. Synthesis of the Subsection

Residues of nanopremix in food-producing animals represent a critical interface between animal nutrition, nanotoxicology, food safety, and regulatory science. Following dietary administration, nano-minerals may undergo dissolution, transformation, systemic distribution, incorporation into physiological metabolic pathways, tissue deposition, and subsequent elimination. The resulting residue may therefore consist of intact nanoparticles, ionic species, protein-associated minerals, or other biologically transformed forms.

Current evidence suggests that appropriately designed nano-mineral formulations administered at nutritionally appropriate levels can improve mineral utilization without necessarily producing excessive or persistent accumulation in edible tissues. Nevertheless, this conclusion cannot be generalized to all nanomaterials or formulations. Differences in particle characteristics, chemical composition, coating, dissolution behavior, dose, exposure duration, animal species, and production system can substantially modify tissue distribution and depletion kinetics.

Consequently, future development of nanopremix should adopt a “total exposure plus particle/speciation” approach to residue assessment. Such an approach combines conventional elemental analysis with particle-specific and chemical-speciation techniques and integrates the resulting data into toxicokinetic and consumer-exposure models. This framework is essential for establishing scientifically defensible safety margins, determining whether additional residue controls are required, and supporting regulatory decisions concerning the use of nanotechnology in animal feed.

From a One Health perspective, consumer safety should be considered together with animal health and environmental safety. An ideal nanopremix should not only improve nutrient efficiency but also minimize unnecessary systemic exposure, tissue persistence, environmental release, and potential downstream exposure of humans and ecosystems. This principle provides an important scientific basis for the development of next-generation nanopremixes according to the Safe-by-Design concept.

3.5.12. Consumer Risk Assessment

Consumer risk assessment represents the final stage of evaluating the potential health implications of residues arising from nanopremix use in food-producing animals. The assessment should follow the internationally recognized risk-analysis framework consisting of four interconnected steps:

1. hazard identification;

2. hazard characterization;

3. exposure assessment; and

4. risk characterization.

For nanopremix, these steps should incorporate both the chemical identity of the constituent mineral or active substance and the specific physicochemical characteristics of the nanomaterial. Where relevant, the assessment should distinguish between exposure to intact nanoparticles, dissolved ionic species, and biologically transformed forms.

The principal parameters considered in consumer exposure assessment include:

· concentration of residues in edible tissues or products;

· food consumption patterns;

· body weight;

· age and potentially vulnerable population groups;

· frequency and duration of exposure;

· contribution from other dietary sources;

· appropriate health-based guidance values; and

· uncertainty associated with analytical and exposure estimates.

For essential minerals such as zinc, selenium, copper, and iron, consumer risk assessment requires particular care because these elements are necessary for normal physiological function but may cause adverse effects when exposure becomes excessive. Consequently, the assessment should consider the total dietary exposure from all relevant sources rather than evaluating the nanopremix-derived contribution in isolation.

The use of an Acceptable Daily Intake (ADI) should also be interpreted cautiously for essential nutrients because conventional ADI-based approaches are not universally applicable to all essential minerals. Depending on the substance and regulatory framework, other health-based guidance values, upper intake levels, reference doses, or physiological requirement ranges may be more appropriate.

Similarly, the Margin of Exposure (MOE) may be informative when a suitable toxicological reference point or dose-response benchmark is available. For nanomaterials, however, the interpretation of MOE should incorporate uncertainties arising from particle-specific behavior, dissolution, transformation, and differences between experimental exposure and human dietary exposure.

A simplified conceptual framework is:

Nanopremix administration → animal exposure → tissue deposition → residue depletion → human dietary exposure → hazard characterization → risk characterization

An acceptable risk conclusion should therefore be based on the integration of residue concentrations, exposure estimates, toxicological evidence, physicochemical characterization, and the biological form of the detected residue.

3.5.13. One Health Perspective

The assessment of nanopremix residues extends beyond consumer safety and should be considered within a broader One Health framework integrating animal health, human health, food safety, and environmental protection.

From the animal-health perspective, an appropriately designed nanopremix should improve nutrient utilization without producing excessive systemic exposure, organ accumulation, or disruption of physiological homeostasis. From the food-safety perspective, potential transfer of nanoparticles or their transformation products into meat, milk, eggs, and aquatic products must be adequately characterized.

The environmental dimension is equally important. Improved nutrient bioavailability could theoretically reduce the quantity of mineral supplementation required to achieve a desired physiological response and thereby decrease mineral excretion. However, this potential benefit should not be assumed solely from the use of nanotechnology. Environmental advantages must be demonstrated through comparative measurements of mineral and nanoparticle excretion, environmental transformation, persistence, and ecotoxicological effects.

In particular, nano-minerals excreted through feces or urine may undergo dissolution, aggregation, adsorption to soil particles, interaction with organic matter, or transformation within aquatic and terrestrial ecosystems. Therefore, reduced total mineral excretion does not automatically imply reduced environmental risk if the remaining material has greater biological activity or persistence.

Accordingly, the environmental assessment of nanopremix should consider:

· total mineral excretion;

· nanoparticle-specific excretion, where measurable;

· transformation and dissolution in manure and wastewater;

· persistence in soil and sediment;

· mobility in aquatic systems;

· effects on soil and aquatic microorganisms; and

· potential trophic transfer.

This integrated approach is essential for determining whether nanopremix provides a genuine environmental advantage over conventional mineral supplementation.

3.5.14. Research Gaps and Future Challenges

Although available evidence indicates considerable potential for the safe application of nano-minerals in animal nutrition, several scientific and regulatory uncertainties remain.

First, standardization of nanoparticle residue analysis remains a major challenge. Conventional elemental analysis cannot reliably distinguish intact nanoparticles from dissolved ions or biologically incorporated mineral species. Harmonized analytical workflows combining total elemental determination, particle-specific measurements, and chemical speciation are therefore needed.

Second, long-term and multigenerational studies remain limited. Most experimental studies have focused on relatively short production periods, whereas information concerning prolonged exposure, reproductive performance, offspring development, and multigenerational effects remains insufficient for several nano-enabled feed additives.

Third, improved and validated speciation and particle-characterization methods are required to support regulatory decision-making. Analytical approaches should be capable of determining not only the concentration of an element but also its physical and chemical form within biological tissues and food products.

Fourth, the question of whether nanomaterial-specific residue criteria are required remains an important regulatory issue. Such criteria may be warranted when the nano-form exhibits biological behavior that differs substantially from the corresponding conventional form, particularly with respect to persistence, tissue distribution, bioavailability, or toxicity.

Fifth, international regulatory harmonization remains necessary. Differences among jurisdictions in the definition of nanomaterials, characterization requirements, toxicological testing strategies, exposure assessment, and regulatory classification can create uncertainty for manufacturers and complicate international trade.

Future research should therefore move toward standardized testing protocols, reference materials, validated analytical methods, long-term animal studies, physiologically relevant exposure models, and integrated animal–food–environment risk assessment.

3.5.15. Synthesis of the Subsection

Residues arising from nanopremix use in food-producing animals represent a fundamental component of consumer safety assessment and regulatory decision-making. Available evidence suggests that nano-zinc, nano-selenium, nano-copper, and nano-iron administered at nutritionally appropriate levels can improve mineral utilization without necessarily producing excessive or persistent residues in edible tissues. However, such observations should not be generalized to all nano-formulations because the biological fate of a nanomaterial is strongly influenced by particle size, surface characteristics, chemical composition, dissolution behavior, dose, exposure duration, animal species, and formulation.

Consequently, consumer safety assessment should integrate toxicokinetics, biodistribution, tissue depletion, residue analysis, chemical speciation, nanoparticle characterization, dietary exposure assessment, and toxicological hazard characterization. Particular attention should be given to distinguishing intact nanoparticles from dissolved or biologically incorporated mineral species.

The application of Safe-by-Design, risk analysis, and One Health principles provides a suitable framework for developing nanopremix systems that maximize nutritional benefits while minimizing potential risks to animals, consumers, and the environment. Future regulatory frameworks should increasingly adopt a product-specific and evidence-based approach rather than assuming that the safety profile of a conventional mineral automatically applies to its nano-form.

3.6. Risk Assessment and International Regulatory Framework for Nanopremix

The development of nanopremix as a new generation of feed additives offers substantial opportunities to improve nutrient-use efficiency, animal health, productivity, and the sustainability of livestock and aquaculture systems. Nevertheless, the nanoscale dimensions, high specific surface area, altered dissolution behavior, and distinctive physicochemical characteristics of nanomaterials may result in biological properties that differ from those of conventional forms of the same substance.

Consequently, safety assessment of nanopremix should not rely exclusively on conventional feed-additive assessment procedures. Instead, it should incorporate a material-specific and lifecycle-oriented risk assessment framework that considers the nanomaterial from formulation and production through gastrointestinal transformation, animal exposure, food residues, environmental release, and potential human exposure.

International risk-analysis frameworks developed by organizations and regulatory authorities such as the Codex Alimentarius Commission, Organisation for Economic Co-operation and Development (OECD), European Food Safety Authority (EFSA), U.S. Food and Drug Administration (FDA), FAO, and WHO provide important foundations for this assessment. However, the specific regulatory requirements and legal classification of nanomaterials differ among jurisdictions and product categories.

The general risk-assessment framework consists of four interconnected stages:

Hazard identification → Hazard characterization → Exposure assessment → Risk characterization

For nanomaterials, each stage should be supplemented with information describing particle-specific properties, transformation behavior, biological fate, and uncertainty.

3.6.1. Hazard Identification for Nanopremix

Hazard identification is the first stage of risk assessment and aims to determine whether a nanopremix or any of its transformation products can cause adverse effects in target animals, consumers, or the environment.

Unlike conventional mineral or vitamin additives, nanoparticle hazards may depend not only on chemical composition but also on physicochemical properties that influence biological interactions.

Key parameters requiring characterization include:

· primary particle size;

· particle-size distribution;

· particle morphology;

· specific surface area;

· surface charge or zeta potential;

· crystallinity;

· porosity;

· aggregation and agglomeration state;

· dispersion stability;

· solubility;

· dissolution rate;

· surface coating and functionalization;

· chemical composition and oxidation state; and

· formation and characteristics of biomolecular coronas.

These characteristics can influence interactions with the intestinal mucus layer, epithelial cells, digestive enzymes, plasma proteins, immune cells, and microbial communities.

Importantly, particle size should not be considered an independent predictor of toxicity. The biological response of a nanomaterial results from the combined effects of particle size, surface chemistry, dissolution, aggregation state, dose, exposure duration, and biological context.

For example, a nano-zinc oxide formulation with a high dissolution rate may produce substantial exposure to Zn²⁺ ions. This can improve zinc bioavailability at an appropriate nutritional dose but may also increase the possibility of adverse effects if systemic exposure exceeds physiological homeostatic capacity.

Similarly, nano-selenium may exhibit biological properties distinct from conventional selenium salts. However, the safety profile of nano-selenium cannot be generalized solely on the basis of its nominal particle size. Particle morphology, surface chemistry, synthesis method, coating, oxidation state, dissolution behavior, dose, and animal species must also be considered.

Accordingly, hazard identification should characterize the complete nanomaterial identity, rather than relying only on a generic label such as “nano-zinc” or “nano-selenium.”

3.6.2. Hazard Characterization

Hazard characterization determines the relationship between exposure and adverse biological effects and establishes appropriate points of departure for subsequent risk assessment.

Depending on the intended application, available evidence, and regulatory requirements, the toxicological evaluation of nanopremix may include:

a. Acute Toxicity

Acute toxicity studies evaluate adverse effects following a single or short-term exposure. Endpoints may include clinical signs, mortality, body-weight changes, hematological responses, biochemical parameters, and gross or microscopic pathological changes.

Although historical toxicology frequently used LD50 or LC50 values as major endpoints, modern risk assessment increasingly emphasizes comprehensive dose-response characterization and clinically or biologically relevant endpoints rather than mortality alone.

b. Subchronic Toxicity

Subchronic studies, commonly involving repeated exposure over approximately 90 days in standardized experimental systems, can evaluate the consequences of sustained exposure.

Important endpoints include:

· hematological parameters;

· serum biochemical markers;

· hepatic function;

· renal function;

· oxidative stress;

· immune responses;

· histopathology;

· organ weights;

· gastrointestinal integrity; and

· tissue concentrations of the relevant element or nanomaterial.

For food-producing animals, the experimental duration should also reflect the intended production period whenever scientifically justified.

c. Chronic Toxicity

Chronic exposure studies are relevant when nanopremix is intended for prolonged or continuous administration. Such studies can help identify delayed effects, cumulative toxicity, persistent tissue retention, or progressive alterations in organ function.

Particular attention should be given to animals with long production or reproductive lifespans and to exposure scenarios that may differ substantially from short-term laboratory experiments.

d. Genotoxicity

Genotoxicity assessment may include complementary assays such as:

· bacterial mutation assays, including the Ames test, where scientifically applicable;

· micronucleus assays;

· comet assays; and

· chromosomal-aberration assays.

Interpretation should consider whether observed genetic damage results from direct nanoparticle interaction, dissolution products, oxidative stress, inflammation, or secondary cellular injury.

e. Reproductive Toxicity

Reproductive toxicity studies evaluate potential effects on:

· fertility;

· reproductive organ function;

· gamete quality;

· mating performance;

· embryonic development;

· pregnancy or gestation;

· parturition; and

· offspring viability and development.

These endpoints are particularly important when nanopremix is intended for breeding animals.

f. Developmental Toxicity

Developmental toxicity assessment is relevant because developing embryos and neonates may exhibit different susceptibility to environmental and nutritional exposures.

Studies should consider developmental endpoints appropriate to the target species and production system, including fetal or embryonic development, postnatal growth, organ development, and functional maturation.

g. Immunotoxicity

Nanopremix may influence innate and adaptive immune responses. Relevant endpoints include:

· cytokine production;

· lymphocyte proliferation;

· macrophage activity;

· immunoglobulin responses;

· inflammatory signaling;

· oxidative stress; and

· vaccine responsiveness.

The interpretation of immunological changes should distinguish beneficial nutritional immunomodulation from pathological immune activation or suppression.

h. Neurotoxicity

Neurotoxicity should be considered when physicochemical characteristics and biodistribution studies indicate potential exposure of the central or peripheral nervous system.

Relevant endpoints may include neurological behavior, neurohistopathology, oxidative stress, neuroinflammatory signaling, and, where appropriate, evidence of passage across biological barriers.

i. Mechanistic and Omics-Based Toxicology

Conventional toxicological endpoints should increasingly be complemented by mechanistic approaches. These may include evaluation of:

· reactive oxygen species (ROS);

· antioxidant defense systems;

· mitochondrial membrane potential and energy metabolism;

· apoptosis;

· autophagy;

· inflammatory signaling;

· DNA damage;

· epigenetic alterations; and

· transcriptomic, proteomic, metabolomic, or other omics responses.

Such approaches can provide mechanistic insight into early biological changes that may occur before overt clinical or histopathological toxicity becomes apparent.

Importantly, a mechanistic response does not automatically constitute an adverse effect. For example, transient activation of antioxidant or immune pathways may represent an adaptive physiological response rather than toxicity. Risk assessment should therefore distinguish adaptive responses, reversible biological effects, and adverse outcomes using a weight-of-evidence approach.

3.6.3. Exposure Assessment

Exposure to nanopremix does not occur exclusively in target animals but may involve multiple stakeholders throughout the production chain. The principal exposure groups that should be considered include the following:

Livestock

Exposure primarily occurs through daily dietary intake of nanopremix throughout the production period.

Feed Mill Workers

Workers may be exposed to nanoparticles, particularly through inhalation, during processes such as:

· feed mixing;

· grinding;

· packaging; and

· transportation.

Livestock Farmers

Farmers may be exposed primarily through inhalation or dermal contact with feed dust during feed handling and ration distribution.

Consumers

Consumers may potentially be exposed through nanoparticle or nano-associated mineral residues in animal-derived foods, including:

· meat;

· eggs;

· milk;

· liver;

· kidneys; and

· fish.

Environment

Nanopremix that is not absorbed by the animal may be excreted primarily through feces and urine, thereby potentially entering environmental compartments such as:

· soil;

· rivers;

· lakes;

· sediments; and

· soil microbial communities.

Accordingly, exposure assessment should consider multiple parameters, including:

· daily dose;

· duration of exposure;

· frequency of consumption;

· animal species;

· animal age;

· exposure route (oral, inhalation, and dermal);

· environmental accumulation and persistence.

Recent approaches have increasingly incorporated Physiologically Based Pharmacokinetic (PBPK) models to predict the absorption, distribution, transformation, and elimination of nanoparticles and to estimate their concentrations in specific tissues and organs.

3.6.4. Risk Characterization

The final stage of risk assessment integrates toxicity and exposure data to estimate the magnitude and likelihood of adverse effects associated with nanopremix exposure.

For nanopremix, risk characterization may consider several key parameters, including:

· Margin of Exposure (MOE);

· No Observed Adverse Effect Level (NOAEL);

· Benchmark Dose (BMD);

· Acceptable Daily Intake (ADI);

· uncertainty analysis; and

· interspecies and species-specific sensitivity.

Because toxicological data for many nanomaterials remain limited, regulatory authorities commonly apply a case-by-case assessment approach. Under this framework, each nanopremix formulation is evaluated individually rather than being presumed safe solely on the basis of its chemical composition.

For example, nano-zinc oxide cannot automatically be assumed to have the same safety profile as conventional zinc oxide, even though both materials contain the same elemental constituent. Differences in particle size, surface area, dissolution kinetics, surface chemistry, aggregation behavior, and biological interactions may substantially alter their toxicological profiles.

3.6.5. International Regulatory Framework

European Food Safety Authority (EFSA)

The European Food Safety Authority (EFSA) has developed an extensive scientific framework for evaluating nanomaterials used in food and feed. Current approaches emphasize the need for comprehensive characterization and product-specific safety assessment of materials exhibiting nanoscale properties.

Depending on the intended application and regulatory context, the assessment may require information on:

· comprehensive physicochemical characterization;

· manufacturing and synthesis processes;

· particle-size distribution and morphology;

· stability during storage and use;

· dissolution and transformation behavior;

· absorption and biodistribution;

· metabolism and biotransformation;

· excretion and elimination;

· tissue residues;

· potential effects on the gut microbiota;

· acute, subchronic, and chronic toxicity; and

· potential environmental effects.

Advanced analytical techniques may be employed to characterize nanomaterials, including:

· Transmission Electron Microscopy (TEM);

· Dynamic Light Scattering (DLS);

· Nanoparticle Tracking Analysis (NTA);

· single-particle ICP-MS (spICP-MS); and

· other appropriate electron-microscopy-based techniques.

A weight-of-evidence (WoE) approach can be used to integrate data from physicochemical characterization, toxicology, toxicokinetics, exposure assessment, and other relevant evidence before regulatory conclusions are reached.

Organisation for Economic Co-operation and Development (OECD)

The OECD, particularly through its work on manufactured nanomaterials, has developed and supported international test methods and guidance relevant to the safety assessment of nanomaterials.

Key areas include:

· harmonization of toxicological testing methods;

· validation of physicochemical characterization methods;

· laboratory testing standards; and

· development and adaptation of OECD Test Guidelines for nanomaterials.

The OECD also promotes alternative approaches such as:

· grouping;

· read-across; and

· Integrated Approaches to Testing and Assessment (IATA),

which can help reduce unnecessary animal testing while maintaining the scientific robustness of risk assessment.

U.S. Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) does not regulate nanotechnology through a single, stand-alone regulatory framework applicable to all products. Instead, the safety assessment is generally conducted within the regulatory framework applicable to the specific product and its intended use.

FDA's approach recognizes that materials engineered at the nanoscale may exhibit altered:

· bioavailability;

· toxicity;

· stability;

· physicochemical properties; and

· biological activity.

Consequently, a change in particle size or the incorporation of nanoscale properties may warrant additional safety assessment and supporting data rather than reliance solely on the safety profile of the conventional material.

Codex Alimentarius

The Codex Alimentarius Commission provides internationally recognized principles for food safety risk analysis that are relevant to emerging technologies, including applications involving nanomaterials.

The Codex risk-analysis framework consists principally of:

· risk assessment;

· risk management; and

· risk communication.

Although Codex does not currently provide a dedicated standard specifically governing nanopremix, its risk-analysis principles provide an important reference for international food-safety governance and the harmonization of standards affecting trade in animal-derived food products.

Food and Agriculture Organization (FAO) and World Health Organization (WHO)

The Food and Agriculture Organization (FAO) and World Health Organization (WHO) emphasize the importance of scientifically based precaution, risk assessment, and appropriate governance when emerging technologies are introduced into food and agricultural systems.

Key considerations include:

· transparent labeling where scientifically and legally warranted;

· traceability throughout the production and supply chain;

· post-market surveillance;

· development and validation of analytical methods for residue characterization; and

· strengthening analytical and regulatory capacity, particularly in developing countries.

3.6.6. Regulation of Nanopremix in Animal Feed

In the feed sector, regulatory authorities may treat a nanopremix as a novel form or novel use of an existing feed additive, depending on the jurisdiction, intended use, and physicochemical characteristics of the product.

Accordingly, manufacturers may be required to provide comprehensive information concerning:

· nanoparticle specifications;

· manufacturing processes;

· quality-control procedures;

· product stability;

· biological efficacy;

· safety for the target animal species;

· consumer safety;

· occupational safety; and

· environmental safety.

This approach is consistent with the concept of “one substance, multiple forms,” under which nanoscale and conventional forms of the same chemical substance may require separate consideration when differences in particle size, morphology, dissolution, surface chemistry, or other properties result in substantially different biological behavior.

Therefore, the safety assessment of nanopremix should not rely exclusively on data generated for the corresponding conventional micron-scale material. Instead, the nanoscale formulation should be adequately characterized and evaluated according to its specific physicochemical and biological properties.

3.6.7. Future Regulatory Challenges

Despite substantial progress in the development of regulatory approaches for nanomaterials, several scientific, methodological, and regulatory challenges remain in the evaluation of nanopremix, including:

1. the absence of a fully harmonized global definition of nanomaterials applicable specifically to the feed sector;

2. limitations in analytical methods for detecting and distinguishing particulate nanomaterials from ionic or molecular forms in animal tissues and food products;

3. insufficient long-term and multigenerational toxicity data across different livestock and aquaculture species;

4. the absence of fully standardized approaches for evaluating interactions between nanopremix, gut microbiota, and the immune system;

5. limited predictive models for in vitro–in vivo correlation (IVIVC) of nanoparticle behavior;

6. the need for greater international regulatory harmonization to facilitate global trade in livestock and aquaculture products produced using nanotechnology.

Future advances are expected to improve the accuracy and efficiency of nanopremix risk assessment through the integration of high-throughput screening, New Approach Methodologies (NAMs), artificial intelligence (AI), Physiologically Based Pharmacokinetic (PBPK) modeling, and multi-omics approaches, including genomics, proteomics, and metabolomics.

The integration of these emerging methodologies with internationally harmonized standards, validated analytical methods, transparent risk communication, and continuous post-market surveillance could provide a more robust regulatory framework for nanopremix. Such a framework should ensure that the potential benefits of nanotechnology in animal nutrition can be realized without compromising animal health, food safety, public health, occupational safety, or environmental integrity, consistent with the principles of Safe-by-Design, One Health, and science-based risk analysis.

 

CHAPTER 4. CHALLENGES, OPPORTUNITIES, AND DEVELOPMENT DIRECTIONS FOR NANOPREMIX IN THE LIVESTOCK INDUSTRY

 

4.1. Scientific, Technological, and Commercialization Challenges of Nanopremix

Although research conducted over the past two decades has demonstrated that nanopremix has the potential to improve nutrient-use efficiency, enhance production performance, improve animal health status, and reduce mineral excretion into the environment, the adoption of this technology at an industrial scale continues to face substantial challenges. Most available evidence remains derived from laboratory-based studies (in vitro) or small-scale biological trials (in vivo), whereas commercial implementation requires more comprehensive evidence regarding safety, efficacy, stability, economic feasibility, and regulatory and consumer acceptance.

The development of nanopremix is inherently multidisciplinary, involving animal nutrition, nanotechnology, materials chemistry, toxicology, pharmacology, microbiology, food science, process engineering, and economic analysis. Consequently, successful commercialization depends not only on the ability to synthesize nanoparticles but also on the capacity to manufacture products that are safe, consistent, economically viable, and suitable for large-scale production through scalable manufacturing processes.

4.1.1. Challenges in Industrial-Scale Production

One of the major challenges is maintaining nanoparticle quality when production is scaled up from laboratory to industrial levels. At small production scales, parameters such as particle size, size distribution, morphology, and surface charge can generally be controlled relatively easily. However, during large-scale manufacturing, variations in mixing intensity, temperature, pressure, reaction time, precursor concentration, and drying conditions may lead to changes in nanoparticle characteristics.

Such variations can substantially affect the bioavailability and safety of the final product. For example, nanoparticles that undergo agglomeration during manufacturing may lose some of their intended biological advantages because their effective particle size increases toward the microscale range. Conversely, excessively small nanoparticles may exhibit increased biological reactivity and, consequently, a greater potential for unintended toxicological effects.

In addition, nanopremix manufacturing should comply with the principles of Good Manufacturing Practice (GMP) and Quality by Design (QbD). Accordingly, each stage of the manufacturing process requires rigorous quality-control (QC) procedures to ensure reproducibility, product consistency, and compliance with predefined quality specifications.

4.1.2. Standardization of Nanopremix Characterization

Another major challenge is the absence of fully harmonized international standards for the characterization of nanopremix. Different studies continue to employ different analytical methods, measurement conditions, and reporting criteria, making direct comparison across studies difficult.

Ideally, nanopremix characterization should include the following parameters:

· primary particle size;

· particle-size distribution;

· Polydispersity Index (PDI);

· particle morphology;

· specific surface area;

· crystallinity;

· zeta potential;

· colloidal stability;

· degree of agglomeration and aggregation;

· chemical composition;

· solubility and dissolution rate; and

· encapsulation efficiency, particularly for nanocarrier-based delivery systems such as nanocapsules and nanogels.

Common analytical techniques include Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), Dynamic Light Scattering (DLS), Nanoparticle Tracking Analysis (NTA), Atomic Force Microscopy (AFM), X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), and Single-Particle Inductively Coupled Plasma Mass Spectrometry (spICP-MS).

Standardization of characterization methods is essential to ensure that the resulting data are scientifically robust, reproducible, comparable across studies, and acceptable to international regulatory authorities. Particular attention should also be given to distinguishing primary particle size from hydrodynamic particle size, because nanoparticles may undergo aggregation or agglomeration when dispersed in complex biological or feed matrices.

4.1.3. Stability During Storage

Nanoparticles possess high specific surface energy and are therefore inherently prone to agglomeration and aggregation during storage. These processes may result in increased effective particle size, reduced specific surface area, changes in surface charge, altered dissolution behavior, and, ultimately, reduced bioavailability.

The stability of nanopremix can be influenced by several factors, including:

· storage temperature;

· relative humidity;

· light exposure;

· oxygen exposure;

· pH;

· the presence of metal ions;

· the type of carrier material; and

· overall premix composition.

The use of stabilizing agents such as polysaccharides, proteins, phospholipids, or biocompatible polymers may improve nanoparticle stability during storage. However, the selection of a stabilizer should also consider its effects on particle–particle interactions, dissolution behavior, gastrointestinal transformation, nutrient release, and biological safety.

In parallel, microencapsulation and nanoencapsulation technologies are increasingly being investigated to protect vitamins, minerals, probiotics, enzymes, and phytobiotics against degradation during storage, transportation, and feed-processing operations. Encapsulation can also provide additional control over nutrient release and improve the physical compatibility of nanopremix with complex feed matrices.

Therefore, stability testing should not be limited to monitoring the appearance or total nutrient concentration of the product. A comprehensive stability program should evaluate changes in particle size distribution, PDI, zeta potential, morphology, aggregation state, dissolution behavior, chemical stability, and biological activity throughout the intended shelf life. Such information is critical for establishing appropriate storage conditions and ensuring that the physicochemical and biological properties of nanopremix remain within predefined specifications until the point of use.

4.1.4. Challenges in Feed Formulation

The integration of nanopremix into animal feed formulations requires particular attention because nanoparticles may interact with various dietary components, including proteins, fibers, lipids, vitamins, and other minerals. Such interactions may affect nanoparticle stability, nutrient release, bioavailability, ingredient compatibility, and mixing homogeneity.

For example, certain metal-based nanoparticles may interact with phytate, tannins, or dietary fiber, thereby reducing mineral solubility and absorption efficiency. Conversely, nanolipid- and nanogel-based delivery systems may enhance the stability and protect the bioactivity of oxidation-sensitive vitamins, particularly vitamins A, D, E, and K. Therefore, nanopremix formulation requires a more sophisticated formulation strategy than conventional premixes, with careful consideration of nanoparticle–nutrient interactions, physicochemical stability, gastrointestinal behavior, and nutrient bioavailability.

4.1.5. Long-Term Safety Evaluation

Most studies on nanopremix have focused primarily on production performance over relatively short feeding periods. In contrast, data regarding the long-term consequences of nanopremix administration across multiple generations of livestock remain limited.

Several aspects require further investigation, including:

· long-term retention or accumulation of nanoparticles in target organs;

· persistent alterations in gut microbiota composition and function;

· effects on adaptive immune responses;

· potential bioaccumulation;

· interactions with veterinary medicinal products;

· reproductive and developmental effects;

· potential epigenetic effects; and

· the potential development of microbial adaptation or resistance to certain nanoparticle-based antimicrobial agents.

Long-term and multigenerational studies are therefore essential to determine whether repeated exposure to nanopremix may produce cumulative or delayed effects that are not detectable during conventional short-term feeding trials. Such studies are particularly important for ensuring animal health, reproductive safety, consumer protection, and the overall sustainability of nanopremix use in livestock production.

4.1.6. Economic Analysis of Nanopremix Production

The current production costs of nanoparticles remain relatively high compared with those of conventional mineral and vitamin premixes. Major cost components include:

· nanoparticle raw materials;

· synthesis technology;

· energy consumption;

· purification processes;

· physicochemical characterization and laboratory testing;

· packaging; and

· quality control and quality assurance.

Nevertheless, the enhanced bioavailability associated with some nano-formulations may allow substantially lower supplementation levels than those required for conventional mineral sources. In several experimental studies, nano-zinc, nano-selenium, and nano-copper have produced comparable or superior biological responses at supplementation levels representing approximately 25–70% of conventional mineral doses. However, these dose reductions should be interpreted on a formulation- and species-specific basis and should not be generalized without supporting evidence.

If improved feed efficiency and reduced mineral excretion can be achieved, the resulting economic benefits may offset the higher manufacturing costs of nanopremix. Accordingly, a comprehensive cost–benefit analysis should consider not only the purchase price of the product but also improvements in animal productivity, nutrient-use efficiency, reductions in veterinary and health-related costs, potential reductions in feed costs, and environmental benefits associated with lower nutrient and mineral losses.

4.1.7. Consumer Acceptance and Public Perception

In addition to technical and economic challenges, the successful commercialization of nanopremix will depend partly on public acceptance of animal-derived foods produced using nanotechnology. In some markets, the term “nano” may still be associated with perceptions of potential health or environmental risks, despite the expanding use of nanotechnology in healthcare, food technology, agriculture, and environmental applications.

Transparent communication, evidence-based risk communication, and proportionate labeling and traceability mechanisms will therefore be important for building consumer confidence. Communication strategies should clearly distinguish between scientifically demonstrated hazards and perceived risks while providing accessible information regarding the intended use, safety assessment, exposure levels, and regulatory status of nanopremix.

The One Health framework is also increasingly relevant because it emphasizes that technological innovation in livestock production should provide benefits not only in terms of productivity and economic efficiency but also for human health, animal health, food safety, and environmental sustainability.

4.2. Future Opportunities for Nanopremix Development

Rapid advances in nanotechnology, biotechnology, materials science, artificial intelligence (AI), and digital technologies are creating new opportunities for the development of next-generation animal feed premixes. Whereas early applications of nanopremix primarily focused on improving the bioavailability of minerals and vitamins, future generations are expected to evolve toward smart nutritional platforms capable of responding dynamically to the physiological and environmental conditions of livestock.

Such systems could potentially optimize nutrient delivery according to physiological requirements, improve production efficiency, enhance resilience to disease and environmental stressors, and simultaneously support more sustainable livestock production systems. In this context, nanopremix should increasingly be regarded not merely as a conventional feed additive, but as a potentially strategic component of precision livestock farming (PLF) and precision nutrition.

This transformation is being driven by the growing global demand for safe, high-quality, nutritious, and environmentally sustainable animal-derived foods produced through resource-efficient production systems. International organizations, including the Food and Agriculture Organization of the United Nations (FAO), the Organisation for Economic Co-operation and Development (OECD), and the World Organisation for Animal Health (WOAH), have emphasized the importance of technological and nutritional innovations capable of improving livestock productivity while minimizing environmental burdens.

Within this broader context, nanopremix has considerable potential to become one of the enabling technologies for future livestock production. Its development may ultimately converge with precision nutrition, controlled-release delivery systems, functional feed ingredients, digital monitoring, artificial intelligence, and real-time decision-support systems. Such integration could facilitate more accurate nutrient delivery, reduce nutrient losses, improve animal health and welfare, and contribute to the development of more resilient and sustainable livestock production systems.

4.2.1. Integration with Precision Nutrition

One of the most promising directions for future development is the integration of nanopremix with the concept of precision nutrition, defined as the delivery of nutrients in accordance with the specific physiological requirements of individual animals or animal groups based on age, production stage, health status, genetic characteristics, and environmental conditions.

Conventional premixes are generally formulated according to the average nutritional requirements of a population. Consequently, individual animals may experience either over-supplementation or under-supplementation of specific nutrients. In contrast, nanopremix may facilitate more precise nutrient delivery because of its potentially enhanced bioavailability and its ability to incorporate controlled-release mechanisms.

In the future, nanopremix formulations may be dynamically adjusted based on data obtained from biosensors and digital animal-monitoring systems. For example, changes in feed intake, body temperature, physical activity, or metabolic biomarkers could be used to inform real-time adjustments in nanopremix composition or dosage. Such an approach could improve nutrient-use efficiency, reduce feed and nutrient losses, and optimize animal production performance while minimizing unnecessary supplementation.

4.2.2. Nanopremix as a Smart Delivery System

Advances in materials science are enabling nanopremix to evolve into a smart delivery system capable not only of transporting nutrients but also of controlling the timing, site, and rate of active-ingredient release.

Emerging delivery platforms include:

· nanoliposomes;

· nanoemulsions;

· nanogels;

· polymeric nanoparticles;

· protein-based nanoparticles;

· solid lipid nanoparticles (SLNs);

· nanostructured lipid carriers (NLCs); and

· polysaccharide-based nanoparticles, including those derived from alginate, chitosan, pectin, and cellulose.

Through surface engineering, nanopremix systems can potentially be designed to remain stable under acidic gastric conditions while selectively releasing their payloads in the small intestine, cecum, or even the colon. Such site-specific delivery may improve nutrient absorption while protecting sensitive bioactive compounds from degradation caused by pH, temperature, oxidation, or gastrointestinal enzymes.

In the longer term, delivery systems capable of responding to changes in pH, enzymatic activity, temperature, or specific inflammatory biomarkers may represent an important direction in next-generation nanotechnology-enabled feed formulations. However, their practical implementation will require rigorous validation of release kinetics, biological efficacy, safety, manufacturing reproducibility, and regulatory acceptability.

4.2.3. Integration with Artificial Intelligence (AI) and Big Data

The development of Industry 4.0 technologies has accelerated the application of artificial intelligence (AI) in livestock production. Integrating nanopremix with AI offers opportunities to optimize feed formulation through the analysis of large and heterogeneous datasets (big data).

Potential data streams include:

· feed intake;

· body-weight gain;

· egg or milk production;

· feed conversion ratio (FCR);

· hematological parameters;

· metabolic profiles;

· gut microbiota composition;

· genomic data; and

· environmental conditions within housing facilities.

Using machine-learning algorithms, AI systems may identify complex relationships between nutrient requirements and biological responses, thereby supporting more adaptive nanopremix formulation. AI could also accelerate research and development by predicting potentially effective combinations of active ingredients, particle sizes, surface characteristics, or delivery systems before experimental validation.

In addition, integration of AI with mechanistic models, multi-omics datasets, and longitudinal animal-performance data could facilitate the development of predictive frameworks for nanopremix efficacy and safety. Such approaches may ultimately reduce the number of empirical formulation iterations required during product development and improve the efficiency of preclinical and feeding trials.

4.2.4. Integration with the Internet of Things (IoT)

The deployment of digital sensors in modern livestock production enables continuous monitoring of animal performance, behavior, and physiological status. Integrating nanopremix with the Internet of Things (IoT) could facilitate the development of adaptive nutritional systems capable of responding to changing on-farm conditions.

Potential sensor technologies include:

· feed-intake sensors;

· drinking-water intake sensors;

· body-temperature sensors;

· activity and behavior sensors;

· rumen sensors;

· computer-vision systems; and

· metabolic biosensors.

Data generated by these systems could be integrated into digital decision-support platforms to adjust nanopremix formulation or dosage according to the actual nutritional and physiological requirements of animals. Consequently, nutritional management could shift from a predominantly static, population-based approach toward a more dynamic and individualized system.

The combination of IoT-enabled monitoring, AI-based analytics, and nanoparticle-enabled nutrient delivery could therefore provide the technological foundation for closed-loop precision nutrition, in which animal data are continuously collected, analyzed, and translated into nutritional interventions.

4.2.5. Development of Multifunctional Nanopremix

Another promising research direction is the development of multifunctional nanopremix, in which multiple bioactive components are incorporated into a single delivery platform.

In addition to vitamins and minerals, future nanopremix formulations may incorporate combinations of:

· probiotics;

· prebiotics;

· synbiotics;

· phytobiotics;

· enzymes;

· organic acids;

· bioactive peptides;

· antioxidants;

· immunomodulators; and

· beneficial microbial metabolites (postbiotics).

A multifunctional approach could potentially generate synergistic effects by simultaneously targeting several physiological pathways. These may include improvement of gastrointestinal health, enhancement of intestinal barrier function, modulation of the gut microbiota, strengthening of immune competence, optimization of metabolic efficiency, and increased resilience to environmental stressors and infectious challenges.

Nevertheless, combining multiple active components within a single nanoscale delivery system also introduces additional challenges related to formulation compatibility, stability, dose optimization, pharmacokinetic interactions, toxicological evaluation, and regulatory classification. Therefore, multifunctionality should be developed on the basis of demonstrated biological complementarity rather than simply increasing the number of active ingredients.

4.2.6. Development of Green Nanotechnology

Growing awareness of environmental sustainability has stimulated the development of green nanotechnology, which seeks to produce nanomaterials using environmentally benign, renewable, and sustainable resources and processes.

Potential biological resources increasingly investigated for nanoparticle synthesis include:

· plant extracts;

· naturally derived polysaccharides;

· plant-based proteins;

· microalgae;

· agricultural residues;

· agro-industrial by-products; and

· microbial biomass.

Biological or green synthesis may offer several advantages over conventional chemical synthesis, including the use of relatively safer solvents and reducing agents, potentially lower energy requirements, reduced generation of hazardous by-products, and improved biocompatibility of the resulting nanomaterials. However, these potential advantages should be demonstrated through systematic life-cycle and comparative environmental assessments rather than assumed solely on the basis of a biological synthesis route.

Within a circular economy framework, the utilization of agricultural residues and agro-industrial by-products as raw materials for nanopremix production could create additional value from biomass while reducing waste generation and environmental burdens. Such approaches may also contribute to the development of locally sourced nanomaterials and more sustainable feed-additive supply chains.

Ultimately, the integration of green nanotechnology with precision nutrition and sustainable livestock production could enable the development of nanopremix systems that simultaneously improve nutrient-use efficiency, reduce resource consumption, minimize environmental losses, and enhance the overall sustainability of animal production.

4.2.7. Integration with One Health and Sustainable Livestock Production

The One Health concept is increasingly becoming a fundamental framework for the development of modern livestock technologies. Nanopremix has the potential to support this approach by simultaneously contributing to animal health, food safety, and environmental protection.

Enhanced nutrient bioavailability may allow lower supplementation levels for certain minerals, thereby potentially reducing mineral excretion into the environment. Improved feed and nutrient-use efficiency may also contribute to reduced consumption of natural resources, lower greenhouse gas emissions, and decreased contamination of soil and aquatic ecosystems.

Furthermore, the integration of nanopremix with phytobiotics, probiotics, or immunomodulatory compounds may contribute to reducing reliance on antibiotics as antibiotic growth promoters (AGPs). Such an approach could support global efforts to mitigate antimicrobial resistance (AMR). However, the potential of nanopremix to reduce antibiotic use should be evaluated through controlled studies and should not be interpreted as evidence that nanopremix can replace therapeutic antibiotics for the treatment of bacterial diseases.

4.2.8. Integration with Nutrigenomics and Nutrigenetics

Advances in genomic science have led to the emergence of nutrigenomics and nutrigenetics, disciplines that investigate interactions between nutrients, gene expression, and genetic variation among individuals or populations.

In the future, nanopremix formulations may become increasingly tailored to the genetic characteristics of specific breeds, strains, or livestock populations rather than being formulated uniformly for an entire production group. Selected nutrients delivered through nanoscale systems could potentially be designed to modulate biological pathways associated with growth, energy metabolism, immune responses, reproduction, and adaptation to environmental stressors such as heat stress.

The integration of nanopremix with genomic information and AI could contribute to the development of precision nano-nutrition, defined as a highly targeted nutritional approach in which nutrient delivery is optimized according to the biological characteristics, physiological requirements, and production conditions of individual animals or defined animal populations.

Nevertheless, the development of precision nano-nutrition will require robust validation of genotype–nutrient interactions, reproducible biomarkers, and reliable predictive models before individualized nutritional recommendations can be translated into commercial livestock production.

4.2.9. Future Research Directions

Although nanopremix technology is advancing rapidly, substantial scientific knowledge gaps remain before its widespread application in the livestock industry can be achieved. Key research priorities include:

1. development of simple, cost-effective, reproducible, and scalable nanopremix synthesis technologies suitable for industrial manufacturing;

2. standardization of physicochemical characterization methods, together with validated approaches for assessing bioavailability, biological efficacy, and safety;

3. long-term, chronic, and multigenerational toxicological studies, including assessment of potential ecological effects;

4. development of nutrient-delivery systems responsive to pH, enzymatic activity, temperature, or physiological biomarkers;

5. exploration of nanopremix platforms based on natural materials and biomass-derived resources to support green nanotechnology;

6. integration of nanopremix with AI, IoT, biosensors, and digital technologies within precision livestock farming systems;

7. application of multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, and microbiomics, to elucidate the mechanisms of action of nanopremix comprehensively; and

8. development of internationally harmonized standards for the evaluation of nanopremix safety, quality, efficacy, and environmental performance as a basis for global regulatory convergence.

Overall, the development of nanopremix indicates substantial potential for this technology to become an important innovation in livestock nutrition during the twenty-first century. Supported by advances in materials science, biotechnology, digital technologies, and science-based regulatory frameworks, nanopremix may contribute to more efficient and sustainable livestock production systems, greater resilience to health and environmental challenges, and the provision of safe and nutritious animal-derived foods for a growing global population. The following chapter synthesizes the principal findings discussed throughout this review and considers their implications for future research, industrial development, and policy.

CHAPTER 5. CONCLUSIONS AND FUTURE PERSPECTIVES

 

5.1. Conclusions

Nanotechnology has emerged as one of the most promising innovations in animal nutrition, particularly through the development of nanopremix as a potential next generation of feed additives. Unlike conventional premixes, nanopremix utilizes nanoscale materials characterized by high specific surface area, distinctive physicochemical properties, and potentially enhanced delivery capabilities. These characteristics may improve the bioavailability and biological utilization of essential nutrients, including minerals, vitamins, amino acids, phytobiotics, probiotics, and other bioactive compounds.

Studies conducted in poultry, pigs, ruminants, and aquaculture species have reported that appropriately formulated nanopremix can improve growth performance, feed efficiency, antioxidant capacity, immune responses, gastrointestinal health, and, under certain conditions, reproductive performance and product quality. Nano-zinc, nano-selenium, nano-copper, nano-iron, nano-enabled vitamin systems, and phytobiotic-based nanomaterials are among the nanopremix components that have demonstrated enhanced biological activity relative to some conventional forms in specific experimental settings. Nevertheless, the magnitude and consistency of these effects remain dependent on nanoparticle composition, particle size, surface characteristics, dose, formulation, animal species, physiological status, and experimental conditions.

A major potential advantage of nanopremix is its capacity to enhance nutrient delivery through improved dissolution, absorption, protection of active compounds from gastrointestinal degradation, and, in appropriately engineered systems, controlled release at specific sites within the gastrointestinal tract. These characteristics may allow more efficient nutrient utilization and potentially reduce the amount of supplementation required to achieve a desired biological response. Consequently, nanopremix could contribute simultaneously to economic efficiency and reductions in mineral and nutrient losses into the environment. However, such benefits must be demonstrated on a formulation-specific basis through rigorous comparative studies rather than assumed solely from nanoscale particle size.

Beyond production performance, nanopremix may have strategic applications in animal health through mechanisms involving maintenance of intestinal barrier integrity, modulation of the gut microbiota, enhancement of innate and adaptive immune responses, and regulation of oxidative stress and inflammatory processes. Integration with phytobiotics, probiotics, prebiotics, synbiotics, enzymes, and immunomodulatory compounds further creates opportunities for multifunctional nutritional systems that address productivity, health, resilience, and animal welfare simultaneously.

From a food-safety perspective, available evidence suggests that several nano-mineral formulations administered at nutritionally appropriate levels can have acceptable safety profiles under specific experimental conditions. Nevertheless, the distinctive physicochemical characteristics of nanomaterials require a more comprehensive safety framework than that applied to conventional premixes. Such assessment should encompass physicochemical characterization, gastrointestinal transformation, absorption, biodistribution, toxicokinetics, tissue residues, effects on gut microbiota, immune responses, reproductive and developmental outcomes, and potential environmental impacts. Accordingly, science-based risk assessment should remain a fundamental prerequisite for the wider adoption of nanopremix in livestock production.

The evolving international regulatory landscape further indicates increasing attention to the safety assessment of nanomaterials in food and feed. Organizations and regulatory authorities, including the European Food Safety Authority (EFSA), Organisation for Economic Co-operation and Development (OECD), U.S. Food and Drug Administration (FDA), Codex Alimentarius, Food and Agriculture Organization of the United Nations (FAO), and World Health Organization (WHO), provide frameworks and scientific principles relevant to the assessment and governance of nanomaterials. Case-by-case assessment, harmonized physicochemical characterization, validated analytical methods for residue and speciation analysis, exposure assessment, and post-market surveillance are likely to remain important components of future nanopremix governance.

Despite its considerable potential, the implementation of nanopremix faces important scientific, technological, economic, and regulatory challenges. Industrial-scale production requires manufacturing processes capable of consistently controlling particle size, morphology, surface properties, composition, and stability. Additional priorities include standardization of characterization methods, long-term and multigenerational toxicological evaluation, ecological risk assessment, cost–benefit analysis, quality assurance, and international regulatory harmonization. Public acceptance also represents an important consideration and will require transparent, evidence-based risk communication and appropriate traceability throughout the feed and food supply chains.

Overall, the available scientific evidence indicates that nanopremix represents a promising technological platform for the transformation of modern animal nutrition. Its potential to enhance nutrient bioavailability and utilization, improve production efficiency, support animal health, and reduce nutrient losses could contribute to more sustainable livestock production. However, the transition from experimental research to widespread commercial application requires rigorous validation of efficacy and safety, standardized characterization, scalable manufacturing, robust regulatory oversight, and long-term monitoring.

The future of nanopremix is therefore likely to depend not simply on the ability to produce smaller particles, but on the development of safe, predictable, scalable, and biologically rational nanoscale nutritional systems. Integration with precision nutrition, controlled-release technologies, AI, IoT, multi-omics, green nanotechnology, and the One Health framework may ultimately transform nanopremix from a conventional feed-additive concept into an advanced nutritional platform for sustainable and precision livestock production.

5.2. Future Prospects

The future development of nanopremix over the next one to two decades is expected to be increasingly shaped by the convergence of nanotechnology, biotechnology, materials science, digital technologies, and artificial intelligence (AI). This convergence will transform nanopremix from a conventional nutritional supplement into a smart nutritional delivery platform capable of dynamically responding to the physiological conditions of livestock.

One of the most promising directions is the integration of nanopremix with precision livestock farming (PLF) systems. Through the use of digital sensors, the Internet of Things (IoT), metabolic biosensors, and AI-driven analytics, the nutritional requirements of livestock can be monitored in real time. Information on feed intake, health status, activity patterns, body temperature, metabolic biomarkers, and environmental conditions within housing systems can be used to adjust the formulation and dosage of nanopremix at the individual or group level. This approach is expected to improve nutrient-use efficiency while minimizing feed wastage and unnecessary nutrient supplementation.

In the field of materials science, research is expected to increasingly focus on the development of stimuli-responsive nanoparticles, which are capable of releasing their active cargo in response to changes in pH, enzymatic activity, temperature, osmotic conditions, or inflammatory biomarkers. Such delivery systems may improve the precision of site-specific nutrient release, thereby enhancing the biological efficacy of nutrients while allowing lower supplementation levels. The development of responsive delivery systems may be particularly relevant for protecting labile nutrients from degradation during gastrointestinal transit and ensuring their release at the intended intestinal site.

The development of green nanotechnology is also expected to become a major research priority. The synthesis of nanoparticles using plant extracts, natural polysaccharides, proteins, microalgae, microorganisms, and agricultural residues may facilitate the development of nanopremix formulations that are potentially safer, more environmentally compatible, and economically viable. This approach is consistent with the principles of the circular economy, which emphasize the conversion of biomass and agro-industrial residues into value-added products while reducing waste generation and environmental burdens.

Advances in multi-omics technologies, including genomics, transcriptomics, proteomics, metabolomics, and microbiomics, are expected to provide deeper insights into the molecular mechanisms through which nanopremix influences metabolism, gene expression, immune responses, and host–microbiota interactions. The integration of omics datasets with AI and machine learning may accelerate the discovery and optimization of novel nanopremix formulations with greater efficacy and specificity for different livestock species, production stages, and environmental conditions.

Another potentially transformative direction is the development of precision nano-nutrition, which may represent a new paradigm in livestock nutrition. Under this approach, nanopremix formulations would no longer be designed as universal products but would instead be tailored according to genetic characteristics, physiological status, production stage, and environmental conditions of specific animal populations. Such a strategy could facilitate a more individualized form of personalized nutrition, enabling more precise optimization of biological performance while reducing unnecessary nutrient inputs.

An additional important prospect is the increasing role of nanopremix in global strategies to reduce the use of antibiotics as antibiotic growth promoters (AGPs). Combining nanopremix with phytobiotics, probiotics, synbiotics, postbiotics, antimicrobial peptides, and immunomodulators may facilitate the development of nutritional strategies that enhance the natural resilience of livestock against disease without increasing the risk of antimicrobial resistance (AMR). This direction is consistent with the global One Health agenda, which recognizes the interconnectedness of animal health, human health, and environmental health.

Nevertheless, the successful implementation of nanopremix in the future will depend substantially on the availability of harmonized regulatory frameworks, internationally validated analytical methods, and robust scientific evidence regarding long-term safety. Research on biodistribution, bioaccumulation, toxicokinetics, residues in foods of animal origin, ecological impacts, and the economic feasibility of large-scale production should therefore be continuously expanded. Such evidence will be essential to ensure that the adoption of nanopremix proceeds in a scientifically justified, responsible, and sustainable manner.

Strategically, nanopremix has the potential to become one of the key technologies supporting the development of livestock production systems that are more productive, efficient, adaptive, and sustainable. Through multidisciplinary collaboration among academia, industry, regulatory authorities, and international organizations, nanopremix could contribute not only to improved livestock productivity but also to global food security, reduced environmental impacts, enhanced animal welfare, and the achievement of the Sustainable Development Goals (SDGs). In particular, its potential contributions are relevant to goals associated with Zero Hunger (SDG 2), Good Health and Well-being (SDG 3), Responsible Consumption and Production (SDG 12), and Climate Action (SDG 13).

CONCLUDING REMARKS

As an emerging technological innovation, nanopremix offers substantial opportunities to transform livestock nutrition from conventional supplementation strategies toward precision nutrition systems enabled by nanotechnology. Although further research is required to address outstanding scientific, technological, economic, safety, and regulatory challenges, the accumulating body of evidence indicates that nanopremix has the potential to become an important component of modern livestock production.

The successful translation of nanopremix from experimental research to practical application will, however, require an evidence-based approach, rigorous application of the precautionary principle, standardized characterization and analytical methodologies, comprehensive long-term safety evaluation, and harmonization of international regulatory frameworks. Particular attention should be given to product-specific physicochemical characterization, toxicokinetics, biodistribution, tissue residues, interactions with the gut microbiota and immune system, environmental fate, and lifecycle sustainability.

With these safeguards in place, nanotechnology-enabled nutritional systems could play an increasingly important role in developing livestock production systems that are safe, efficient, economically competitive, resilient, and environmentally sustainable. Ultimately, the responsible development of nanopremix may contribute to a more resource-efficient animal production sector capable of meeting the growing global demand for safe and nutritious foods of animal origin while minimizing environmental pressures and supporting the broader goals of sustainable development.

 

REFRENCES

 

Acosta, E. (2009). Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Current Opinion in Colloid & Interface Science, 14(1), 3–15. https://doi.org/10.1016/j.cocis.2008.01.002

 

Allen, A., & Flemström, G. (2005). Gastroduodenal mucus bicarbonate barrier: Protection against acid and pepsin. American Journal of Physiology-Gastrointestinal and Liver Physiology, 288(1), G1–G19. https://doi.org/10.1152/ajpgi.00173.2004

 

Andersson, M., de Benoist, B., Rogers, L., & Darnton-Hill, I. (2010). Guidelines on food fortification with micronutrients. World Health Organization & Food and Agriculture Organization of the United Nations.

 

Aviagen. (2022). Ross 308 Broiler: Nutrition Specifications. Aviagen Ltd.

 

Benzie, I. F. F., & Wachtel-Galor, S. (Eds.). (2011). Herbal medicine: Biomolecular and clinical aspects (2nd ed.). CRC Press.

 

Berckmans, D. (2017). General introduction to precision livestock farming. Animal Frontiers, 7(1), 6–11. https://doi.org/10.2527/af.2017.0102

 

Bouwmeester, H., Dekkers, S., Noordam, M. Y., Hagens, W. I., Bulder, A. S., de Heer, C., ten Voorde, S. E. C. G., Wijnhoven, S. W. P., Marvin, H. J. P., & Sips, A. J. A. M. (2009). Review of health safety aspects of nanotechnologies in food production. Regulatory Toxicology and Pharmacology, 53(1), 52–62. https://doi.org/10.1016/j.yrtph.2008.10.008

 

Brandenberger, C., Mühlfeld, C., Ali, Z., Lenz, A.-G., Schmid, O., Parak, W. J., Gehr, P., & Rothen-Rutishauser, B. (2010). Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small, 6(15), 1669–1678.

 

Burt, S. (2004). Essential oils: Their antibacterial properties and potential applications in foods—A review. International Journal of Food Microbiology, 94(3), 223–253. https://doi.org/10.1016/j.ijfoodmicro.2004.03.022

 

CAB International. (2023). Animal feed resources information system. CAB International.

 

Cheatham, C. L., Goldman, B. D., Fischer, L. M., da Costa, K. A., & Zeisel, S. H. (2006). Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function. The Journal of Nutrition, 136(4), 1091–1098.

 

Chen, H., Weiss, J., & Shahidi, F. (2006). Nanotechnology in nutraceuticals and functional foods. Food Technology, 60(3), 30–36.

 

Chen, L., Remondetto, G. E., & Subirade, M. (2006). Food protein-based materials as nutraceutical delivery systems. Trends in Food Science & Technology, 17(5), 272–283. https://doi.org/10.1016/j.tifs.2005.12.011

 

Coelho, M. B. (2002). Vitamin stability in animal feeds. Feed International, 23(4), 15–20.

 

Codex Alimentarius Commission. (2003). Code of practice on good animal feeding (CAC/RCP 54-2004). Food and Agriculture Organization of the United Nations & World Health Organization.

 

Codex Alimentarius Commission. (2023). Procedural manual (29th ed.). Food and Agriculture Organization of the United Nations & World Health Organization.

 

Cromwell, G. L. (2009). ASAS centennial paper: Landmark discoveries in swine nutrition in the past century. Journal of Animal Science, 87(2), 778–792. https://doi.org/10.2527/jas.2008-1323

 

de Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. Journal of Controlled Release, 116(1), 1–27. https://doi.org/10.1016/j.jconrel.2006.08.013

 

Dubourg, G., Pavlović, Ž., Bajac, B., et al. (2024). Advancement of metal oxide nanomaterials on agri-food fronts: A review. Materials Today Sustainability.

 

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). (2023). Modification of the terms of authorisation of zinc-L-selenomethionine as a feed additive for all animal species. EFSA Journal, 21, e08459.

 

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). (2024). Consumer safety of feed additives containing selenium. EFSA Journal, 22, e08857.

 

EFSA (European Food Safety Authority). (2021). Guidance on the assessment of the efficacy of feed additives. EFSA Journal, 19(5), e06541.

 

EFSA Scientific Committee. (2021). Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: Human and animal health. EFSA Journal, 19(8), e06768. https://doi.org/10.2903/j.efsa.2021.6768

 

El Sabry, M. I., McMillin, K. W., & Ahmed, E. (2022). Applications of nanotechnology in poultry nutrition and health. Animals, 12(8), 1026. https://doi.org/10.3390/ani12081026

 

Elkhateeb, F. S. O., Ghazalah, A. A., Lohakare, J., et al. (2024). Selenium nanoparticle inclusion in broiler diets for enhancing sustainable production and health. Scientific Reports, 14, 18557.

 

Ensign, L. M., Cone, R., & Hanes, J. (2012). Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews, 64(6), 557–570. https://doi.org/10.1016/j.addr.2011.12.009

 

European Commission. (2022). EU feed additives register. Publications Office of the European Union.

Evci, Ş. (2024). Uses of nanotechnological feed additives and nanofeeds in poultry feeding. Journal of Poultry Research, 21(1), 27–33.

 

Fadeel, B., Farcal, L., Hardy, B., Vázquez-Campos, S., Hristozov, D., Marcomini, A., Lynch, I., & Valsami-Jones, E. (2018). Advanced tools for the safety assessment of nanomaterials. Nature Nanotechnology, 13(7), 537–543. https://doi.org/10.1038/s41565-018-0185-0

 

 

Fahrenholz, A. C. (2012). Particle size reduction, feed manufacturing, and mixing. Feedstuffs, 84, 12–18.

 

FAO. (2023). The State of Food and Agriculture 2023. Food and Agriculture Organization of the United Nations.

 

FAO. (2024). The State of Food and Agriculture 2024. Food and Agriculture Organization of the United Nations.

 

Florence, A. T. (2005). Nanoparticle uptake by the oral route: Fulfilling its potential? Drug Discovery Today: Technologies, 2(1), 75–81. https://doi.org/10.1016/j.ddtec.2005.05.006

 

Gadde, U., Kim, W. H., Oh, S. T., & Lillehoj, H. S. (2017). Alternatives to antibiotics for maximizing growth performance and feed efficiency in poultry: A review. Animal Health Research Reviews, 18(1), 26–45. https://doi.org/10.1017/S1466252316000207

 

Gelaye, Y. (2024). Application of nanotechnology in animal nutrition: Bibliographic review. Cogent Food & Agriculture, 10(1), 2290308.

 

Hashemipour, H., et al. (2024). Nano-phytogenic feed additives: Current advances and future opportunities in poultry nutrition. Poultry Science.

 

Hosseintabar-Ghasemabad, B., Kvan, O. V., Sheida, E. V., et al. (2024). Nano selenium in broiler feeding: Physiological roles and nutritional effects. World's Poultry Science Journal.

 

Hurrell, R., & Egli, I. (2010). Iron bioavailability and dietary reference values. The American Journal of Clinical Nutrition, 91(5), 1461S–1467S. https://doi.org/10.3945/ajcn.2010.28674F

 

International Organization for Standardization. (2019). ISO/TS 21633:2019—Nanotechnologies: Label-free impedance technology to assess the toxicity of nanomaterials in vitro. ISO.

 

International Organization for Standardization. (2020). ISO/TR 22293:2020—Nanotechnologies: Guidance on the characterization of engineered nanoscale materials for toxicologic assessment. ISO.

 

International Organization for Standardization. (2021). ISO 21363:2020—Nanotechnologies—Measurements of particle size and shape distributions by transmission electron microscopy. ISO.

 

Kelsall, R. W., Hamley, I. W., & Geoghegan, M. (2005). Nanoscale Science and Technology. John Wiley & Sons.

 

Khan, I., Saeed, K., & Khan, I. (2019). Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 12(7), 908–931. https://doi.org/10.1016/j.arabjc.2017.05.011

 

Leeson, S., & Summers, J. D. (2008). Commercial Poultry Nutrition (3rd ed.). Nottingham University Press.

 

Makkar, H. P. S., & Beever, D. E. (Eds.). (2013). Optimization of Feed Use Efficiency in Ruminant Production Systems. FAO Animal Production and Health Proceedings No. 16. Food and Agriculture Organization of the United Nations.

 

McClements, D. J. (2020). Nanotechnology Approaches for Improving Oral Bioavailability of Nutraceuticals. Woodhead Publishing.

 

McClements, D. J., & Xiao, H. (2017). Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles. NPJ Science of Food, 1, Article 6. https://doi.org/10.1038/s41538-017-0005-1

 

McClements, D. J., Decker, E. A., & Park, Y. (2009). Controlling lipid bioavailability through physicochemical and structural approaches. Critical Reviews in Food Science and Nutrition, 49(1), 48–67. https://doi.org/10.1080/10408390701764245

 

McDowell, L. R. (2000). Vitamins in Animal and Human Nutrition (2nd ed.). Iowa State University Press.

Meulbroek, M., & Jansman, A. J. M. (2019). Precision feeding in livestock: Current status and future challenges. Animal Frontiers, 9(2), 17–24.

 

Miller, D. D., & Welch, R. M. (2013). Food system strategies for preventing micronutrient malnutrition. Food Policy, 42, 115–128. https://doi.org/10.1016/j.foodpol.2013.06.008

 

Mohapatra, P., Swain, R. K., Mishra, S. K., et al. (2014). Effects of dietary nano-selenium supplementation on the performance of layer chickens. Asian Journal of Animal and Veterinary Advances, 9(10), 641–652.

 

Mottet, A., de Haan, C., Falcucci, A., Tempio, G., Opio, C., & Gerber, P. J. (2017). Livestock: On our plates or eating at our table? A new analysis of the feed/food debate. Global Food Security, 14, 1–8. https://doi.org/10.1016/j.gfs.2017.01.001

 

Nel, A., Xia, T., Mädler, L., & Li, N. (2006). Toxic potential of materials at the nanolevel. Science, 311(5761), 622–627. https://doi.org/10.1126/science.1114397

 

Nicholson, F. A., Smith, S. R., Alloway, B. J., Carlton-Smith, C., & Chambers, B. J. (2003). An inventory of heavy metals inputs to agricultural soils in England and Wales. Science of the Total Environment, 311(1–3), 205–219. https://doi.org/10.1016/S0048-9697(03)00139-6

 

Noyes, A. A., & Whitney, W. R. (1897). The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society, 19, 930–934.

 

National Research Council. (2012). Nutrient Requirements of Swine (11th rev. ed.). National Academies Press.

 

Organisation for Economic Co-operation and Development. (2012). Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials. OECD Publishing.

 

Organisation for Economic Co-operation and Development. (2022). Important Issues on Risk Assessment of Manufactured Nanomaterials. OECD Publishing.

 

Organisation for Economic Co-operation and Development. (2023). OECD Series on the Safety of Manufactured Nanomaterials. OECD Publishing.

 

Rai, M., Ingle, A. P., Gupta, I., et al. (2021). Smart nanoparticle-based delivery systems for agriculture and animal production. Applied Microbiology and Biotechnology, 105, 1559–1573.

 

Rajendran, D. (2013). Application of nano minerals in animal production system. Research Journal of Biotechnology, 8(3), 1–3.

 

Selle, P. H., & Ravindran, V. (2007). Microbial phytase in poultry nutrition. Animal Feed Science and Technology, 135(1–2), 1–41. https://doi.org/10.1016/j.anifeedsci.2006.06.010

 

Singh, J., Dutta, T., Kim, K.-H., Rawat, M., Samddar, P., & Kumar, P. (2018). 'Green' synthesis of metals and their oxide nanoparticles: Applications for environmental remediation. Journal of Nanobiotechnology, 16, Article 84. https://doi.org/10.1186/s12951-018-0408-4

 

Sogias, I. A., Williams, A. C., & Khutoryanskiy, V. V. (2008). Why is chitosan mucoadhesive? Biomacromolecules, 9(7), 1837–1842. https://doi.org/10.1021/bm800276d

 

Surai, P. F., & Fisinin, V. I. (2014). Selenium in poultry breeder nutrition: An update. Animal Feed Science and Technology, 191, 1–15. https://doi.org/10.1016/j.anifeedsci.2014.02.005

 

Suttle, N. F. (2010). Mineral Nutrition of Livestock (4th ed.). CAB International.

 

Swain, P. S., Rao, S. B. N., Rajendran, D., Dominic, G., & Selvaraju, S. (2015). Nano zinc, an alternative to conventional zinc as animal feed supplement: A review. Animal Nutrition, 1(3), 134–141. https://doi.org/10.1016/j.aninu.2015.06.003

 

Underwood, E. J., & Suttle, N. F. (1999). The Mineral Nutrition of Livestock (3rd ed.). CAB International.

 

Windisch, W., Schedle, K., Plitzner, C., & Kroismayr, A. (2008). Use of phytogenic products as feed additives for swine and poultry. Journal of Animal Science, 86(Suppl. 14), E140–E148. https://doi.org/10.2527/jas.2007-0459

 

World Health Organization. (2023). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2023. World Health Organization.

 

World Health Organization. (2023). One Health Joint Plan of Action (2022–2026): Implementation Guide. World Health Organization.

 

World Organisation for Animal Health. (2023). Annual Report on Antimicrobial Agents Intended for Use in Animals. WOAH.

 

World Organisation for Animal Health. (2023). Terrestrial Animal Health Code (2023 ed.). WOAH.

 

Younas, Z., Mashwani, Z. U. R., Ahmad, I., Khan, M., Zaman, S., Sawati, L., & Sohail. (2023). Mechanistic approaches to the application of nano-zinc in the poultry and biomedical industries: A comprehensive review of future perspectives and challenges. Molecules, 28(3), Article 1064. https://doi.org/10.3390/molecules28031064

 

Zhang, J. S., Wang, X. F., Xu, T. W., et al. (2008). Biological effects of selenium nanoparticles in animal nutrition. Journal of Nanoscience and Nanotechnology, 8, 1–8.

 

Zhu, Y., Romain, C., & Williams, C. K. (2016). Sustainable polymers from renewable resources. Nature, 540(7633), 354–362. https://doi.org/10.1038/nature21001

 

#Nanopremix

#Nanotechnology

#AnimalNutrition

#FeedEfficiency

#LivestockInnovation